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SUMMARY
High, titre monospecific polyclonal antisera have been raised 
against purified mitochondrial 2-oxoglutarate dehydrogenase complex 
(OGDC) and its component enzymes, 2-oxoglutarate dehydrogenase (El), 
lipoyl succinyltransferase (E2) and lipoamide dehydrogenase (E3).
These specific antisera have been employed to monitor molecular events 
in the biosynthesis, import and maturation of this multimeric 
assembly. In antiserum raised against native, intact 2-oxoglutarate 
dehydrogenase complex, lipoamide dehydrogenase elicits a poor antibody 
response in comparison to the other polypeptides of the complex. It is 
thought this may reflect the conserved nature of lipoamide 
dehydrogenase which is involved in highly differing subunit 
interactions with the distinctive lipoyl acyltransferase (E2) 'core' 
enzymes of each of the individual 2-oxo acid dehydrogenase complexes.
In cultured porcine kidney (PK-15) and bovine kidney (NBL-1)
35cells, incubated with [ S]methionine in the presence of uncouplers of 
oxidative phosphorylation, appearance of higher M^ forms of the 
individual enzymes can be detected by specific immune precipitation 
and fluorographic analysis. In the cases of 2-oxoglutarate 
dehydrogenase, El, and lipoamide dehydrogenase, E3, the initial 
translation products have subunit M values 1000-3000 greater than the 
mature enzyme while the precursor of lipoyl succinyltransferase, E2, 
contains an additional sequence of M 6000—6000. Competition studies 
have revealed the Immunological similarity of the precursor molecules 
to the native subunits. The precursor form of lipoyl
succinyltransferase (pre-E2) is located In the cytoplasm of the cell
XV
prior to its conversion to the mature form and import into 
mitochondria. These precursor molecules are relatively stable, 
remaining in the cell for several hours if the cells are maintained in 
the presence of uncouplers. On removal of uncouplers, processing is 
rapidly initiated and is complete within 40 min. Interestingly 
antiserum to native 2-oxoglutarate dehydrogenase complex fails to 
recognise E2 precursor molecules which can be immunopreclpitated, 
however, by antibodies raised against the denatured E2 subunit. It is 
concluded that pre-E2 is conformationally dissimilar to native E2 
which exists normally as a highly-ordered, multimolecular aggregate in 
the native complex.
CHAPTER ONE
INTRODUCTION
1.1 PROTEIN SORTING
Eukaryotic cells exhibit a high degree of organisational 
complexity. Intracellular membranes divide the cells, physically and 
biochemically, into several discrete compartments, each of which 
performs a different specialised function. This function is reflected 
in the unique protein composition of each organelle. Most cellular 
polypeptides are located exclusively in one particular compartment.
Since the vast majority of protein synthesis occurs in the 
cytoplasm, biogenesis of protein is therefore often associated with 
passage of newly-synthesised proteins through biological membranes. 
This is seen in the case of integral membrane proteins, secreted 
proteins and proteins bound for the Intracellular organelles.
In the cell there is a requirement for these newly-synthesised 
proteins to be sorted from each other and routed for export, or 
targetted to the correct intracellular membrane or compartment. One 
of the simplest hypotheses proposed to explain this predicts that each 
protein contains a specific sequence or structure which is recognised 
by a complementary structure on the membrane to which it is targetted. 
The repertoire of these distinct "topogenic sequences", constituting a 
permanent or transient part of the polypeptide chain, is predicted to 
be relatively small as many different proteins will be bound for the 
same intracellular site (Blobel, 1980).
Intracellular membranes must have the ability not only to 
recognise proteins specifically destined for the compartment which 
they delineate, but also the capacity to translocate these proteins 
across the lipid bilayer, a remarkable feat when the size and 
hydrophilic nature of many of these proteins is taken into account.
The precise nature of the information required and events 
involved in directing proteins to a particular location have been 
subject to intense study over the past fifteen years.
1.2 AN OVERVIEW OF MEMBRANE AND ORGANELLE ASSEMBLY
The mechanisms involved in unidirectional transport of proteins 
across membranes and their insertion into membranes may be divided 
into two classes of process, cotranslational and posttranslational 
(Sabatini et , 1982). In the case of proteins traversing the 
membrane of the endoplasmic reticulum the mechanism generally employed 
is cotranslational, i.e. vectorial transport across the membrane is 
concomitant with protein synthesis. A contrasting scheme applies to 
proteins destined for the nucleus (De Robertis et al., 1978), 
peroxisomes (Goldman & Blobel, 1978), glyoxisomes (Zimmerman &
Neupert, 1980b), chloroplasts (Chua & Schimdt, 1978; Highfield & Ellis, 
1978) and mitochondria (Neupert & Schatz, 1981). This alternative 
mechanism is a posttranslational process in which translocation is 
independent of protein synthesis.
1.2.1 COTRANSLATIONAL TRANSPORT
Many proteins are translated on ribosomes tightly-associated with 
the endoplasmic reticulum. They are vectorially discharged through the 
membrane during the elongation phase of protein synthesis. Completed 
polypeptides belonging to this class of proteins are never seen on the 
cytosolic side of the membrane which binds the ribosomes. For many of 
these proteins transfer across the endoplasmic reticulum is the first 
step in a complicated process of transfer to locations such as the
FIGURE 1.1 General scheme for distribution 
of proteins in eukaryotes.
Initiation of 
Protein Synthesis
Membrane-bound
Polysomes
Free
Polysomes
y External Space 
Plasma Membrane 
Lysosomes
Nucleus 
Mitochondria 
^  Peroxisomes 
Chloroplasts 
Glyoxisomes
Primary 
* sorting'
Secondary 
'sorting’
lysosomes, golgi apparatus, plasma membrane or to secretory granules 
for eventual release from the cell (see Fig.1.1).
Blobel & Dobberstein, (1975) first proposed, in the 'signal 
hypothesis', a detailed mechanism describing how cotranslationally 
transported proteins could reach their correct initial location i.e. 
the endoplasmic reticulum. This hypothesis has been extensively 
modified since then and to date entails the following steps: 
Polypeptide synthesis is initiated on free ribosomes. A 'signal 
sequence' of 15-30 amino acids in length, located at the NH^-terminus 
of the nascent polypeptide chain (Milstein et al., 1972), protrudes 
from the ribosome once a polypeptide of approx. 60-70 amino acids in 
length has been synthesised. An oligomeric 'signal recognition 
particle* (SRP), containing 6 proteins, ranging in from 9000-72000 
(Walter & Blobel, 1980), and a 7S RNA molecule (Walter & Blobel,
1982), then binds to the freely accessible 'signal sequence* and 
arrests further elongation of the polypeptide chain (Walter et al., 
1981). Interaction of the SRP-polysome complex with the cytoplasmic 
domain of a 72000 'docking protein' (Meyer et , 1982a), located 
in the endoplasmic reticulum membrane releases the arrest of 
elongation (Meyer et al., 1982b), and translation coupled to 
translocation proceeds. Ribosome-membrane interactions may be further 
stabilised by binding of the large ribosomal subunit to other proteins 
of the endoplasmic reticulum, such as the ribophorins (Kreibich 
et al., 1978a,b). Cleavage of the 'signal peptide', at a specific 
amino-acyl bond, usually before the polypeptide chain is completed, is 
accomplished by a specific integral membrane endoproteinase, known as 
'signal peptidase', located at the luminal side of the endoplasmic
reticulum membrane (Jackson & Blobel, 1977).
This sequence of events ensures efficient, specific translocation 
of proteins across the endoplasmic reticulum and guards against an 
inappropriate accumulation of these proteins in the cytoplasm.
1.2.2 POSTTRANSLATIONAL TRANSPORT
In contrast to the above scheme posttranslationally imported 
proteins are synthesised on free polysomes. Completed polypeptide 
chains are released into the cytosol to form pools of free precursor 
which are rapidly depleted by uptake of proteins into the organelles. 
Precursor polypeptides are distinct from their mature counterparts 
either in size, charge or conformation. A common feature of precursor 
proteins is the presence of an NH^-terminal extension sequence. 
Specific receptor molecules,located on the outer surface of the 
organelles, are proposed to mediate direct interaction of precursors 
with their target membranes. Processing of the precursors to their 
mature form accompanies translocation across the membrane. Removal of 
the amino-terminal extension sequences of larger precursors is 
effected by a specific endoprotease. Conformational changes associated 
with the processing event are thought to result in the mature protein 
being trapped in the membrane or inside the organelle. Synthesis of 
the polypeptides and subsequent transport and processing are evidently 
separate events (Sabatini et al., 1982).
1.2.3 ASSEMBLY OF MITOCHONDRIA DEPENDS ON TWO GENETIC SYSTEMS
The posttranslational import mechanism described above applies to 
nuclei, peroxisomes, glyoxisomes, chloroplasts and mitochondria (see 
Fig.1.1). However the biogenesis of chloroplasts and mitochondria is 
further complicated in that it requires contributions from more than 
one genetic system: the nuclear system and a second system located in 
the organelle itself (Schatz & Mason ,1976). These genetic systems are 
physically separate and there is no transfer of mRNA between the two 
compartments. Molecules derived from both genomes have received so 
much attention in the past few years that each system now constitutes 
a separate area of research.
Mitochondrial DNA is generally circular and varies considerably 
in size between species from 1.6 x 10 bp in animal cells to 2.6 x 
lO^bp in some higher plants (de Vries & van't Sant, 1983). The nature 
of the genetic information encoded in mitochondrial DNA has gradually 
become apparent in the last fifteen years and is roughly the same in 
all cases studied. Complete sequence analysis of a number of 
mitochondrial DNAs has been performed, the human mitochondrial DNA 
sequence being first to be elucidated (Anderson et al., 1981). 
Transcription products of mitochondrial DNA include two rRNA species, 
all tRNAs required for mitochondrial protein synthesis, and mRNAs 
coding for a limited number of proteins. Proteins encoded by 
mitochondrial DNA are mainly hydrophobic subunits of the respiratory 
complexes of the inner mitochondrial membrane: cytochrome bc^» 
cytochrome c oxidase and the mitochondrial ATPase. In Saccharomyces 
cerevisiae (hereafter referred to as yeast) and Neurosgora crassa, an
additional ribosome-associated protein is encoded in the mitochondrial 
DNA (Terpstra & Butow, 1979; LaPolla & Lamboviitz, 1981). However in a 
study performed in a bovine kidney cell line, Schieber & O'Brien 
(1985) found that all mitochondrial ribosomal proteins were 
synthesised in the cytosol and encoded in nuclear DNA. Sequence 
analysis of human mitochondrial DNA revealed the presence of several 
unidentified reading frames (URF) potentially coding for protein, 
raising the number of possible translation products in the human 
system to thirteen. A recent report has suggested that six of these 
URFs code for proteins of the NADH dehydrogenase complex (Chomyn 
et al., 1985).
Considering the total number of mitochondrial proteins, 
approximately 95% are synthesised in the cytoplasm and imported into 
mitochondria posttranslationally.
1.2.4 MITOCHONDRIAL PROTEINS ARE FOUND IN ONE OF FOUR LOCATIONS
Mitochondria consist of two membranes which differ in chemical 
composition, permeability and enzyme content. These two membranes 
divide the mitochondria into two different compartments: the 
intermembrane space and the matrix. This means that mitochondrial 
proteins must be routed to one of four locations: the inner membrane, 
the outer membrane, the intermembrane space or the matrix. Each of 
these compartments is unique with respect to its protein composition.
In comparison to other cellular membranes an unusual permeability 
is displayed by the outer mitochondrial membrane. This is due to the 
large channels, formed by porin, the most abundant protein in the 
outer membrane, which render the membrane permeable to molecules of M
< 6000. Relatively few other proteins have been identified in this 
membrane.
The inner membrane has a high protein content, displays selective 
permeability and contains a number of carrier systems, allowing the 
passage of low M metabolites required by the enzymes of the matrix. 
Extensive Invagination of the inner membrane provides a large surface 
area for enzymes, and components of cellular respiration and oxidative 
phosphorylation.
Soluble enzymes of the inter-membrane space include adenylate 
kinase, sulphite oxidase (rat liver) and cytochrome b^ (yeast). The 
latter two interact with cytochrome c, also located in the inter- 
membrane space but bound loosely to the inner membrane, where it 
mediates electron transfer between the cytochrome bc^ and cytochrome c 
oxidase complexes.
The matrix of the mitochondrion contains a large number of 
soluble and hydrophilic enzymes, in particular those of the citric 
acid cycle. Replication and transcription of mitochondrial DNA and 
intra-mitochondrial protein synthesis also take place in this 
compartment.
Each membrane should present a barrier to the passage of most 
proteins. Therefore the transfer of several hundred mitochondrial 
proteins across these membranes to the various mitochondrial 
subcompartments is a complicated process. Experiments conducted in 
several laboratories over the past 5-6 years have led to a basic 
understanding of how mitochondria integrate the proteins synthesised 
in the cytosol.
FIGURE 1.2 Biogenesis of mitochondria
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2. R e c o g n i t i o n  an d  binding to mitochondria.
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Incorporation of cytoplasmlcally-synthesised proteins into 
mitochondria can be conceptually divided into 5 stages (see Fig.1.2):
1. synthesis of the precursor polypeptide
2. recognition and binding of the precursor to the mitochondrial 
surface
3. translocation of the precursor across one or two mitochondrial 
membranes
4. processing of the precursor to the mature protein
5. assembly of the subunits into functional holoenzymes.
1.3 SYNTHESIS AND POSTTRANSLATIONAL TRANSPORT OF 
MITOCHONDRIAL PROTEINS
The two experimental approaches which have been used to study 
synthesis of mitochondrial precursors and their translocation into the 
organelle have employed highly specific antiserum raised against the 
mature protein with the assumption that cross-reaction with the 
precursor will occur. In the majority of cases studied to date this 
assumption has proved valid.
Cell-free translation systems allow the analysis of precursors as
they are released from the ribosome. ^  vitro translation systems most
commonly used are reticulocyte lysates and wheat germ extracts, both
of which can be efficiently programmed with mRNA from any eukaryotic
source. Translation is performed in the cell-free system, programmed
with suitable mRNA, in the presence of l^^Sjmethionine or 
14( C)leucine. The radioactive products are then treated with 
detergents, usually Triton X-100 or SDS, and incubated with highly 
specific antiserum raised against the protein of interest. Since
mitochondrial proteins are present in the translation mixture in such 
small amounts (0.02-0.5%) Indirect immune precipitation is required, 
generally employing formalinised Staphylococcus aureus cells or 
protein A from Staphylococcus aureus coupled onto a solid support, 
such as Sepharose beads. Immune precipitated proteins are then resolved 
by SDS-polyacrylamide gel electrophoresis, visualised by fluorography 
and should be directly compared with radiolabelled, mature protein.
Translocation can be studied in this system by incubating 
Isolated intact mitochondria with precursor proteins synthesised 
in vitro. Mitochondria can then be removed by centrifugation, 
solubilised and subjected to immune precipitation as described above.
In order to establish that the precursor has been imported across the 
mitochondrial membrane(s) it must be shown that it has reached a 
protease-resistant location.
The second approach is based on experiments performed in vivo.
Cells are subjected to 'pulse' or 'pulse-chase* labelling with 
35 14[ S]methionine or [ C]leuclne. Detergent extracts of the cells are 
employed for immune precipitation, SDS-PAGE and fluorography as 
previously described. Difficulties inherent in this second approach 
include low incorporation of radio-labelled amino acid into protein 
during the pulse, and the short half-life of precursor proteins in the 
extra-mitochondrial pool. An alternative procedure involves radio­
labelling whole cells under conditions which prevent import of 
precursors into mitochondria, such as in the presence of uncouplers of 
oxidative phosphorylation (see section 1.5.1). The use of such a 
procedure is validated by the fact that the accumulated precursors can 
be chased into the mitochondria by reversing the effect of the 
uncouplers.
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This whole cell approach, despite its greater technical 
difficulty, offers the advantage of studying posttranslational 
import in vivo, thus ascertaining the validity of the 
results obtained in vitro as applied to the physiological situation.
The extreme sensitivity of these immunological techniques has 
been indispensable in the studies of biogenesis of mitochondria and 
other organelles.
1.3.1 MITOCHONDRIAL PROTEINS ARE SYNTHESISED AS LARGER 
PRECURSORS
In a report incorporating both of the approaches outlined 
above, Maccecchini et al. (1979a) revealed that the three largest, 
nuclear-encoded, subunits of the mitochondrial ATPase were initially 
synthesised as larger M^ precursors. These precursors were transferred 
in vitro into isolated mitochondria and cleaved to the corresponding 
mature forms in the absence of protein synthesis.
These results were similar to those already obtained in 
chloroplasts in a study involving the small subunit of ribulose-1,5- 
bisphosphate carboxylase (Chua & Schmidt, 1978; Highfield & Ellis, 
1978).
In recent years evidence has accumulated for the existence of 
larger M precursors to many mitochondrial proteins (see Table 1.1).
As can be seen from the table there are precursors to proteins of all 
mitochondrial compartments.
The difference in M between precursors and their mature
r li
counterparts varies between 500 and 10000, a difference generally 
greater than that observed in the case of secretory proteins.
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In a few cases this difference in size has been shown to be
directly due to an extra sequence of amino acids at the NH^-terminus
of the polypeptide. Comparison of the protein sequence of mature
subunit IX of the N. erassa mitochondrial ATPase, with that of the
precursor, deduced from the nucleotide sequence of the cloned gene,
reveals an NH^-terminal extension of 66 amino acids (Viebrock et al.,
1982). A presequence consisting of 68 amino acids has also been
predicted, from the gene sequence, for yeast cytochrome c peroxidase
(Kaput et al., 1982). Primary translation products of the yeast F^-
ATPase d ,^ , and t subunits, and subunits IV to VI of the cytochrome c
oxidase complex have been labelled specifically at the NH^-terminus 
35using N-formyl-( Sjmethionine (Lewin et al.,1980; Mihara & Blobel, 
1980). Since eukaryotic cells lack the methionine amino-peptidase 
required to remove this N-formyl-methionine, the fact that it is 
absent from the imported mature protein suggests the removal of a 
sequence from the NH^-terminus of the precursor.
Specific labelling of the cytochrome c oxidase subunits with this 
reagent also refutes earlier claims that subunits IV - VII are 
synthesised as a polyprotein (Poyton & McKemmie, 1979).
There appears to be no correlation between the size of these 
extension sequences and the location of proteins in the mitochondrion, 
neither do precursors to subunits of the same multi-protein complex 
have a standard number of additional amino acids (Teintze e^ al.,
1982).
In a few cases, comparison of precursor and mature forms does not 
reveal a difference in M . Proteins which do not have larger 
precursors include cytochrome c, located in the inter-membrane space 
(Korb & Neupert, 1978), isopropylmalate synthase, a matrix enzyme
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(Casser et al., 1982a), the inner membrane ADP/ATP carrier (Zimmermann 
et al., 1979b; Hatalova & Kolarov, 1983) and porin, a major component 
of the outer membrane (Freitag et al., 1982b; Gasser & Schatz, 1983). 
For cytochrome c and the ADP/ATP carrier it has been demonstrated that 
import occurs without removal of NH^-terminal amino acids by 
specifically labelling the protein with N-formyl-[^^S]methionine and 
showing that the mature, imported form still retains this label 
(Zimmermann et al., 1979a,b). Proteolytic cleavage therefore is not an 
obligatory step in protein transport.
The presence of highly hydrophobic membrane proteins in the 
cytosol, en route to mitochondria, indicates possible
conformational differences between the precursor and mature forms. In 
the case of subunit IX of the ATPase complex, which is highly 
hydrophobic, the 66 amino acid presequence, already mentioned, is very 
polar and may function to maintain the protein in a soluble form. 
Conformational dissimilarities between mature and precursor proteins 
have been demonstrated for the precursor of the ADP/ATP carrier which 
binds hydroxylapatite where the mature form does not (Zimmermann & 
Neupert, 1980a) and the precursor form of the matrix enzyme fumarase, 
which differs from the mature form in that it does not bind to the 
pyromellitic acid-Sepharose 6B affinity column (Ono et al., 1985). 
Another indication of differences in tertiary structure is revealed in 
differential protease sensitivities of the mature and precursor forms 
of porin (Gasser & Schatz, 1983) and aspartate aminotransferase 
(Jaussi et al., 1982). In a minority of cases, a conformational 
difference is inferred when antiserum raised against the mature 
protein falls to recognise the precursor (Schmidt et al., 1983b). The
12
best example of this is in the case of cytochrome c of N. erassa. The 
apocytochrome c has the same as the holoenzyme but lacks the 
covalently attached haem group. Antibodies raised against the 
holoenzyme fail to recognise the apocytochrome and vice versa (Hennig 
& Neupert, 1981). Obviously the haem group governs the different 
folding of the polypeptide chain in the two forms of the cytochrome 
and covalent attachment of the haem induces a strong conformational 
change in the protein.
Differences in tertiary structure are further suggested by 
demonstrating that precursor proteins, accumulated in the cytosol, 
tend to form aggregates. The precursor to fumarase (M^ 45000) migrates 
with an apparent M of 270000-360000 on gel filtration (Ono et al., 
1985) and the in vitro synthesised ADP/ATP carrier (M 32000) forms 
aggregates of M 120000-500000 (Zimmermann & Neupert, 1980a). Sucrose 
density gradient analysis shows an apparent M of 80000-240000 for the 
precursor to subunit IX of the ATPase complex of N. crassa (Schmidt 
et al., 1983b). Other precursor proteins existing in aggregated states 
include the p-subunit of yeast F^-ATPase and glutamic oxaloacetic 
transaminase, carbamyl phosphate synthetase and ornithine 
carbamyltransferase of rat liver (Miura et , 1981; Sakakibara 
et al., 1983; Hay et al., 1984). Whether these aggregates are homo­
oligomers or associations of precursor with other proteins in the 
cytosol required for import remains to be established (see section 
1.5.3).
Of all the precursors so far studied only the precursor of 
glutamate dehydrogenase has been reported to have enzymatic 
activity (Felipo et al., 1983).
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Possible roles for the NH^-terminal extension sequence include 
holding the protein in a suitable conformation in the cytosol for 
proper presentation to mitochondria, or to protect it from 
proteolysis or, in the majority of cases, to ensure that it is 
enzymically inactive, perhaps by altering the active site or by 
preventing cofactor binding. Evidence for the last idea comes from the 
observation that some precursors have failed to bind to affinity 
columns specific for the mature protein (Kalousek et al., 1984; Ono 
et al., 1985).
1.3.2 INTRACELLULAR SITE OF SYNTHESIS OF MITOCHONDRIAL PROTEINS
Determining the subcellular site of synthesis of mitochondrial 
precursors has been central to the question of how mitochondria take 
up proteins in vivo.
Early studies on the biosynthesis of proteins such as cytochrome c 
and glutamate dehydrogenase were carried out in vivo by injecting 
animals with radiolabelled amino acids and following the distribution 
of radioactive proteins into various subcellular fractions. In general 
the highest specific activities at early time points were found in the 
microsomal fraction.
The site of synthesis of glutamate dehydrogenase (GDH) was also 
studied by isolating free and membrane-bound polysomes from the livers
3
of rats injected with [ H]leucine. Nascent chains released from the 
ribosomes were screened for nascent glutamate dehydrogenase with 
pepsin-digested anti-GDH. A preferential reaction of anti-GDH with 
nascent chains from membrane-associated polysomes was observed. This 
data suggested that synthesis of mitochondrial precursors occurred on
14
polysomes associated with microsomal membranes.
However there are now serious reservations regarding the validity 
of these results. One concerns the selective redistribution of newly- 
synthesised mitochondrial protein during tissue homogenisation. In 
fact, it has been shown that radiolabelled protein, added to liver 
homogenates, becomes preferentially associated with the microsomal 
membranes in a non-specific fashion. The second concerns the immune 
assays on nascent chains which tend to form aggregates and could 
result in non-specific precipitation. Indeed the relationship 
of the nascent chains to glutamate dehydrogenase was never proven.
An alternative approach has been used by several laboratories to 
determine the subcellular site of synthesis of these mitochondrial 
proteins. Free or membrane-bound polysomes or polyadenylated mRNA 
isolated from these classes of polysomes were translated in cell-free 
systems and the translation products screened immunochemically for 
mitochondrial proteins. The translation of cytochrome c, porin and 
subunit IX of the mitochondrial ATPase complex of N. crassa (Zimmermann 
et al., 1979a; Freitag et al., 1982b; Schmidt et al., 1983b); the 
outer membrane protein OMM35 of rat liver and several matrix enzymes 
of higher eukaryotes (Raymond & Shore, 1979; Morita et al., 1981;
Shore et al., 1981; Mihara et al., 1982b; Sonderegger et al., 1982) 
and of twelve mitochondrial precursors in yeast (Suissa & Schatz,
1982) occurs predominantly on free ribosomes. This suggests, at least 
for these proteins, a posttranslational mode of import into 
mitochondria.
Further evidence supporting a posttranslational import mechanism 
comes from studies ^  vivo. Fractionation of 'pulse-labelled' cells 
reveals that appearance of radioactive protein in mitochondria shows a
15
characteristic lag phase as compared to the kinetics of labelling of 
cytosolic proteins (Hallermeyer et al., 1977). This suggests that 
newly-synthesised mitochondrial proteins have to pass through an 
extra-mitochondrial precursor pool before entering the organelle. This 
pool has been localised to the cytoplasm and at early stages of the 
'pulse'» precursor forms are found here whereas mature forms are 
located inside the organelle (Hallermeyer et al., 1977; Raymond &
Shore, 1981; Jaussi et al., 1982; Mihara et al., 1982b; Mori et all, 
1981a; Reid & Schatz, 1982). The half-lives of precursor molecules in 
the cytosol are very short, generally of the order of 1-2 min, although 
these half-lives are probably not constant since pool sizes vary 
depending on physiological conditions. Factors which cause a decrease 
in the rate of protein synthesis will also tend to decrease the size 
of the precursor pools (Reid & Schatz, 1982).
Observations of cytoplasmic polysomes attached to the 
mitochondrial outer membrane in cycloheximide-treated yeast cells 
(Ades & Butow, 1980a) cannot easily be reconciled with free ribosomes 
being the exclusive site of synthesis of mitochondrial protein. If 
these polysomes are allowed to complete their nascent chains in an in 
vitro "read-out" system they apparently release their products into 
the interior of the mitochondrion (Ades & Butow, 1980a). However, it is 
not clear whether translocation occurs before completion of the 
polypeptide chain. Compared to mRNA isolated from free polysomes, mRNA 
extracted from these mitochondrially-associated polysomes was found to 
be enriched in mRNAs for mitochondrial proteins (Reid & Schatz, 1982). 
However, in no case was the total amount of mRNA for a particular 
mitochondrial protein found to be preferentially, or exclusively,
16
associated with the polysomes bound to the mitochondria.
It is possible that under conditions which prevent protein 
synthesis,some nascent chains, with their attached ribosomes may bind 
to mitochondria, but whether those chains actually span the membrane 
during translocation has yet to be proven. There is no firm evidence 
to suggest that these bound polysomes are essential for importing 
mitochondrial proteins.
While binding of cytoplasmic polysomes to the mitochondrial 
surface does not seem to be obligatory for the import process, this 
binding may reflect the specificity of the interactions between 
precursor polypeptides and mitochondria and as such may serve as 
probes to help in identifying mitochondrial import receptors. Indeed 
cytoplasmic ribosomes are preferentially attached to regions of close 
contact between the inner and outer mitochondrial membranes (Kellems 
et al., 1975). Such 'contact sites' may be entry sites of nuclear- 
encoded polypeptides into the organelle.
1.4 INTERACTION OF PRECURSORS WITH BINDING SITES ON MITOCHONDRIA
Following their translation in the cytosol, precursors of 
mitochondrial proteins must find their way to and into 
mitochondria. The first step in the transfer process requires the 
recognition of precursors by the cytoplasmic face of the outer 
membrane.
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1.4.1 PRECURSORS ARE BOUND TO MITOCHONDRIA VIA SPECIFIC 
RECEPTOR SITES
In order to study the interaction between precursors and 
mitochondria it is necessary to inhibit translocation. It is also 
essential to have purified precursor in sufficiently large amounts to 
monitor its binding to specific mitochondrial recognition sites.
One protein which fulfils these requirements is cytochrome c of 
N. crassa. Although there is no size difference between the precursor 
and mature forms, they can be differentiated by non-crossreacting 
antibodies. The precursor, apocytochrome c, can be prepared in large 
amounts from holocytochrome c by chemical means (Hennig et al., 1983).
It can then be radiolabelled by reductive méthylation, bound to 
mitochondria, translocated into the organelle and converted to 
holocytochrome c by addition of haem. Translocation can be inhibited 
by the haem analogue deuterohemin (Hennig & Neupert, 1981). Under 
these conditions, bound, radioactive apocytochrome c can be exchanged 
for unlabelled apocytochrome c but not for holocytochrome c. Ligand 
binding to these sites involves some species specificity. In 
competition studies equine apocytochrome c was ten-fold less 
effective in displacing N. crassa apocytochrome c than the homologous 
protein and apocytochrome c from Paracoccus denitrificans was not 
effective at all (Hennig et al., 1983). Precursor binds in a saturable
_7
manner to high affinity receptors (K^ = 2.2 x 10 M ) which, from 
Scatchard analysis, are present at 90 pmol/mg mitochondrial protein.
This association constant is comparable to the constants determined 
for polypeptide hormones (Hennig & Neupert, 1983). The observations 
that bound apocytochrome c is sensitive to proteases and that trypsin 
treatment of mitochondria prevents binding and import of apocytochrome c
18
suggests that these receptor molecules are proteins located at the 
cytoplasmic surface of mitochondria.
Once inhibition of haem attachment is relieved by addition of 
excess protohaem these bound precursors are translocated and converted 
to holocytochrome c, implying a functional role for these binding 
sites. Thus it appears that the mitochondrial binding sites not only 
selectively interact with apocytochrome c but may also orientate it 
properly with respect to the membrane to facilitate the initial stages 
of translocation.
To prove, convincingly, the identity of a particular component as 
the mitochondrial receptor for apocytochrome c requires its isolation 
and demonstration of the same high affinity and specificity of binding 
as intact mitochondria. Preliminary reports state that the protein 
responsible for high affinity binding of apocytochrome c to crassa 
mitochondria has been purified to homogeneity and exhibits such 
properties (Harmey & Neupert, 1984; Schmidt & Neupert, 1984; Zwizinski 
et al., 1984).
1.4.2 MORE THAN ONE TYPE OF RECEPTOR IS PRESENT ON THE 
MITOCHONDRIAL SURFACE
The search for receptors for mitochondrial proteins other than 
cytochrome c has been limited by the availability of precursors in 
only minute amounts. However the existence of such receptors is 
suggested from the following evidence.
Precursors bound to mitochondria under conditions where 
translocation is prevented e.g. de-energised mitochondria (Zwizinski 
et al., 1983), can be processed and internalised once import
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conditions are restored. It seems likely, therefore, that this binding 
is functionally related to Import of proteins into mitochondria.
Competition studies have revealed that excess apocytochrome c 
does not Interfere with the binding of various other precursors 
e.g. ADP/ATP carrier, ATPase subunit IX or cytochrome Cj (Zimmermann 
et al., 1981; Teintze et al.,1982), indicating the presence of more 
than one kind of receptor.
That these receptor molecules are exposed to the cytoplasmic 
surface is revealed from the evidence that treatment of mitochondria 
with protease inhibits their ability to bind and import precursors 
(Gasser et al., 1982a; Argan et al., 1983; Zwizinski et al., 1984) and 
also from the fact that bound precursors are sensitive to proteases 
(Freitag et al., 1982b; Riezman et al^, 1983b).
Different import mechanisms are also suggested by the different 
import requirements. Neither cytochrome c, the ADP/ATP carrier or 
isopropylmalate synthase are synthesised as larger precursors but 
import of the latter two requires energy. Also cytochrome c and 
cytochrome c^, which are both destined for the same compartment, have 
widely different mechanisms of import. Cytochrome c is synthesised 
with the same as the mature form and is taken up into the inter­
membrane space without a detectable energy requirement. Cytochrome c^ 
on the other hand is made as a larger precursor, and undergoes an 
energy dependent import step involving two proteolytic cleavages as 
will be discussed later (section 1.6.2 ).
Attempts have been made to study precursor binding to isolated 
outer membrane vesicles (Riezman et al., 1984a,b). This binding 
displays many of the characteristics of a receptor mediated event. It 
is rapid and reversible, both ligand and membrane specific and is
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located on the cytoplasmic surface of the mitochondrial outer 
membrane. This binding activity can be reconstituted from solubilised 
membranes but unfortunately saturable binding or limited binding sites 
cannot be shown owing to the minute amounts of available precursor.
Ono & Tuboi (1985) have reported partial purification of the 
receptor protein essential for import of pre-ornithine 
aminotransferase into mitochondria. The purification procedure 
involved ammonium sulphate fractionation, followed by gel filtration, 
of solubilised outer membrane of rat liver mitochondria. However the 
composition of the fraction containing this receptor was not shown.
Import of proteins into the outer membrane is likely to occur by 
a different mechanism from import into the internal mitochondrial 
compartments. It is not accompanied by proteolysis of larger 
precursors, nor does it require protease-sensitive binding sites or an 
energised inner membrane (Freitag et al., 1982b; Mihara et al., 1982a; 
Gasser & Schatz, 1983). Still import is membrane specific and appears 
to be by far the simplest of mechanisms discovered so far.
It seems unlikely that each precursor has its own specific 
receptor. Indeed the electrophoretic profiles of the outer membrane 
would not support such a view. The existence of a limited number of 
different and conserved recognition mechanisms is suggested by the 
following two observations. Transfer of proteins ^  vitro does not 
exhibit species specificity e.g. pre-ornithine carbamyltransferase 
from rat liver can be imported into mitochondria from pigeon, frog and 
carp liver (Schleyer et al., 1982; Teintze et al., 1982; Schmidt 
et al., 1983a; Takiguchi et al., 1983). Also precursors from one cell 
type can be imported into mitochondria from another cell type which do
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not contain this protein vivo, indicating that translocation and 
processing are common for different mitochondrial proteins (Morita 
et al., 1982; Mori et al., 1981b). These results suggest that there 
are possibly common features of the uptake machinery which are neither 
specific for one species nor specific for individual precursor 
proteins of the same species.
1.4.3 WHICH PART OF A PRECURSOR IS RECOGNISED BY MITOCHONDRIAL 
RECEPTORS
Mature proteins do not compete with their precursors for binding 
to mitochondria, nor are mature, or in vitro processed, proteins 
taken up into the organelle. Although there have been reports of 
incorporation into mitochondria of mature aspartate aminotransferase 
(Passarella et al., 1984), this is controversial especially as a 
precursor form of this protein has been identified (Sonderegger 
et al., 1982). Some feature of the precursor, therefore, as opposed to 
the mature form, allows binding of the precursor to mitochondria and 
its subsequent processing and internalisation.
Mutual recognition between receptors and precursors which do not 
contain an additional sequence must obviously be via some sequence 
present in the mature protein. Cytochrome c provides important 
information in this respect. Since incorporation of cytochrome c is 
mediated by a mechanism which recognises structural features of the 
newly-synthesised molecule, these features must be contained in a 
segment which is masked in the holocytochrome in its native 
conformation.
Competition studies, employing cyanogen bromide fragments 
of cytochrome c, have localised the receptor binding 'signal* to a
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segment that encompasses, evolutionarily, the most highly conserved 
region of the protein i.e. residues 70-80 by standard nomenclature 
(Matsuura et al., 1981). It is interesting in this respect to note 
that this invariant sequence of eukaryotic cytochromes is not present 
in cytochrome c of Paracoccus denitrificans which, as has been 
mentioned already (section 1.4.1), fails to compete with the 
homoprotein for binding to N. crassa mitochondria.
Recent studies have identified the sequences involved in 
targetting two outer membrane proteins of yeast to mitochondria: a 
70000 protein of unknown function and the pore forming 29000 
protein, porin, neither of which are made as larger precursors.
Initial attempts to clone the gene for the 70000 protein 
resulted in isolation of a truncated gene which had lost a large part 
of its 3’ end during the cloning procedure. The truncated 
polypeptide, lacking 203 amino acids at the C-terminus, is still found 
associated with mitochondria, suggesting that regions in the NH^- 
terminal 2/3 of the 70000 protein, are responsible for addressing 
and anchoring the protein to mitochondria (Riezman et al., 1983c).
More specific localisation of this addressing and anchoring region has 
been achieved by deleting various regions throughout the polypeptide 
chain and also by fusing amino terminal regions of different length to 
p-galactosidase, introducing these altered genes into yeast and 
determining the intracellular fate of the polypeptide product. This 
has revealed that the information is located in an amino terminal 
region accounting maximally for 7% of the protein. This region 
contains a typical transmembrane segment, of hydrophobic amino acids, 
between residues 9-38, flanked by charged amino acids. A role in
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membrane anchoring has been assigned to this region, whereas the 
sequence responsible for targetting proteins to mitochondria is 
proposed to include the 11 amino-terminal amino acids (Hase et al., 
1964). Comparison of the amino acid sequence of this region with the 
NHg-terminal region of the outer membrane protein, porin, reveals 
structural similarities between the two, providing circumstantial 
evidence that the NH^-terminal portion of porin, like that of the 
70000 protein, functions as both targetting and anchoring signals 
(Mihara & Sato, 1985).
In the case of proteins synthesised as larger precursors, 
the presequences are required for mitochondrial import. Thus, with one 
possible exception (Passarella et al., 1984) mature proteins are not 
taken up into mitochondria (Riezman et al., 1983b). To test the 
hypothesis that the presequence contains sufficient information to 
direct the import of precursors by mitochondria, nucleotide sequences 
corresponding to leader sequences have been fused to genes for 
cytosolic proteins and the ability of mitochondria to import these 
chimeric proteins has been examined.
Hurt et al.(1984a,b) have shown that as little as 23/25 amino 
acids of the leader sequence of cytochrome c oxidase subunit IV is 
sufficient to transport cytosolic dihydrofolate reductase into the 
mitochondrial matrix in vitro. The leader sequence of the human matrix 
enzyme, ornithine carbamyltransferase, is also sufficient to allow 
import and processing of cytosolic dihydrofolate reductase both in 
vitro and in vivo in a CHO-derived cell line (Horwich et al., 1985a). 
Even p-galactosidase is not restricted in its ability to cross a 
eukaryotic membrane when fused to the presequence of the nuclear- 
encoded p-subunit of the mitochondrial ATPase (Schekman, 1985).
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A similar situation occurs in chloroplasts, where the fusion of 
the transit peptide of the small subunit of ribulose-J,5-bisphosphate 
carboxylase to a bacterial gene produces a hybrid protein which is 
taken up and processed in chloroplasts of tobacco plants and into 
isolated chloroplasts in vitro (Van den Broeck et al., 1985; Schrier 
et al., 1985). These results seem to eliminate the possibility that 
translocation involves some special features of the precursor 
polypeptide in addition to the NH^-terminal targetting sequence. It 
will be of interest to determine the characteristics of these 
presequences which are important for recognition; charge, secondary 
and/or tertiary structure. Recent results infer that the arginine 
residues of the human ornithine carbamyltransferase leader sequence 
are related to function (Horwich et al., 1985b). This is not 
surprising as a basic amino acid composition is a striking feature of 
all leader sequences reported to date (Hay et al., 1984).
1.5 TRANSLOCATION OF PRECURSORS INTO MITOCHONDRIA
After selective binding of precursors to mitochondria, the next 
stage involves translocation into one of the four mitochondrial 
subcompartments. Virtually nothing is known about how translocation is 
accomplished. An understanding of the precise mechanism would require 
detailed knowledge concerning the conformation of precursors and the 
molecular events initiated by specific interaction with the 
membrane. One intriguing clue to the mechanism of translocation 
is provided by the observation that import of precursors is 
an energy-dependent process.
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1.5.1 UPTAKE OF MOST PRECURSORS INTO MITOCHONDRIA REQUIRES A 
MEMBRANE POTENTIAL
Posttranslational transfer of proteins into the mitochondria and 
their subsequent processing is blocked in whole cells or isolated 
mitochondria treated with uncouplers of oxidative phosphorylation 
(Mori et ai., 1981b; Reid & Schatz, 1982; Teintze et al., 1982). As 
already described (section 1.4.2), these uncouplers inhibit transport 
of precursors into mitochondria but do not affect their binding to the 
outer membrane. Observations that proteins such as the ADP/ATP carrier 
and isopropylmalate synthase, which are not synthesised as larger 
precursors, still require energy for import, suggested that it was the 
translocation event and not processing which was energy dependent 
(Zimmermann et al., 1981; Hampsey et al., 1983). This was confirmed by 
evidence showing that processing of the p-subunit of F^-ATPase by 
lysed mitochondria was not dependent on addition of an energy source 
(Gasser et al., 1982a).
Early work with yeast spheroplasts revealed that import and 
cleavage of several mitochondrial precursors was blocked by the 
uncoupler CCCP, or by depleting matrix levels of ATP in non-respiring 
yeast. From these results it is impossible to distinguish between a 
requirement for ATP and the need for a membrane potential, since, 
according to the chemiosmotic hypothesis, a membrane potential can 
generate ATP from ADP and P^ or ATP hydrolysis can generate a membrane 
potential. From the observation that uptake and processing still occur 
in rho mutants of yeast, which cannot form a membrane potential 
because they lack both a functional respiratory chain and a proton- 
translocating ATPase, the authors concluded that matrix ATP was
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probably the immediate energy donor (Nelson & Schatz, 1979).
Definitive evidence to the contrary has been obtained recently 
using N. crassa, rat liver (Schleyer et al., 1982) and yeast 
mitochondria (Gasser et al., 1982a). These studies have employed an in 
vitro import assay in which precursors synthesised in vitro are 
incubated with isolated mitochondria. Translocation is checked by 
showing inaccessibility to added protease and correct processing by 
immune precipitation and SDS-PAGE to compare the M value of the 
processed precursor with the mature form.
In one study, conditions were employed in which the level of 
matrix ATP was elevated but the membrane potential was dissipated. 
Under those conditions precursors to subunit IX of ATPase and the 
ADP/ATP carrier were not imported into mitochondria. On the other 
hand, conditions were created where the matrix ATP was low but the 
membrane potential was not destroyed, and in this case protein import 
into the organelle was inhibited. Matrix levels of ATP in the presence 
of these various reagents were measured indirectly by following a 
reaction requiring ATP in the matrix, namely mitochondrial protein 
synthesis. These results indicate that it is the electrochemical 
potential and not intramitochondrial levels of ATP which is the 
primary energy source (Schleyer et al., 1982).
Confirmation of this conclusion was provided by studies on yeast 
mitochondria (Gasser et al., 1982a). In an in vitro import system, 
dependent on the addition of ATP, it was shown that import was 
inhibited by both carboxyatractyloside and oligomycin, inhibitors of 
ATP. uptake and ATP hydrolysis respectively. This indicated that in 
order for import to occur ATP must be taken up into the matrix of 
mitochondria and hydrolysed. The most likely explanation for this
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would be that ATP is used to generate an electrochemical gradient 
across the inner mitochondrial membrane. Indeed this import is 
abolished, if the gradient is collapsed with CCCP or valinomycin, in 
the presence of oligomycin to prevent the ATPase activity generating a 
membrane potential.
The electrochemical potential gradient is a sum of two 
components: a proton gradient and a membrane potential generated from 
the separation of charged species across the inner membrane. 
Observations that nigericin, which causes breakdown of the proton 
gradient without affecting the membrane potential, does not inhibit 
import and processing (Schleyer et al., 1982) and that valinomycin, 
which dissipates the membrane potential, does (Schleyer et al., 1982; 
Casser et , 1982a), seem to indicate that it is the membrane 
potential and not the proton gradient which is necessary to drive 
uptake of precursors.
An electrochemical potential is also required for the 
translocation of polypeptides across bacterial membranes (Date et al.,
1980). Since the potential has the same polarity in mitochondria as in 
bacteria whereas the movement of proteins occurs in opposite 
directions, it is unlikely that the transmembrane potential acts as a 
simple electrophoretic gradient. It may induce interactions of 
components of the membrane or alter protein conformation to allow a 
polypeptide to cross the membrane. Another possibility is that it 
could labilise the lipid bilayer and facilitate transmembrane movement 
of polypeptides via transient formation of inverted lipid micelles 
(Cullis & de Kruijff, 1979). The lipids of the mitochondrial membranes 
may have a role in translocation but this has not been extensively
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investigated as yet.
1.5.2 NOT ALL PROTEINS REQUIRE A MEMBRANE POTENTIAL FOR IMPORT 
INTO MITOCHONDRIA
Not all proteins require the presence of a membrane potential for 
import into mitochondria. Proteins which insert into mitochondria in 
an energy-independent fashion include cytochrome c (Zimmermann et al.,
1981), and the proteins of the outer membrane (Gasser & Schatz, 1983; 
Riezman et al., 1983b). In both cases it could be argued that there is 
no reason for such a requirement since transport across the inner 
membrane is not required. However, other inter-membrane space proteins 
such as cytochrome b^ and cytochrome c^ in yeast, are imported only 
into energised mitochondria (Gasser et al., 1982b). Substantial 
evidence has been presented to support an import pathway for these 
proteins which involves a transient interaction with the inner 
membrane and a two step proteolytic processing mechanism (see section 
1. 6 . 2).
Attachment of haem to apocytochrome c is required for completion 
of import of the precursor into mitochondria. The covalently attached 
haem strongly affects the conformation of the polypeptide chain and it 
has been suggested that this conformational change provides the 
driving force to pull the cytochrome through the outer membrane (Korb 
& Neupert, 1978).
Haem addition is also required for completion of import and 
processing of cytochrome c^ (Gasser et al., 1982b) and 
G-aminolevulinate synthase (Ades, 1983) but not for insertion of 
cytochrome b^ (Daum et al., 1982). This further illustrates the 
diversity of mechanisms of translocation existing for mitochondrial
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proteins.
Import of proteins into the outer membrane differs in three 
respects from other mitochondrial proteins; these proteins are not 
synthesised as larger precursors, with one possible exception in rat 
liver (Shore et al., 1981); they do not require an electrochemical 
gradient across the inner membrane for import into mitochondria and 
their import does not seem to require protease-sensitive sites on the 
outer membrane (Gasser & Schatz, 1983; Freitag et al., 1982b).
Membrane specific insertion has been demonstrated: porin inserts 
exclusively into mitochondria and is not incorporated into microsomes 
(Gasser & Schatz, 1983). When isolated mitochondria are incubated with 
in vitro synthesised precursors at 4°C a large proportion of the porin 
is bound to the mitochondria in a protease-sensitive form indicating 
that binding and integration are separate events. As already mentioned 
(section 1.3.1), the precursor of porin has a different sensitivity to 
proteases from the mature form suggesting that there must be a 
conformational difference between the two. This property of acquired 
protease resistance can be used to check for integration into the 
membrane.
Recently the nuclear gene coding for a major 70000 outer 
membrane protein in yeast has been cloned and sequenced (Hase et al.,
1983). From the deduced protein sequence a striking feature of the 
NH^-terminal region is a typical transmembrane segment and a strongly 
basic region which may function as an addressing signal.
The various mechanisms which catalyse the translocation of 
proteins into the mitochondria seem to depend in part, on the presence 
or absence of an NH^-terminal extension sequence, on the final
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destination of the protein in the mitochondria and probably on 
characteristics of the polypeptides themselves.
1.5.3 CYTOSOLIC FACTORS INVOLVED IN TRANSLOCATION
Several recent reports have centred on the requirement for 
cytosolic factors in the import of precursors into the mitochondria.
In a study concerning requirements for in vitro uptake of 
ornithine carbamyltransferase, synthesised in a rabbit reticulocyte 
lysate cell free system, into rat heart mitochondria, Argan et al.
(1983) observed that import was inhibited if the lysate was subjected 
to gel filtration on Sephadex G25 prior to incubation with 
mitochondria. Confirmation of this was reported by Ohta & Schatz
(1984) who observed a similar effect on import of cytochrome b^ into 
yeast mitochondria. Addition of non-radioactive reticulocyte lysate to 
the system stimulated import of the ^  vitro synthesised cytochrome.
It was concluded that the factor in the lysate responsible for this 
behaviour was either very small or reacted in a non-specific manner 
(ionically or hydrophobically) with the gel matrix (Argan et al.,
1983).
Further evidence as to the nature of the component Involved was 
achieved in a study on in vitro import of ornithine 
carbamyltransferase into rat liver mitochondria. The stimulatory 
activity was retained in a dialysed reticulocyte lysate supernatant 
fraction but was lost on trypsin treatment or heat treatment at 100 C 
for 2 min (Miura et al., 1983). It was also reported that, in the 
absence of this factor, in vitro synthesised precursor was found in 
the supernatant fraction, not associated with mitochondria.
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suggesting the factor is responsible for binding or transport and not 
processing.
An alternative approach involved purification of the precursor to 
the p-subunit of the Fj ATPase from the rho yeast mutant grown in the 
presence of CCCP (Ohta & Schatz, 1984). This purified precursor was 
processed very inefficiently by isolated yeast mitochondria although 
the reaction could be stimulated by reticulocyte lysate or a cytosolic 
fraction of yeast. As the stimulatory agent can be precipitated by 
ammonium sulphate and inactivated by trypsin, it implies the 
involvement of a protein. Gel filtration revealed that the stimulatory 
activity migrated with an apparent of 40000. This factor is 
unlikely to function in a manner analogous to the SRP (section 1.2.1) 
as this complex prevents completion of polypeptide chains in the 
cytosol in the absence of target membranes and mitochondrial proteins 
are usually transported posttranslationally. One hypothesis would be 
that this cytosolic factor binds to precursors and triggers their 
correct association with the appropriate receptors. Until the agent 
responsible has been purified to homogeneity, its exact nature, 
mechanism of action and biological function will remain unknown.
1.6 PROCESSING OF PRECURSORS TO THEIR MATURE FORMS
During or shortly after translocation, precursors carrying NH^- 
terminal extension sequences are proteolytically cleaved to their 
mature forms by a neutral, chelator-sensitive, matrix protease. This 
enzyme has been found in mitochondria from yeast (McAda & Douglas, 
1982; Bohni et al., 1983); rat liver (Mori et al., 1980) and N. crassa 
(Schmidt & Neupert, 1984).
32
Characteristics of the yeast enzyme include a pH optimum
of 7.5, inhibition by chelating agents such as EDTA, GTP and 1,10-
2+  2+
phenanthroline, which is reversible on readdition of Zn or Co , and 
insensitivity to serine protease inhibitors and sulphydryl reagents 
(Bohni et al., 1983). The protease is specific for mitochondrial 
precursors and does not cleave either non-mitochondrial proteins or 
denatured precursors. This suggests, that some particular conformation of the 
precursor, is required for correct cleavage. However, the protease 
processes a variety of in vitro synthesised mitochondrial precursors 
and demonstrates little species specificity. Correct processing of 
subunit V of cytochrome c oxidase by this enzyme has been demonstrated 
by comparing the amino acid sequence of the NH^-terminus of mature and 
in vitro synthesised precursor treated with partially-purified 
protease (Cerletti et , 1983). Further purification revealed an 
apparent M of 115000 by gel filtration. Although this fraction still 
consists of several protein bands, McAda & Douglas (1982) have reported 
that the processing activity co-purifies best with the presence of one 
major 59000 M^ band.
The processing activity in rat liver differs slightly in its 
sensitivity to inhibitors e.g. it is inhibited by 2mM leupeptin and 
2mM antipain, unlike the yeast enzyme. Co-fractionation of this enzyme 
with markers of the inter-membrane space has been observed but this 
may reflect cross-contamination of the sub-fractions (Mori et al.,
1980).
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1.6.1 TWO STEP PROCESSING
Several mitochondrial precursors studied so far are reported to 
be cleaved to their mature forms in two discrete steps. Cytochrome b^ 
in yeast, a soluble component of the inter-membrane space, is 
synthesised initially as a larger M precursor of 68000, which is 
taken up into the mitochondria in an energy dependent fashion and 
cleaved to an intermediate form of 63000. This intermediate form, 
observed when in vitro synthesised cytochrome b^ is incubated with 
isolated mitochondria or partially—purified protease and also during 
in vivo 'pulse-chase' studies in yeast spheroplasts (Reid et al., 
1982; Daum et al., 1982), is thought to be bound to the outer surface 
of the inner membrane (Daum et al., 1982). Conversion of the 
intermediate to the mature 58000 form of cytochrome b^ is brought 
about by a protease, distinct from the matrix protease, which is 
insensitive to 1,10-phenanthroline and probably associated with the 
outer aspect of the inner mitochondrial membrane (Daum et al., 1982).
Processing of cytochrome c^ is similar in many respects to that 
of cytochrome b^ except that the second proteolytic cleavage requires 
energy (Teintze et al., 1982) and is dependent upon the addition of 
haem to the intermediate form (Gasser et a^«, 1982b; Ohashi et al., 
1982). Presumably this covalent attachment of the haem brings about a 
conformational change which renders the protein sensitive to the 
second protease. Following this second proteolytic cleavage, unlike 
cytochrome b^, cytochrome c^ remains attached to the inner 
mitochondrial membrane.
Although no intermediate form of cytochrome c peroxidase 
has been observed in vivo its conversion is thought to take place via
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a two step mechanism. It Is synthesised as a larger precursor 
(Maccecchini et al., 1979b), and cleaved to an intermediate form by 
the partially-purified matrix protease (Gasser et al., 1982b). This 
processing in vivo is blocked by 1,10-phenanthroline (Reid et al.,
1982) again suggesting a role for the matrix protease. Maturation of 
cytochrome c peroxidase is much slower than that of cytochrome b^ in 
vivo. After a 3 min 'pulse' the cytochrome c peroxidase precursor 
appears to be located inside the mitochondria, bound to the inner 
membrane, since a subsequent chase is insensitive to uncouplers of 
oxidative phosphorylation (Reid et al., 1982). Failure to observe an 
intermediate form could be explained if the first cleavage step was 
rate limiting, as the intermediate would then not be detected for kinetic 
reasons.
A recent report revealed that subunit IX of the N. crassa ATPase 
was processed in two steps, both of which were assumed to be catalysed 
by the same enzyme (Schmidt & Neupert, 1984).
An apparent intermediate form of ornithine carbamyltransferase is 
observed upon import and processing by isolated mitochondria (Mori et 
al., 1980; Morita et al., 1982; Argan et al., 1983). This intermediate 
form is not observed in vivo in isolated hepatocytes (Mori et al.,
1981a), does not chase into isolated mitochondria and is located 
outside the mitochondria (Argan et al., 1983). A protease has been 
partially purified from rat liver mitochondria which cleaves the 
precursor of ornithine carbamyltransferase only to the intermediate 
form (Mori et , 1980). The role of this protease and that of the 
37000 M polypeptide intermediate in processing and transport remains 
to be determined.
Other types of posttranslational modification, involved in the
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conversion of precursor to mature forms, include covalent attachment of 
haem or flavin nucleotides, méthylation of amino-acyl side chains and 
acétylation of the mature NH^-terminus. In general, although these 
modifications are essential for protein function, the role played by 
the enzymes responsible for cofactor attachment in precursor import is 
unclear.
1.7 ASSEMBLY OF NEWLY-SYNTHESISED PROTEINS INTO FUNCTIONAL 
UNITS
The final stage in the import process, following translocation 
and processing, is assembly of newly-synthesised polypeptides into 
functional units inside the mitochondrion. This may involve association 
to form homooligomers or heterooligomers or, in the case of several 
respiratory complexes of the inner membrane, the association of 
cytoplasmically-synthesised polypeptides with mitochondrially 
-synthesised polypeptides.
In comparison to the other steps in the pathway, there have been 
relatively few reports on assembly of mitochondrial proteins. One 
reason for this is probably the difficulty involved in determining 
suitable criteria to define correct assembly.
A few studies have addressed the problem of correct Intra- 
mitochondrial location of newly-synthesised proteins which could be 
considered the first step in the assembly process. Several precursors 
of matrix, inter-membrane space and inner membrane proteins have been 
shown to be taken up by isolated yeast mitochondria into their correct 
locations (Gasser et , 1982a) and newly-synthesised 
carbamylphosphate synthetase is imported into the matrix fraction of
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rat liver mitochondria (Campbell et , 1982).
Correct insertion into the appropriate membrane has been inferred 
for the outer membrane, porin, and the inner membrane, ADP/ATP 
carrier, by virtue of the different structural properties of the 
precursor and mature forms as mentioned in section 1.3.1 (Zimmermann & 
Neupert, 1980a; Gasser & Schatz, 1983; Freitag et al., 1982b). An 
increase in specific activity of carbamylphosphate synthetase in 
isolated mitochondria incubated with pre-carbamylphosphate synthetase, 
which is enzymatically inactive, reveals an assembly of the mature 
polypeptide into the active dimeric form (Campbell et al., 1982). 
Evidence has also been presented that translocated and processed 
ornithine carbamyltransferase can form trimers resembling the native 
enzyme which bind to a substrate analogue affinity column (Kalousek et 
al., 1984). Neither the precursor nor the reported intermediate of 
ornithine carbamyltransferase bind to this column. In a study on the 
assembly of F^-ATPase in isolated yeast mitochondria, Lewin & Norman 
(1983) showed that newly-synthesised 4C, ^ & ^-subunits at least, appear 
to combine to form heterooligomers. It has also been observed that 
antibody to F^-ATPase can immunoprecipitate subunit IX, an integral 
membrane subunit of the ATPase, which suggests an association of 
subunit IX with the F^ section of the mitochondrial ATPase (Schmidt 
et al., 1983b).
Assembly of some of the respiratory complexes of the inner 
membrane and the mitochondrial ribosomes requires products of both 
cytoplasmic and mitochondrial protein synthesis. Little is known about 
the mechanism or control of assembly of these complexes. Specific 
inhibition of either cytoplasmic or mitochondrial protein synthesis 
should ultimately result in shortage of part of the components of
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these complexes and, consequently, in impaired assembly. The processes 
co-ordinating the expression of the different genetic systems are 
largely unknown but there is not tight coupling between the two (de 
Vries & vant Sant, 1983).
1.8 FUTURE AIMS IN MITOCHONDRIAL BIOGENESIS
It seems likely that future work in this field will rely heavily 
on techniques of DNA manipulation with the aims of further dissection 
of sequences reponsible for targetting proteins to the mitochondria 
and production of large amounts of pure precursor. The latter 
achievement would allow binding to receptor molecules to be examined 
in more detail and perhaps a more specific description of the 
conformation of precursors as opposed to mature proteins to be 
produced.
Another technique which is likely to feature strongly is genetic 
manipulation. Yeast strains defective in import and maturation have 
been produced (Yaffe & Schatz, 1984). Examination of the lesions 
involved could lead to the identification of components of the Import 
pathway, such as the receptor molecules, proteases responsible for 
maturation or factors in the cytosol required for import.
Although yeast is the best system in which to carry out the work 
described above due to the well established nature of yeast genetics, 
problems which may still be addressed in other systems, such as 
mammalian cells, include addition of cofactors and assembly of 
multiprotein complexes.
The ultimate aim of these studies, i.e. the reconstitution 
of an import and maturation system from purified components, must
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surely be realised within the next decade.
1.9 MULTIENZYME COMPLEXES
As stated in section 1.1, eukaryotic cells exhibit a high degree 
of organisational complexity, being subdivided into a number of 
organelles, each of which has a unique function and protein 
composition. The separate functions of each subcellular compartment 
are interdependent. Specific interaction of cellular components in 
space and time is important to biological function as is illustrated 
in the proceeding sections. Probably the best example of this, already 
cited, is the cotranslational transport of proteins across the 
endoplasmic reticulum (section 1.2.1): protein synthesis is initiated 
on free ribosomes (assemblies of protein and RNA) in the cytoplasm; up 
to a certain time after initiation of protein synthesis, an SRP (again 
an association of protein and RNA) can bind to the growing chain and 
prevent further elongation; this SRP-polysome complex then binds to 
specific proteins in the endoplasmic reticulum resulting in relief of 
arrest and allowing translation coupled to translocation to proceed. 
These interactions ensure that the nascent protein appears in the 
correct cellular location. Basic cellular processes from DNA synthesis 
to ATP generation depend upon the interaction of proteins.
Metabolic pathways in the cell consist of a number of consecutive 
reactions, catalysed by individual enzymes functioning sequentially. 
Thus the product of one reaction is a substrate for the next enzyme in 
the chain. It has become apparent that these interrelated enzymes are 
not randomly distributed but are often specifically organised into 
functional assemblies. Functionally related enzymes may aggregate to
39
form multienzyme complexes. Physical interactions of the enzymes in 
these complexes result in a distinctive morphology. The most highly 
organised multienzyme complexes in the cell are probably the arrays of 
membrane-bound enzymes of oxidative phosphorylation in mitochondria.
The most commonly studied multienzyme complexes such as the fatty 
acid synthetase (Lynen, 1972), 2-oxo acid dehydrogenase complexes 
(Reed, 1974; Perham, 1975) and the multienzyme complexes involved in 
aromatic amino acid biosynthesis (Yanofsky & Crawford, 1972; Lumsden & 
Coggins, 1977), are composed of 2-6 enzymes and have values ranging 
from thousands to millions. All of the associated proteins play an 
active role and there are no nucleic acids or lipids integrated into 
the complexes.
Structures of a number of these complexes have been described in 
great detail while in some cases the individual components have been 
resolved and reconstituted to form particles resembling the native 
complex.
Association of proteins to form multienzyme complexes provides 
opportunities for increased specificity, efficiency and modes of 
control not possible with structurally-independent enzymes.
In a few cases the activity of one component of a complex is 
modified by interaction with others. One example of this is the 
tryptophan synthetase complex of coli (Yanofsky & Crawford, 1972), 
a tetrameric enzyme with subunit structure Tryptophan synthetase
catalyses the last reaction in the tryptophan pathway:- 
Indole-3-glycerolphosphate + L-serine --->
L-tryptophan + D-glyceraldehyde-3-phosphate 1
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The enzyme is also capable of catalysing the two half- 
reactions : -
Indole-3-glycerolphosphate --->
Indole + D-glyceraldehyde-3-phosphate 2
Indole + L-serine -- > L-trytophan 3
Resolution of the complex results in 06 and species both of
which are catalytically active, ot in reaction 2 and in reaction 3. 
However, neither are active in the overall reaction. In the assembled 
complex the overall reaction can take place, the catalytic 
efficiencies of o4 and much higher and potentially competitive
side reactions such as the serine deaminase activity of are 
suppressed.
Where intermediates are retained on the surface of the complex 
this may be regarded as a form of segregation and may exclude 
competition from enzymes of another pathway. The arom complex of N. 
crassa provides the best documented example of this kind. N. crassa is 
capable of synthesising an inducible dehydroquinase, which probably 
serves a catabolic function, in addition to the constitutive 
dehydroquinase which Is part of the complex (Giles et al., 1967). It 
has been suggested that because the constitutive enzyme is a component 
of a multienzyme complex it can compete effectively for the 
dehydroquinate substrate channelling it preferentially along the 
biosynthetic pathway. Other complexes for which a channelling function 
seems plausible, where intermediates are strongly bound to the 
complex, include the 2-oxo acid dehydrogenase complexes and the yeast 
fatty acid synthetase.
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Association of enzymes within cells may be far more extensive 
than was originally imagined. Some evidence has been presented which 
indicates that glycolytic enzymes form a functional particle (Gorringe 
& Moses, 1978). Also it has been suggested that certain enzymes of the 
citric acid cycle are physically associated in the cell (D’Souza & 
Srere, 1983; Sumegi & Srere 1984).
Multienzyme complexes participate in reactions involving 
a number of different substrates and have been found in a variety of 
biological systems. The natural occurrence of such complexes is 
probably fairly frequent. Whether they can be isolated depends on 
their structural stability under the conditions employed.
Purified complexes provide the opportunity for study of assembly 
and subunit interactions. Such studies will result in a deeper insight 
into mechanisms whereby proteins influence the behaviour of other 
proteins and the integration of protein function. This knowledge can 
be applied to the principles governing cellular organisation.
1.10 2-0X0 ACID DEHYDROGENASE COMPLEXES
Multienzyme complexes which catalyse the lipoic acid-mediated 
oxidative decarboxylation of 2-oxo acids have been isolated from 
microbial and eukaryotic cells as functional units of high M^. Three 
categories of 2-oxo acid dehydrogenase have been Identified: one 
specific for pyruvate, one specific for 2-oxoglutarate and one 
responsible for oxidation of branched chain 2-oxo acids. All 2-oxo 
acid complexes purified to date consist of three catalytic components; 
a substrate specific dehydrogenase, a lipoate acyltransferase and with 
one possible exception in the case of Pseudomonas putida (Sokatch
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TABLE 1.2 Specific reactions catalysed by the 2-oxo acid
dehydrogenase complexes.
COMPLEX R SUBSTRATE PRODUCT
2-oxoglutarate
dehydrogenase
CO^.CH^.CHg- 2-oxoglutarate succinyl-CoA
pyruvate
dehydrogenase
CH^- pyruvate acetyl-CoA
branched-chain 
2 - 0 X 0  acid 
dehydrogenase
(CH^)2.CH.CH2-
(CH^.CH2).(CH2).CH-
2-oxoisocaproate
2-oxo~3~methyl-
valerate
2-oxo-iso-
valerate
isovaleryl-CoA
2-methyl-
butyr^l-CoA
isobutyryl-CoA
et al-, 1981a) a flavoprotein common to all three complexes. These 
component enzymes self assemble to form ordered, symmetrical 
structures of distinct morphology. Five coenzymes and prosthetic groups 
are involved in the sequence of reactions catalysed by the complex: 
thiamine pyrophosphate, lipoic acid, CoA, FAD and NAD .
The overall oxidative decarboxylation reaction can be represented
as :~
R.CO.COgH + CoA + NAD* --->
R.CO.CoA + CO^ + NADH + H*
The specific reactions catalysed by the 2-oxoglutarate 
dehydrogenase complex (OGDC), the pyruvate dehydrogenase complex (PDC) 
and the branched chain dehydrogenase complex (BCDC) are shown in 
Table 1.2.
Succinyl-CoA, produced by OGDC, is required for the oxidation of 
ketone bodies and the biosynthesis of porphyrins, leucine and 
methionine. PDC provides acetyl-CoA, a key precursor in the 
biosynthesis of many different lipids, leucine, lysine (in fungi), 
acetylcholine and a metabolite of the glyoxylate cycle in plants. 
Oxidation of acetyl-CoA via the citric acid cycle is a major source of 
reducing power as NADH and energy in the form of ATP. BCDC is involved 
in the degradation of the branched chain amino acids valine, leucine 
and isoleucine. In humans, a deficiency of this activity causes Maple 
Syrup Urine Disease, a major symptom of which is the presence in the 
urine of high levels of branched chain 2-oxo acids (Chuang et al., 
1981).
Purification of each of the 2-oxo acid dehydrogenase complexes 
has been achieved from several sources. The following lists provide
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FIGURE 1.3 Reaction mechanism of the 2-oxo acid dehydrogenase
complexes
NAD+
,SH S,
[FADH] NADH+H^ :
COg [RC-TPP]
RC-SCoA
[TPP]
CoASH
TPP
Lip
R
thiamine pyrophosphate 
lipoic acid 
see table 1.2
examples of these. PDC and OGDC have been isolated from coli (Koike 
et al., 1960; Reed & Mukherjee, 1969; Danson et al., 1979), Azotobacter 
vinelandii (Bosma et al., 1982), bovine heart (Stanley & Perham,
1980), bovine kidney (Linn et al., 1972; Kresze & Steber, 1979), 
porcine heart (Massey et al., 1960; Koike & Koike, 1976) and 
Saccharomyces cerevisiae (Hirabayashi & Hirada, 1971; Kresze & Ronft, 
1981a,b). In addition, PDC has also been purified from Pseudomonas 
aeruginosa (Jeyaseelan et al., 1980), Bacillus stearothermophilus 
(Henderson & Perham, 1980), Bacillus subtilis (Visser et al.,1980; 
Hodgson et al., 1983) and porcine liver (Roche & Cate, 1977). BCDC has 
been isolated from Pseudomonas putida (Sokatch et al., 1981b), bovine 
liver (Danner et al., 1979) and bovine kidney (Pettit et al., 1978).
1.11 STRUCTURE AND FUNCTION OF THE 2-OXOGLUTARATE 
DEHYDROGENASE COMPLEX
The multienzyme system responsible for the oxidation of 
2-oxoglutarate has been isolated from the sources listed above as a 
functional unit with M^ 2.5-2.7 x 10^. OGDC is composed of multiple 
copies of three different enzymic activities; 2-oxoglutarate 
dehydrogenase (EC 1.2.4.2), lipoate succinyltransferase (EC 2.3.1.6) 
and lipoamide dehydrogenase (EC 1.8.1.4). These, and the corresponding 
activities from the other 2-oxo acid dehydrogenase complexes, are 
generally referred to as El, E2 and E3 respectively. Acting in 
sequence, these enzymes catalyse the reaction shown in Fig.1.3 (Reed, 
1974).
In a reaction involving the coenzyme TPP, El catalyses the 
decarboxylation of 2-oxoglutarate. This enzyme is also responsible for 
the subsequent reductive acylation of the lipoyl moiety, covalently
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bound to E2. Acylation of lipoic acid results in formation of a 
thioester and opening of the dithiolane ring, generating a free thiol.
E2 catalyses the transfer of the acyl group from the lipoic acid to 
CoA, releasing one of the final reaction products, succinyl-CoA. 
Reoxidation of the dihydrolipoyl moiety is catalysed by E3. This 
enzyme contains a covalently bound FAD prosthetic group and a 
disulphide bridge which are both involved in the reaction mechanism. A 
chief feature of this reaction is a catalytic intermediate where two 
electrons are shared between the FAD and the reactive disulphide 
(Massey, 1960; Massey & Veeger, 1961; Massey, 1963). NAD is the 
ultimate electron acceptor.
SDS-PAGE reveals that purified OGDC contains three different 
polypeptide chains. Apparent M^ values for these chains in porcine heart 
OGDC are 113000, 55000 and 48000 (Koike et al., 1974) and in coll 
OGDC 94000, 54000 and 47000 (Perham & Thomas, 1971; Pettit et al.,
1973). Resolution of OGDC into its component enzymes has been achieved 
by gel filtration in the presence of chaotropic agents (Tanaka et al., 
1972; Pettit et al., 1973). This has allowed assignment of the 113000, 
55000 and 48000 M polypeptides of porcine heart to the functions of El, 
E3 and E2 respectively (Koike et al., 1974). Similarly the 94000,
54000 and 47000 M proteins of E- coli OGDC were found to correspond 
to the El, E3 and E2 activities respectively (Pettit et al., 1973).
Sedimentation equilibrium analysis of the component enzymes 
revealed that, at normal ionic strength and pH, El and E3 exist as 
dimers whereas the E2 component is isolated as an assembly of high M^, 
approx. 1 X 10^ (Tanaka et al., 1972; Pettit et al., 1973).
Of the three protein bound cofactors, all of the TPP is found
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associated with the El component whereas the lipoic acid and FAD were 
isolated with E2 and E3 respectively.
The three isolated enzymes reassemble spontaneously to produce a 
large unit resembling the native complex in composition and enzymic 
activity. Native OGDC has a sedimentation coefficient of approx. 375 
(Hirashima et al., 1967; Stanley & Perham, 1980), an of approx. 2.7 
X 10^ (Pettit et al., 1973; Koike & Koike, 1976) and a diameter of 25- 
26 nm (Ishikawa et al., 1966; Tanaka et al., 1972). Binding studies 
reveal that El and E3 do not interact with each other but each of 
these enzymes does associate with E2 (Tanaka et al., 1972; Pettit 
et al., 1973). This suggests that E2 plays a key role in the 
structural organisation of the complex as well as in its enzymatic 
activity. From these studies the idea of structural organisation 
suggested was one of an organised mosaic of enzymes in which each 
subunit is uniquely located to permit efficient implementation of the 
consecutive reactions.
Results of electron microscopic studies, X-ray crystallographic 
studies and sedimentation equilibrium determinations revealed that 
the E2 core enzyme of OGDC consists of 24, apparently identical, 
polypeptide chains, grouped into 8 trimeric morphological units, 
arranged with 432 molecular symmetry in a cube-like particle (DeRosier 
et al., 1971; Tanaka et al., 1972). Limited proteolysis of E^ coll 
lipoate succinyltransferase revealed that each chain consists of two 
principal domains (Perham & Roberts, 1981):
1. A compact domain (M^ 36000) which contains the intersubunit 
binding regions and the transsuccinylase catalytic site. This 
domain which forms a closed structure, the E2 inner core, 
determines the stoichiometry and quaternary structure of the
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complex;
and
2. A (M^ 11000) fragment bearing the lipoyl groups.
These domains are apparently connected by a hinge region.
The mobility of the flexible 'lipoyl-bearing* domain is revealed 
by proton NMR spectroscopy where unexpectedly sharp resonance lines 
are observed superimposed on the broad resonances expected of such a 
large protein complex (Perham & Roberts, 1981). By analogy with 
E. coli PDC (Perham et al., 1981), these sharp resonances have been 
attributed to the high mobility of the lipoyl domains. Indeed all the 
evidence is consistent with a random coil-like structure for these 
highly mobile regions of polypeptide chain, though small parts of 
these regions could have defined three dimensional structure. The 
existence of part of the lipoyl domain other than the lipoyl-lysine 
bearing segment is shown by analysis of the structure remaining after 
trypsin releases the 11000 lipoyl-bearing fragment. A flexible 
region still remains attached to the inner core (Perham & Roberts,
1981). One possibility is that E2 consists of three domains: the inner 
core, a structured lipoyl-containlng domain and a highly flexible 
region of random coil which links the two. This structure seems to be 
present in transuccinylases from bovine heart and bovine kidney also 
(Kresze et al., 1981; Warwrzynczak et al., 1981), although protease 
treatment of bovine kidney OGDC, while producing an E2 fragment which 
remains assembled in a structure of high M , apparently damages the El 
and E3 binding sites on E2 resulting in dissociation of these 
subunits.
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From the determination of cofactor content of the purified 
complex and consideration of the subunit the stoichiometry of
polypeptide chains in the coll OGDC was estimated at 10 El: 24 E2:
10 E3 (Pettit et al., 1973), although E3 contents of 12 chains per 24 
E2 subunits were observed on occasions. It was suggested from this 
that the native ratio is probably E1;E2:E3 = 12:24:12. Titration of 
OGDC with the transition state analogue Inhibitor of El, thiamine 
thiazolone pyrophosphate, also indicated the presence of 12 El active 
sites per complex (Angelides & Hammes, 1979). By use of the radio- 
amidination procedure of Bates et al. (1975), the chain ratio of 
porcine heart OGDC was estimated as 12 El: 24 E2: 12 E3 (Koike &
Koike, 1982). The possibility cannot be ruled out, however, that OGDC, 
like E^ coli PDC, is heterodisperse. Gilbert & Gilbert (1980) showed 
that a symmetrical Schleiren peak is not neccessarily unequivocal 
proof of homogeneity.
Determination of coenzyme content of native OGDC has shown that
the porcine heart complex contains 6 moles TPP, 8 moles lipoic acid and
12 moles PAD per mole of complex. This means that every El dimer has an
associated TPP, every 3 E2 chains contain 1 lipoic acid and each E3
chain contains an PAD group (Tanaka et al., 1972). In the case of the
E. coli OGDC the lipoic acid content was determined by measuring
14incorporation of [4- C]succinyl groups into E2, following incubation 
14with 2-(5- C]oxoglutarate or incorporation of 
14N-ethyl{2,3- ]maleimlde into the free thiol, generated by reductive 
acylation of lipoic acid. Each E2 chain was shown to contain one 
lipoic acid (Collins & Reed, 1977; Angelides S> Hammes, 1979). This was 
confirmed by isotopic dilution analysis of the lipoic acid content 
performed by White et al. (1980). Accurate determination of the lipoyl
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content of transacylases has proved difficult. Variable results have 
been obtained from microbial assays (used to determine lipoic acid 
content of porcine heart OGDC) and measurement of content of radioactive 
lipoic acid in complexes isolated from coli grown in the presence 
of l^^S^llipoic acid (Collins & Reed, 1977).
A key functional role in the co-ordinated sequence of reactions 
is played by E2. The lipoyl group, covalently bound to this 
polypeptide, undergoes a series of transformations in the catalytic 
cycle; reductive acylation, acyl transfer and electron transfer. These 
involve interaction with prosthetic groups or coenzymes of 3 distinct 
enzymes and no reaction intermediates are released from the complex. 
Highly favourable positioning of the active sites of the 3 enzymes 
must be assumed in order to account for the occurrence of the overall 
reaction. Lipoic acid was found to be attached via an amide linkage to 
a lysine residue of E2 (Nawa et al., 1960). Subsequently it was 
proposed that this provided a flexible arm 1.4 nm long which permitted 
the lipoyl moiety to rotate between the catalytic sites of all 3 
enzymes. Indeed e.s.r. spectroscopy of E^ coli PDC, a complex with 
similar structural and functional properties to OGDC (Reed & Oliver, 
1968), indicated the flexibility of these lipoyl moieties (Ambrose & 
Perham, 1976).
Fluorescence energy transfer measurements of the distance between 
the catalytic sites of the enzyme components of ^  coli OGDC were 
consistent with a mechanism involving rotation of a single lipoyl 
group between catalytic sites during the reaction cycle (Angelides & 
Hammes, 1979). Discovery of flexible lipoyl domains however, has led 
to a proposal that movement of these domains and not merely the
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lipoyl-lysine provides the means to span the physical gaps between the 
catalytic sites (Stepp et al., 1981).
In titrations of E2-E3 subcomplexes with El, the overall activity 
was a linear function of El added and maximal activity was observed 
with chain ratio 12 El: 24 E2 (Reed & Oliver, 1982). Similar results 
were observed when OGDC was inactivated by titration of El with the 
transition state analogue, thiamine thiazolone pyrophosphate 
(Angelides & Hammes, 1979). This indicates that the reaction catalysed 
by El is rate-limiting in the reaction sequence, (Fig. 3).
However, when 9 out of 12 El polypeptides of OGDC were inhibited 
with thiamine thiazolone pyrophosphate, rapid incorporation of approx. 
20 succinyl groups per molecule of complex was observed (Collins & 
Reed, 1977). Treatment of OGDC with dimaleimide in the presence of 
substrate resulted in cross-linked dimers of E2. Dimaleimide cross­
links E2 via succinyldihydrolipoyl or dihydrolipoyl groups. The 
presence of cross-linked E2 dimers indicates that E2 contains only one 
lipoyl per chain and that these lipoyl groups can interact (Collins & 
Reed, 1977). In addition, quantitative removal of lipoyl groups by 
lipoamidase or lipoyl domains by trypsin and monitoring of residual 
enzyme activity points to interaction of lipoyl groups. On removal of 
50% of lipoyl moieties OGDC retained 75% of its original activity 
(Stepp et al., 1981). These results suggest each El subunit may 
transfer succinyl groups to more than one lipoyl domain. Computer 
analysis has suggested a model whereby each El services 2 lipoyl 
groups (Hackert et al., 1983). Although the capacity for succinyl 
transfer between lipoyl groups is present in the complex, it has not 
been demonstrated that such transfer is on the main catalytic pathway 
(Angelides & Hammes, 1979).
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Consideration of the structure of OGDC reveals that not all E3 
polypeptide chains are positioned identically with respect to the 
lipoyl domains of E2. Titration of E1-E2 subcomplex with E3 indicates 
the presence of multiple Interconnected pathways from El to E3 (Pettit 
et al., 1973). Therefore it is unlikely that all dihydrolipoyl 
moieties are re-oxidised by direct interaction with E3 and electron 
transfer between oxidised and reduced lipoyl groups appears an 
essential property of the complex (Reed & Oliver, 1982). The geometry 
of possible arrangements of E3 dimers shows that probably only one 
thiol disulphide exchange is required to transfer one electron pair to 
E3.
This active site coupling seems to be a common property of all 
OGDC and PDC complexes studied so far. Active site coupling obviously 
has advantages in that under physiological conditions where CoA and 
2 —0 X 0  acid levels are so low that the joint probability of binding to 
adjacent sites is very low the reaction can still proceed. In addition 
it is also neccessary in situations where active sites are not present 
in equal numbers.
1.12 REGULATION OF 2-OXOGLUTARATE DEHYDROGENASE
Under most metabolic conditions, the reaction catalysed by OGDC 
is the primary site of control for the segment of the citric acid 
cycle from 2-oxoglutarate to malate. 2-oxoglutarate is a branch point 
metabolite of the citric acid cycle which may be oxidised via the 
citric acid cycle to produce energy or withdrawn from the cycle for 
energy—requiring biosynthetic pathways. Regulation at this step would 
ensure that the requirements of the cell for energy in addition to
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biosynthetic intermediates are kept in balance.
A general feature of the regulation of OGDC is feedback 
inhibition by the reaction products succinyl-CoA and NADH which is 
reversed by .CoA and NAD respectively (Garland, 1964; Hansen &
Henning, 1966; Parker & Veitzman, 1973). The site of action of NADH is 
proposed to be located on the E3 subunit (Hansen & Henning, 1966; 
Parker & Weltzman, 1973), although there may be an additional site for 
NADH action on the El component of OGDC from Aclnetobacter Iwoffi 
(Parker & Weitzman, 1973). Lipoate succinyltransferase contains the 
site for succinyl-CoA inhibition (Koike & Koike, 1976). In addition to 
acting as a substrate for Acetobacter xylinum OGDC, NAD also appears 
to act as an allosteric modifier decreasing the Km for 2-oxoglutarate 
(Kornfeld et al., 1977). In this system positive cooperativity with 
respect to 2-oxoglutarate has also been observed.
The activity of OGDC is also affected by the presence of adenine 
nucleotides. ATP has an inhibitory effect on OGDC (Hansford, 1972; 
Ohne, 1975; McCormack & Denton, 1979; Williamson & Cooper, 1980), 
whereas AMP or ADP stimulate OGDC activity in all cases studied except 
Ic. coll (Wedding & Black, 1971; Parker & Weitzman, 1973; Kornfeld 
et al., 1977; McCormack & Denton, 1979; McCormack & Denton,1981). This 
effect on enzymatic activity is achieved by an alteration in the Km 
for 2-oxoglutarate. ATP does not act by causing phosphorylation of 
OGDC as is true in the cases of PDC and BCDC (Reed & Yeaman, 1985).
The effect appears to be mediated by adenine nucleotides binding to a 
site on El (Kornfeld et al., 1977). The specificity of this binding is 
demonstrated by the preference for adenine nucleotides, the presence 
of 2' and 3’ -OH groups and the presence of a phosphate group attached
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to the cyclo-furan ring (Wedding & Black, 1971). AMP is an indicator 
of a low energy state in the cell, its concentration varying inversely 
with that of ATP. Control of OGDC by adenine nucleotides may serve as 
a physiological mechanism for regulating energy metabolism by 
increasing flux around the citric acid cycle and away from 
biosynthetic pathways when the energy demands of the cell require it.
Inhibitory effects of succinyl-CoA and NADH may provide 
additional mechanisms whereby flux could be related to the oxidation- 
reduction state of the cell and via succinyl-CoA synthetase to the 
phosphorylation state of cellular nucleotides.
The activity of porcine heart OGDC has been shown to be inhibited 
by branched chain 2-oxo acids suggesting that the complex is 
regulated by relative levels of various 2-oxo acids, including 
branched chain 2-oxo acids derived from intermediary metabolism of 
branched chain amino acids (Kanzaki ^  al., 1969; Koike & Koike,
1976). Branched chain 2-oxo acids can act as substrates for OGDC and 
form acyldihydrolipoyl thloesters. Inactivation of OGDC is observed as 
these acyl groups are only very slowly transferred to CoA. This 
covalent modification of OGDC may be a major cause of the toxaemia 
associated with Maple Syrup Urine Disease (Jackson & Singer, 1983).
There have been reports of micromolar levels of Ca^^ stimulating 
OGDC by decreasing the Km for 2-oxoglutarate in a manner independent 
to that of adenine nucleotides in all vertebrate tissues studied so 
far but not in OGDC from insect or plant sources or coli (McCormack 
& Denton, 1979; Denton & McCormack, 1980; McCormack & Denton, 1981; 
Roche & Lawlis, 1982). In insect sources such as OGDC from blowfly 
flight muscle the most important regulatory agent appears to be the 
ATP/ADP ratio (Hansford, 1972). Two other mitochondrial dehydrogenases
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2+  +
are stimulated by similar concentrations of Ca : NAD -dependent
2+
isocitrate dehydrogenase and PDC. In the former case the Ca effect
on enzymic activity is direct as with OGDC. In the case of PDC,
however activation is achieved by dephosphorylation of the El«6
component of PDC by a specific PDC phosphatase whose activity Is 
2+stimulated by Ca . The fact that the activities of three important
mitochondrial dehydrogenases are all affected by a similar
2+concentration of Ca , points to a regulatory role for this ion. It
2+
has been suggested, that Ca is, perhaps, the means whereby extrinsic
agents, such as hormones, could regulate Intramitochondrial metabolism
(Murphy et al., 1980; McCormack & Denton, 1981). Denton et al. (1980)
predicted that the intramitochondrial [Ca^^] was in the range 0.1-2.0
uM which is the correct range for a regulatory effect. However other
workers have reported concentrations of 30 uM and above which would
2+
completely saturate the Ca binding sites on these enzymes
2+
(Williamson & Cooper, 1980). The concentration of free Ca inside the
mitochondria must be determined before any role involving Ca^ "*" in
2+
regulation can be proposed. If Ca is a regulatory factor then the 
possibility of a mitochondrial calmodulin-like protein must be 
considered.
An alternative regulatory mechanism exists in ^  coli. In this 
organism OGDC is an inducible enzyme not synthesised during anaerobic 
growth. During growth on carbon sources requiring terminal oxidation, 
e.g. glutamate, OGDC is synthesised, but in cells grown on lactate or 
glucose, OGDC is not synthesised until substantial levels of 
metabolite have accumulated. Physiological induction of OGDC synthesis 
may be brought about by 2-oxoglutarate (Amarasingham & Davis, 1965). 
OGDC is also inducible in Bacillus subtilis where levels increase at
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the end of the exponential growth phase because a functional citric 
acid cycle is required for sporulation. Again 2-oxoglutarate or 
glutamate, which is formed from 2-oxoglutarate by transamination, is 
thought to be the agent responsible for induction (Ohne, 1975).
1.13 AIMS OF PROJECT
From the preceeding sections it can be seen that in comparison to 
the work carried out regarding the structure, function and regulation 
of OGDC, few studies have addressed the problem of biosynthesis of 
this multienzyme complex.
The aims of this project, therefore, were to study the biosynthesis 
of the component enzymes of OGDC in mammalian cell lines, to 
investigate the possible existence of larger M^ precursors for the 
individual polypeptides and to obtain data relating to the import of 
these polypeptides into mitochondria.
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CHAPTER TWO
MATERIALS AND METHODS
2.1 MATERIALS
2.1.1 CHEMICALS AND BIOCHEMICALS
Benzamidine-KCl, PMSF, 1,10-phenanthroline, leupepCin, DOC, Tween
20, 2,4-DNP, digitonin, TEMED, Coomassle Brilliant Blue R-2S0, pyruvic
acid (monosodium salt), 2-oxoglutarlc acid (monosodium salt), NAD ,
TPP, NEM, antifoam A concentrate, iodoacetamide, MOPS, EGTA, DTNB,
acetyl-CoA, oxaloacetic acid and malic acid were purchased from Sigma
Chemical Co., Poole, Dorset, U.K..
DMSO, DTT, PPG, toluene and sucrose came from Koch-Light
Laboratories Ltd., Colnbrook, Berks., U.K..
Tris, CoA (trilithium salt) and ATP were the products of
Boehringer Corporation (London) Ltd., Lewes, East Sussex, U.K..
Acrylamide, N,N'-methylenebisacrylamide, EDTA (disodium salt),
SDS, Folin Ciocalteu's Phenol reagent and L-cystelne-HCl were
obtained from BDH Chemicals Ltd., Poole, Dorset, U.K..
Polyethylene glycol 6000 was purchased from Serva, Heidelberg,
TMWest Germany. lodogen came from Pierce and Warriner (U.K.) Ltd., 
Chester, U.K.. Triton X-100 was bought from Rohm and Haas (U.K.) Ltd., 
Croydon, U.K.. Pyronin Y was obtained from George T. Gurr Ltd., London 
SW6, U.K.. 2-mercaptoethanol was supplied by Riedel-de-Haën, via A. & 
J. Beveridge Ltd., Edinburgh, U.K.. Salicylate (sodium salt or free 
acid) came from Aldrich Chemical Co., Gillingham, Dorset, U.K.. FCCP 
was the gift of Dr P.G. Heytler, E.I. Du Pont De Nemours and Co.
(Inc.), Delaware, U.S.A..
All other chemicals were of analytical grade or of the highest 
available purity.
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2.1.2 RADIOCHEMICALS
3
N-[Et-2- H]Ethylmalelmide (50 Cl/mmol) was purchased from New
England Nuclear, Southampton, U.K..
35
L-[ Sjmethionine (approx. 1200 Ci/mmol) was obtained from
Amersham International p.I.e., Bucks., U.K..
125
Na I, carrier free, came from the Western Infirmary, Glasgow, 
U.K..
2.1.3 PROTEINS AND ENZYMES
The following commercial enzyme and protein preparations were 
obtained from Sigma Chemical Co., Poole, Dorset, U.K.:- 
citrate synthase (EC 4.1.3.7) from porcine heart 
fumarase (EC 4.2.1.2) from porcine heart 
TPCK-treated trypsin (EC 3.4.21.4) from bovine pancreas 
p-galactosldase (EC 3.2.1.23) from Escherichia coli 
protein A from Staphylococcus aureus, Cowan I strain 
bovine serum albumin.
Diaphorase (lipoamide dehydrogenase) (EC 1.8.1.4) from porcine 
heart was purchased from Boehringer Corporation (London) Ltd., Sussex, 
U.K..
Electrophoresis calibration kit for low M^ proteins came from 
Pharmacia (G.B.) Ltd., Milton Keynes, Bucks., U.K..
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2.1.4 CHROMATOGRAPHY MATERIAL
Sepharose CL-2B, Sephadex G-25, DEAE—Sephacel and phenyl-Sepharose 
were the products of Pharmacia (G.B.) Ltd., Milton Keynes, Bucks.,
U.K. .
Procion Red A and Cibacron Blue A dye matrix column materials 
were purchased from Amicon Ltd., Scientific Systems Division, Upper 
Mill, Stonehouse, Gloucestershire, U.K..
2.1.5 CELL CULTURE MATERIALS
Glasgow-modified Eagle's medium, L-glutamine (200mM), PK-15, NBL-1 
and BRL cell lines were purchased from Flow Laboratories Ltd., Irvine, 
Ayrshire, U.K..
Glasgow-modified Eagle’s medium without L-methionine and 
L-glutamine, myo-clone foetal calf serum, newborn calf serum, MEN non 
essential amino acids (lOOx) and Nunc, sterile Roux flasks and petri- 
dishes were obtained from Gibco Europe Ltd., Paisley, Renfrewshire, 
U.K..
The following sterile solutions and sterile glassware were 
supplied by the staff of the tissue culture unit associated with this 
department:- 
Trypsin
trypsin IS.OOg
trisodium citrate 17.76g
NaCl 36.90g
phenol red 1% (w/v) 9.00ml
distilled water to 6.001
pH 7.8
Sterilise - millipore filtration. Store at -20°C
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Versene
NaCl 80.00g
KCl 2.00g
Na HPO 11.50g
KH^PQ^ 2.00g
versene (EDTA) 2.00g
phenol red 1% (w/v) 15.00ml
distilled water to 10.001
Sterilise - autoclave. Store at room temperature.
§2ËiH!5 bicarbonate
NaHCO 56.00g
phenol red 1% (w/v) 1.5ml
distilled water to 1.01
Sterilise - millipore filtration. Store at room temperature.
Penicillin/Streptomycin
penicillin 10000000.OOU
streptomycin lO.OOg
distilled water to 1.01
Sterilise - millipore filtration. Store at -20*C.
2.1.6 PHOTOGRAPHIC MATERIALS
X-Omat S and XAR-5 X-ray films, Kodak FX-40 liquid fixer and Kodak 
LX-24 X-ray developer were purchased from Kodak Ltd., Manchester,
U.K..
2.1.7 ANIMALS
New Zealand White rabbits and 150-350g female rats (Albino Wistar 
strain) were provided by the departmental animal house. Bovine hearts 
were obtained from Glasgow Abbatoir, Duke Street, Glasgow or from 
Paisley Abbatoir, Sandyford Road, Paisley. The hearts were removed 
from the animals within one hour of slaughter, chilled immediately on
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ice and were used in the laboratory within two hours of slaughter.
2.1.8 MISCELLANEOUS
Freund’s Adjuvants (complete and incomplete) were obtained from 
Difco Laboratories, West Moseley, Sussex, U.K..
Normal rabbit serum came from the Scottish Antibody Production 
Unit, Law Hospital, Carluke, Lanarkshire, U.K..
Heat-inactivated horse serum was purchased from Gibco Europe Ltd., 
Paisley, Renfrewshire, U.K..
Nitrocellulose paper (0.45pm pore size) was the product of 
Schleicher and SchUll, Dassel, West Germany.
Pansorbin (standardised 10% (w/v) formalinised 
Staphylococcus aureus cells) was obtained from Calbiochem-Behring 
Corp., Bishop Stortford, Herts., U.K..
Nalgene sterilisation filter units, type S (115ml, 0.20 ^ m pore 
size) were from Nalge Company, Rochester, New York, U.S.A..
Cronex ’Lightning-Plus' intensifying screens came from Du Pont 
(U.K.) Ltd., Stevenage, Herts., U.K..
Plast-X cassettes, for exposure of X-ray films, were obtained from 
Anthony Monk [Eng.] Ltd., Sutton-in-Ashfield, U.K..
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2.2 METHODS
2.2.1 ENZYME ASSAYS
âi 2-Oxo Dehydrogenase Complexes
The overall activities of the 2-oxoglutarate dehydrogenase and 
pyruvate dehydrogenase complexes were assayed according to the method 
of Brown & Perham (1976).
Assays were carried out at 30°C in a final volume of 1.0ml of 
50mM potassium phosphate buffer, pH 8.0, containing 2.5mM NAD^, 0.2mM 
TPP, l.OmM MgClg, 0.13mM CoASH, 2.6mM cysteine—HCl and 2.OmM sodium 
2-oxoglutarate (or 2.OmM sodium pyruvate). The assay was started by 
addition of enzyme and the reaction followed by monitoring NADH 
formation at 340nm.
1 unit of activity (Ratal) is defined as the amount of enzyme 
required to catalyse the conversion of one mole of substrate per 
second under the conditions of the assay.
Citrate Synthase
Citrate synthase is assayed, by measuring the appearance of the 
free sulphydryl group of the released CoA using DTNB (Ellman’s 
reagent), as described by Srere (1969). This reaction is followed at 
412nm where the resulting mercaptide ion has a strong absorption (E^^^ 
13600).
Assays were carried out at 25°C by adding, in this order, 200pl 
of 0.5M Tris-HCl, pH 8.0; 200pl of 0.5mM DTNB; lOOpl of 3mM acetyl-CoA; 
distilled water and enzyme to 0.90ml. The change in absorbance at 
412nm is measured initially to check for acetyl-CoA deacylase 
activity. To start the reaction lOOpl of 5mM oxaloacetate was added
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and the change In absorbance at 412nm monitored once more.
1 unit of activity is defined as the amount of enzyme required to 
release lumol CoA per min at 25^C.
c) Fumarase
Fumarase was assayed using a modification of the method of Racker 
(1950).
The reaction mixture was made up as follows:- 336mg L-malic acid 
was dissolved in approx. 40ml of O.IM potassium phosphate buffer, 
pH7.6. The pH was readjusted to 7.6 with approx. 5ml of 2N NaOH before 
adjusting to a final volume of 50ml with O.IM potassium phosphate 
buffer, pH 7.6.
0.97ml of reaction mixture was placed in a cuvette and the 
reaction initiated by the addition of up to 30pl of enzyme. The
reaction was followed by monitoring the appearance of fumarate, which
has a carbon-carbon double bond absorbing at 240nm (E^^^ 2.44).
1cm 240
2.2.2 PROTEIN DETERMINATION
Protein was determined by using a modification of the Lowry 
et al. (1951) procedure as described by Markwell et al. (1976) using 
bovine serum albumin as a standard.
Stock solutions were prepared as follows;- 
Solution A: 2% (w/v) NaCO^, 0.4% (w/v) NaOH, 0.16% (w/v) sodium
tartrate and 1% (w/v) SDS
Solution B: 4% (w/v) CuSO^.SH^O
Solution C: 100 parts A mixed with 1 part B
BSA stock; Img/ml BSA stock stored at —20°C
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Folin Ciocalteu’s phenol reagent ; diluted 1:1 (v/v) with
distilled water on day of use 
A sample volume of 1.0ml containing lO-lOOpg protein was mixed with 
3.0ml of solution C and incubated at room temperature for 10-60 min. 
Samples were then mixed vigorously with 0.3ml of diluted phenol 
reagent and incubated at room temperature for a further 45 min before 
reading the absorbance at 660nm.
2.2.3 GEL FILTRATION
Glass chromatography columns were washed with a dilute detergent 
solution and rinsed thoroughly with distilled water. A slurry of the 
gel was poured into the column and packed by allowing a gentle flow of 
buffer (approx. 5ml/h). Equilibration was performed by pumping 2-3 bed 
volumes of the required buffer through the column. Samples were pumped 
through the columns using an LKB 2132 microperpex peristaltic pump and 
fractions were collected using an LKB 2112 fraction collector.
2.2.4 POLYACRYLAMIDE GEL ELECTROPHORESIS (SDS-PAGE)
a) Analytical Gels
SDS-PAGE was carried out using the discontinuous Tris-glycine 
buffer system of Laemmli (1970).
Stock solutions were prepared as follows:- 
Solutlon A: 3.0M Tris-HCl, pH 8.8, containing 0.25% (v/v) TEMED
Solution B: 28% (w/v) acrylamide containing 0.735% (w/v)
N,N’-methylenebisacrylamide, deionised.
Solution C: O.IM Tris-HCl, pH 6.8, containing 0.8% (w/v) SDS and
0.25% (v/v) TEMED
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Solution D: 20% (w/v) SDS
Reservoir buffer : 25mM Tris base containing 192mM glycine and
0.1% (w/v) SDS
Gels were cast using our own, home-made, apparatus in slabs of 19.0cm 
X 9.5cm X 0.15cm, or, if longer gels were required, using a Bio-rad 
Protean 16cm apparatus in slabs of 18.0cm x 16.0cm x 0.15cm.
Separating gels of the required percentage were prepared from 
stock solutions according to the following table:-
Percentage acrylamide
6% 7.5% 10% 12.5% 15%
Solution A 25.0 25.0 25.0 25.0 25.0
Solution B 42.3 52.9 71.5 89.3 105.0
Solution C 1.0 1.0 1.0 1.0 1.0
distilled water 129.2 118.6 100.0 82.2 66.5
(all volumes in the table are in ml)
These solutions were mixed, degassed and polymerisation was 
initiated by adding 150mg ammonium persulphate. The mixture was 
degassed again before pouring into the casting apparatus.
Stacking gels were made from stock solutions as follows:-
Percentage acrylamide 
6% 3%
Solution B 
Solution C 
distilled water
17.5 8.8 
10.0 10.0 
55.0 63.7
(all volumes in the table are in ml)
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Polymerisation was initiated with 150mg ammonium persulphate and 
the stacking gel was allowed to polymerise around a teflon template to 
allow well formation.
b) Preparative Gels
Preparative polyacrylamide gels were prepared in the same manner 
as described above but the gel thickness was increased to 0.3cm.
c) Preparation Of Samples For SDS-PAGE And Conditions Of 
Electrophoresis
Stock solutions were prepared in the following manner 
Laemmli sample buffer: 62.5mM Tris-HCl, pH 6.8, containing
2% (w/v) SDS, 10% (w/v) sucrose and 0.01% (w/v) 
pyronin Y 
DTT: IM DTT. Store at -20°C.
Iodoacetamide; IM iodoacetamide. Store in dark at 4*C.
Protein samples were heated to 100°C for 2 min in Laemmli sample 
buffer containing 5% (v/v) 2-mercaptoethanol or lOmM DTT, before being 
applied to the gel. In addition to the above, iodoacetamide was added 
to O.IM in cell extracts and cell subfractions which were to be used 
for immunoblotting analyses. Electrophoresis was carried out at 50mA 
until the dye front was within 0.5cm of the bottom of the gel.
d% Staining And Scanning Of Polyacrylamide Gels
Protein bands were visualised by immersing the gels in a solution 
of (i) 0.04% (w/v) Coomassie Brilliant Blue R-250 in 25% (v/v) 
isopropanol, 10% (v/v) acetic acid for 16-20h followed by destaining
in 10% (v/v) acetic acid.
\
or (ii) 0.1% (w/v) Coomassie Brilliant Blue R-250 in 50% (v/v)
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methanol, 10% (v/v) acetic acid for Ih followed by destaining in 20% 
(v/v) methanol, 10% (v/v) acetic acid.
Destained polyacrylamide gels were scanned using an LKB 2202 
Ultroscan Laser Densitometer.
2Î From SDS-Polyacrylamide Gels 
determinations were carried out by comparing the mobility of a 
protein band on SDS-polyacrylamide gels with those of a set of low M 
standard proteins including:- phosphorylase b, 92000; BSA, 67000; 
ovalbumin, 45000; carbonic anhydrase, 30000; trypsin inhibitor, 21000 
and g(-lactalbumin, 14000 plus ^-galactosidase, 116000.
2.2.5 RADIOLABELLING TECHNIQUES
î2Ëi2Ë2î2S Of E22&2É2 6 A W  M Standards
Protein A and standards were iodinated using the solid phase
oxidising agent, lodogen as described by Salacinski et al. (1981).
Img of lodogen was dissolved in 0.5ml chloroform and coated onto
the surface of a vial by blowing off the chloroform using an air
stream. Protein A (Img) or standards (578pg) dissolved in 0.5ml
20mM Tris-HCl, pH 7.2, containing 0.15M NaCl was added to the vial
125coated with lodogen together with 300-500^Ci of Na I. lodination was
allowed to proceed for 15 rain before the reaction was stopped by
removing the sample and applying it to a 8.0cm x 1.3cm Sephadex G-25
column equilibrated in 20mM Tris-HCl, pH 7.2, containing 0.15M NaCl.
125
Fractions containing I-labelled protein A were pooled, divided into 
small aliquots and stored at -20^C.
66
b) Labeling Of 2%0xog!Wta^W Dehydrogenase With 
3
N-[ Hlethylmaleimide
Thiol groups of dissociated 2-oxoglutarate dehydrogenase complex 
were labelled with N-[^HJethylmaleimide as follows:- 
lOOpg of purified OGDC was precipitated in 80% (v/v) acetone for 
several hours at -20°C. The pellet was dissolved in 200^1 of 20mM 
Tris-HCl, pH 7.2, containing 2% (w/v) SDS and incubated with 50^Ci 
(5mM) N-[^H)ethylmaleimide for 30 min at 25°C. Termination of the 
reaction was achieved by the addition of 2-mercaptoethanol to a final 
concentration of 5% (v/v). Labelled protein was precipitated in 
acetone as before. The pellets were washed once in cold acetone, 
dried, redissolved in 200jil of 2% (w/v) SDS and diluted five fold with 
lOmM Tris-HCl, pH 7.4, containing 300mM NaCl, 5mM EDTA and 1% (v/v) 
Triton X-100 (Triton buffer). Radiolabelled protein was stored in 
small aliquots at -20°C.
2.2.6 DETECTION OF RADIOACTIVITY
2Î. 2®ÎD!n® Radiation
125Radioactivity in samples radiolabelled with I was determined 
by counting in an LKB Wallac 1275 minigamma counter.
b) Liquid Scintillation Spectrometry
Aqueous samples of total volume 0.5ml were made up to 5.0ml with 
0.5% (w/v) PPO and 35% (v/v) Triton X-100 in toluene and counted in a 
Beckman LS6800 liquid scintillation counter.
To facilitate estimation of radioactivity incorporated into 
protein, 5-50pl samples were placed on Whatman No. 1 filter discs
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(2.5cm diam.). Discs were dropped into ice-cold 10% (w/v) TCA, washed 
a further twice with 10% (w/v) TCA and once with ethanol. All washes 
were carried out for 30 min at 4°C. Dried discs were placed in 
scintillation vials containing 5.0ml scintillation fluid and analysed 
as above.
c) Autoradiography
125Autoradiography was employed to visualise I-labelled proteins 
in polyacrlyamide gels or on nitrocellulose paper. The nitrocellulose 
paper was dried at room temperature and the gels dried under vacuum 
before exposure to X-Omat-S X-ray film at -70°C with a Cronex 
'Lightning Plus' intensifying screen to enhance autoradiographic 
detection (Laskey & Mills, 1977).
d) Fluorography
Gels for analysis by fluorography were stained in Coomassie blue 
as described in section 2.2.4 d, or fixed in 25% (v/v) methanol, 10% 
(v/v) acetic acid before processing with DMSO-PPO as detailed by 
Bonner & Laskey (1974). Gels were incubated for 3 x 30 min in DMSO, 
then for 3-4h with 20% (w/v) PPG in DMSO, and washed finally for l-2h 
in running water before being dried under vacuum. Thereafter gels were 
exposed to XAR-5 or X-Omat S X-ray film at -70°C.
Alternatively, gels were processed according to the method of 
Chamberlain (1979) using the water-soluble fluor, salicylate. Gels 
were stained or fixed (as above) then washed for 30 min in 2-3 changes 
of distilled water to remove all traces of acid. Incubation in IM 
salicylate for 30 min at room temperature was carried out prior to 
drying the gel and exposure to X-ray film as described previously.
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2.2.7 TISSUE CULTURE
a) Medium
PK-15 cells were routinely grown in Glasgow modified Eagle's 
medium supplemented with 5% (v/v) foetal calf serum, 1% (v/v) non 
essential amino acids, lO^U/1 penicillin, lOOmg/1 streptomycin and 
2.24g/l NaHCO^ (normal growth medium-NGM).
NBL-1 and BRL cells were grown in the above medium containing 10%
(v/v) foetal calf serum and 10% (v/v) newborn calf serum respectively.
Minus methionine medium (MMM) consists of Glasgow modified 
Eagle's medium (without L-glutamine or L-methionine) supplemented with
1% (v/v) non essential amino acids, 2mM L-glutamine, lO^U/1
penicillin, IOOmg/1 streptomycin and the appropriate serum type and 
concentration described above.
Low methionine medium (LMM), used during incorporation of 
(^^Sjmethionine into cellular protein, was 5% (v/v) normal growth 
medium in minus methionine medium.
b) Roybine Culture Of Cells
Cells were maintained in normal growth medium in plastic Roux 
bottles at 37°C in an atmosphere of 95% (v/v) air/5% (v/v) CO^ and 
were subcultured every 3-4 days.
Monolayers were rinsed twice with versene solution (section 
2.1.5), once with trypsin solution (section 2.1.5), then incubated at 
37°C with sufficient trypsin to cover the cell monolayer. On release 
of the cells from the plastic surface, 20ml of NGM was added and the 
cells disaggregated by gentle passage up and down a sterile pipette. 
Cells were counted in a haemocytometer and 3-5 x 10^ cells were
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returned to the Roux flask in approx. 50ml NGM.
35
si Labelling Of Cells With £ S]methlonine
35
For incorporation of [ Sjmethionine into protein, cells were 
introduced into 10cm diam. sterile petri-dishes at a concentration of 
3-3.5 X 10 cells/ml in 10ml of NGM. Petri-dishes were incubated at 
37 C in a humidified incubator containing an atmosphere of 95% (v/v) 
air/5% (v/v) CO^ for 24-48h until semi-confluent monolayers were 
observed. NGM was replaced with 4.0ml of LMM after an initial rinse in 
the same medium, then incubated for a further Ih to deplete 
intracellular pools of methionine. After addition of 100-200pCi 
[ Sjmethionine to the medium, dishes were incubated at 37^C for 
either 4h or overnight. Lysis of the cells and preparation of extracts 
was as described in section 2.2.8 a.
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d) Labelling Of Cells With ^ Sjmethionine In The Presence Of 
Uncouplers Of Oxidative Phosphorylation
Replicate dishes of cells were cultured in NGM as before, 
including preincubation with LMM for Ih before the addition of 4.0ml 
of LMM containing uncoupler added from freshly-made stocks of 200mM 
2,4-DNP or ImM FCCP. After 5-15 min at 37°C 200pCi [^^Sjmethionine was 
introduced asceptically and the incubation continued at 37°C for 4h 
before preparation of cell lysates (section 2.2.8 a).
e) Pu^e^C^se Labeling Of Cells
35
Cells were labelled for 4h with [ Sjmethionine in the presence 
of uncoupler as described above. Radioactive medium was discarded, the 
cells rinsed in NGM and incubated in 10ml NGM at 37°C for various 
lengths of time before preparation of cell lysates (section 2.2.8 a).
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To monitor the stability of cytoplasmically-located mitochondrial
proteins, synthesised in the presence of uncouplers, an alternative
protocol was adopted in which the chase was carried out in NGM
supplemented with uncoupler at the same concentration as in the 4h 
35incubation with [ Sjmethionine.
2.2.8 PREPARATION OF CELL EXTRACTS AND SUBFRACTIONS OF CELLS
2l î52i2ËÎ2D Of îîi222bondr^ From Tissue Culture Cells
Mitochondria were prepared from cultured cells following the 
procedure of Attardi & Ching (1979) starting from approx. 2 x 10^ 
cells. All procedures were carried out at 4°C.
Cell monolayers were rinsed, scraped into 40ml ice-cold PBS 
(section 2.2.8 a) and centrifuged for 10 min at 800g. The cells were 
washed twice in 0.13M NaCl containing 5mM KCl and ImM MgCl^ before 
being resuspended in 6.0ml of lOmM Tris-HCl, pH6.7, containing lOmM 
KCl and 0.13mM MgCl^. Homogenisation was carried out in a Potter- 
Elvenhjem teflon-glass homogeniser at half maximal speed for 3 
strokes, after which the sample was checked under a light microscope 
for cell breakage. On addition of 0.25M sucrose the solution was 
centrifuged at ISOOg for 3 min to remove nuclei. Mitochondria were 
pelleted from the supernatant fluid by centrifugation at 5000g for 10 
min. Pellets were resuspended in 2ml lOmM Tris-HCl, pH 6.7, containing 
O.lSmM MgClg and 0.25M sucrose. The last two centrifugation steps were 
repeated. Remaining mitochondria were resuspended in 1.0ml of lOmM 
Tris-acetate, pH 7.0, containing 0.25M sucrose and the protein 
concentration was determined by the modified Lowry procedure (section 
2.2.2).
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Fractionation Of Cells U s ^ g  Digitonin
Digitonin fractionation was used to prepare soluble and 
particulate fractions of cells using a modification (Mori et al., 
1981a) of the method of Zuurendonk & Tager (1974).
Cells were grown in 10cm diam. petri-dishes as described in 
section 2.2.7 b until semi-confluent. These cells were washed in PBS, 
scraped off into 0.3ml 2OmM K Hepes, pH 7.4, containing 0.25M 
sucrose and 3mM EDTA then resuspended to a single cell suspension. 
Protein concentration was determined as in section 2.2.2 before cells 
from one petri-dish were incubated with 0.25-10.Omg digitonin per ml 
cell suspension for 2 min on ice. Centrifugation for 1 min at 14000g 
in an MSE Microcentaur microfuge separated the soluble and particulate 
fractions. Soluble fractions were assayed for citrate synthase 
(section 2.2.1 b) and fumarase (section 2.2.1. c) activities in 
order to determine the concentration of digitonin required to break 
open the highest percentage of cells without disrupting the 
mitochondria.
35
In the case of [ Sjmethionine-labelled cells, monolayers were 
washed with PBS and the cells scraped into the above buffer 
supplemented with ImM benzamidine-HCl and ImM 1,10-phenanthroline. 
Digitonin was added to a previously defined concentration and the 
cytosolic and particulate fractions separated as described above. The 
particulate fractions were suspended in lOOmM Tris-HCl, pH 8.2, 
containing lOOmM KCl, 5mM MgCl^, 1% (v/v) Triton X-100, 0.5% (w/v) SDS 
and 1.0% (w/v) DOC (3D-TKM), and the cytosolic fractions diluted with 
an equal volume of two times concentrated 3D-TKM. Both fractions were 
centrifuged at 24000g for 30 min and the clear supernatant fractions
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utilised immediately for immune precipitation (section 2.2.9) or
stored at -70°C.
35c) Preparation Of Cell Lysates From Sjmethionine-Labelled 
Cells
The following standard solutions were prepared and sterilised by 
passage through a Nalgene filter (pore size, 0.20^m):- 
PBS; section 2.2.8.a
Trlton-TKM; lOOmM Tris-HCl, pH 8.2, containing lOOmM KCl, 5mM 
MgCl^ and 1% (v/v) Triton X-100 
3D-Lysis buffer: lOOmM Tris-HCl, pH 8.2, containing lOOmM KCl,
5mM MgCl^, 1% (v/v) Triton X-100, 1% (w/v) SDS 
and 2% (w/v) DOC
All solutions were supplemented with ImM benzamidine-HCl and ImM 
1,10-phenanthroline immediately before use. All procedures were 
carried out at 4°C. Cell monolayers were washed three times in ice- 
cold PBS before harvesting into 1.0-1.5ml Triton-TKM. Nuclei were 
removed by centrifugation at lOOOg for 5 min. The supernatant fraction 
was diluted 1:1 (v/v) with 3D-Lysis buffer. Samples were centrifuged 
at 24000g for 30 min to remove any remaining cellular debris. Lysates 
were used immediately for immune precipitation or stored at -70°C.
b) Preparation Of Rat Liver Mitochondria
Mitochondria from rat liver were prepared according to Chance & 
Hagihara (1963). The following isolation medium was used throughout 
the preparation:-
2mM MOPS, pH 7.2, containing 0.225M mannitol, 0.075M sucrose and 
0.4mM EDTA.
All procedures were carried out at 4°C.
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starved female rats of the Wistar strain (150-350g) were killed 
by cervical dislocation. Livers removed from these animals were rinsed 
twice in isolation medium and chopped finely using scissors. 
Homogenisation was carried out in a Potter-Elvenhjem homogeniser with 
a loose-fitting teflon pestle for 2 passes at maximal speed to 
facilitate tissue breakdown followed by 5 passes with a tight-fitting 
teflon pestle (setting 5, clearance 0.006-0.008 in) to cause cell 
disruption. The homogenate was centrifuged at 800g for 7 min to remove 
the nuclei, red blood cells and cellular debris. Mitochondria were 
collected from the supernatant fraction by centrifugation at 6500g for 
15 min. The pellets were washed twice in half the initial volume of 
isolation medium and again mitochondria were collected by 
centrifugation as previously described. Mitochondria were resuspended 
in isolation medium at a final concentration of approx. 20mg/ml.
Isolated mitochondria were purified on a discontinuous sucrose 
density gradient made up as follows:- 
4.0ml 54% (w/w) sucrose in lOmM Tris-HCl, pH 7.5
10.0ml 45% (w/w) sucrose in lOmM Tris-HCl, pH 7.5
10.0ml 39% (w/w) sucrose in lOmM Tris-HCl, pH 7.5
6.0ml 20% (w/w) sucrose in lOmM Tris-HCl, pH 7.5
The gradients were centrifuged at 49000g for 2h in a Beckman SW27 
rotor.
After centrifugation 3 bands were visible: the upper band of
3
density 1.16g/cm consists principally of microsomes and plasma
3
membrane; the middle band of density 1.19g/cm represents purified
3
mitochondria; the lower band of density 1.22g/cm is composed mainly 
of lysoGomes with some mitochondrial contamination. Mitochondria
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harvested from the gradient are diluted slowly In isolation medium and 
centrifuged at 6500g for 10 min to remove the sucrose and collect the 
mitochondria.
c) Preparation Of Bovine Heart Mitochondria
Mitochondria were prepared from bovine heart by Miss Anne Phelps 
in our laboratory, following the general procedure described by Smith 
(1967).
Bovine hearts obtained from the slaughterhouse were immediately 
chilled and all subsequent operations were carried out at 6*C. After 
trimming off fat and connective tissue, the heart was cut into 5cm 
cubes, 300g of which were passed through a mincer. Minced tissue was 
placed in 400ml of lOmM Tris-HCl, pH 7.8, containing 0.25M sucrose and 
the pH was adjusted to 7.5+0.1 using 2M Tris base. After 
neutralisation, the ground tissue was placed in cheesecloth, squeezed 
free of sucrose, then resuspended in 400ml of lOmM Tris-HCl, pH7.8, 
containing 0.25M sucrose, ImM Tris-succinate and 0.2mM EDTA (sucrose 
solution). 3ml of 2M Tris base were added to maintain the correct pH 
and the material was blended at high speed for 15 sec in a Waring 
blender. A further 3ml of 2M Tris base were added and blending 
continued for a further 5 sec. The pH of the solution was further 
adjusted to 7.8 with 2M Tris base and the homogenate was centrifiged 
at lOOOg for 15 min. The supernatant fluid was centrifuged at 5000g 
for 30 min. Pellets from this spin were washed once or twice more in 
sucrose solution. Mitochondria were resuspended in sucrose solution at 
a final protein concentration of 20-40mg/ml.
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2.2.9 IMMUNOLOGICAL TECHNIQUES
This protocol, which follows a modification (Batteiger et al.,
1982) of the method of Towbin et al. (1979), permits the immunological 
detection of proteins following their electrophoretic transfer from 
polyacrylamide gels to nitrocellulose paper.
A homogeneous 10% (w/v) polyacrylamide gel was used for 
resolution of the proteins. Transfer of proteins was carried out 
electrophoretically as described by Towbin et al. (1979) in 25mM Tris 
base containing 192mM glycine, 0.02% (w/v) SDS and 20% (v/v) methanol 
for either 4h at 400mA or I6-20h at 40mA. Excess binding sites on the 
nitrocellulose were blocked by incubation for 60 min at room 
temperature in 20mM Tris-HCl, pH7.2 containing 0.15M NaCl, 0.5% (v/v) 
Tween 20 and 5mg/ml NaN^ (washing buffer). This buffer was discarded 
and the nitrocellulose incubated for 90 rain at room temperature in 
washing buffer supplemented with 0.5% (v/v) heat-inactivated horse 
serum and antiserum at a final dilution of 1:50 or Is 100. The 
nitrocellulose was then washed five times in washing buffer over the
space of Ih before incubation for 60 min at room temperature in
125 6
washing buffer containing I-labelled protein A (approx. 10 c.p.ra.).
After being washed another five times in Ih with washing buffer, the
nitrocellulose was dried and the antigen was located by
autoradiography (section 2.2.6 c ).
Following autoradiography the nitrocellulose paper could be 
stained for protein by immersion in 0.1% (w/v) Amido Black, 50% (v/v) 
methanol, 10% (v/v) acetic acid for 2-3 min followed by destaining in 
50% (v/v) methanol, 10% (v/v) acetic acid for 2-5 min.
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b) Immune Ptecigitation Of ^H%]^^lled 2-Oxoglutarate 
5®!îXË£2ë ®D2®ë Complex
Immune precipitalon of ^H-labelled OGDC was carried out in a 
final volume of lOOpl containing 2jag (approx. 30000c.p.m.) of the 
labelled complex in either Triton buffer (section 2.2.5 b) or 3D-TKM 
(section 2.2.8 b). Samples were incubated with 2-25^1 of antiserum 
for Ih at room temperature followed by 16-20h at 4°C. At this stage 
50^1 of Pansorbin was added and the incubation continued for Ih at 
room temperature in order to precipitate the immune complexes. The 
pellets were washed three times in Triton buffer or 3D-TKM and once in 
lOmM Tris-HCl, pH 7.4 by resuspending the pellets in the appropriate 
buffer and then collecting the immune complexes by centrifugation at 
14000g for 2 min. Immune complexes were dissociated from the surface 
of the aureus cells by boiling for 5 min in 50pl of Laemmll sample 
buffer (section 2.2.4 c). A 5pl aliquot was counted for radioactivity 
and the remainder of the sample was analysed by SDS-polyacrylamide gel 
electrophoresis followed by fluorography (section 2.2.6 d).
35
c) Immune Precipitation Of ^ S]methionine-labelled Cell 
Extracts
The composition of the buffer containing the cell extracts was
adjusted to equal that of 3D-TKM (section 2.2.8 b)). Aliquots (100-
1000^1) of cell extract containing 10-20 x lO^c.p.m. were incubated
with 10-50^1 of antiserum for Ih at room temperature followed by 16- 
o
2Oh at 4 C. The immune complexes were precipitated using 100^1 of 
Pansorbin and were washed and analysed as described above.
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CHAPTER THREE
PURIFICATION OF 2-OXOGLUTARATE DEHYDROGENASE 
FROM BOVINE HEART
3.1 INTRODUCTION
The initial stages of the project were concerned primarily 
with isolating the bovine heart 2-oxoglutarate dehydrogenase 
multienzyme assembly in a homogeneous state. This purified enzyme 
complex would then be employed to raise specific antisera, necessary 
for future work on the biosynthesis, import and maturation of the 
component enzymes of OGDC.
Several earlier purification procedures for the isolation of 
mammalian OGDC required preliminary purification of large amounts of 
mitochondria (Ishikawa et al., 1966; Linn et al., 1972; Koike & Koike, 
1976; Roche 6. Cate, 1977). In 1980, Stanley & Perham described a new 
method allowing the parallel purification of OGDC and PDC from bovine 
heart. In this method, the multienzyme complexes were isolated from 
whole tissue extracts solubilised in the non-ionic detergent Triton 
X-100. The composition and specific activity, (195 nkat/mg) of OGDC 
purified by this procedure compared favourably with the same complex 
purified from bovine heart (220 nkat/mg) by Linn et al. (1972), and 
porcine liver (188 nkat/mg) by Roche & Cate (1977) employing 
procedures starting from isolated mitochondria. These specific 
activities-were much higher than those reported by Koike & Koike (1976) 
for OGDC purified from porcine heart mitochondria (88 nkat/mg) and by 
Linn et al. (1972) for OGDC from bovine kidney (130 nkat/mg). The 
method described by Stanley & Perham (1980) was rapid and avoided the 
need for large-scale preparation and stockpiling of mitochondria. 
Moreover, the yield of multienzyme complex was much improved, being 
80-200 fold higher than that obtained by previous procedures (Linn 
et al., 1972; Roche & Cate, 1977).
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However, in our hands, initial attempts at purifying OGDC from 
bovine heart resulted in a product of lower specific activity and 
yield than reported for this procedure (Stanley & Perham, 1980). We 
also observed an pronounced instability of OGDC during later stages of 
the purification. Therefore, the basic procedure of Stanley & Perham 
(1980) was modified in an attempt to improve the product.
3.2 METHODS
3.2.1 PURIFICATION OF 2-OXOGLUTARATE DEHYDROGENASE FROM BOVINE 
HEART
All operations were carried out at 4°C and fresh bovine hearts 
were always employed as starting material.
Bovine hearts, chilled immediately after slaughter, were trimmed 
of fat and connective tissue and cut into 2cm cubes. 250g of tissue 
was blended for 5 min in a Waring blender at maximum speed in 500ml of 
ice-cold 50mM MOPS, pH 6.8, containing 2.7mM EDTA, 0.ImM DTT, 3% (v/v) 
Triton X-100, ImM PMSF, ImM benzamidine-HCl and silicone antifoam 
(0.5ml/l). An equal volume of ice-cold 50mM MOPS, pH 7.0, containing 
2.7mM EDTA, 0.ImM DTT and 3% (v/v) Triton X-100 was added to the 
homogenate and the mixture was centrifuged at lOOOOg for 20 min. The 
pellets were resugpended in 500ml of 50mM MOPS, pH 6.8, containing 
2.7mM EDTA, 0.ImM DTT and 3% (v/v) Triton X-100 before centrifugation 
as already described. Supernatant fractions from these two 
centrifugation steps were combined and the pH was adjusted to 6.45 by 
adding 10% (v/v) acetic acid. The mixture was stirred for 30 rain with 
0.12 vol. 35% (w/v) PEG before the precipitate was collected by 
centrifugation at 25000g for 10 min. The precipitate was resuspended
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in 400ml of 50mM MOPS, pH 6.8, containing 2.7mM EDTA, O.lmM DTT,
1% (v/v) Triton X-100, 0.15pM leupeptin and 0.5% (v/v) rat blood serum 
(RBS). Full resuspension was achieved by sonlcatlon at lOOW for 3 x 30 
sec on 100ml batches using a Dawes Soniprobe. Clarification of the 
solution was achieved by centrifugation of the sonicate at 25000g for 
40 min, followed by filtration of the supernatant fluid through 
muslin. This filtrate was maintained at pH 7.0 with 0.5M NaOH while 
MgClg was added at a final concentration of 13mM. Sodium phosphate 
buffer (IM), pH 6.3 was added to a final concentration of 50mM to 
raise the ionic strength. This step was necessary in order to avoid 
the formation of a precipitate when the pH was lowered for the second 
PEG precipitation. The pH was then lowered to 6.45 prior to addition 
of 0.12 vol. 35% (w/v) PEG. After stirring for 30 min, the PEG 
precipitate was collected by centrifugation at 25000g for 10 min. 
Resuspension of the pellet was achieved by standing overnight in 50mM 
MOPS, pH 6.8, containing 2.7mM EDTA, O.lmM DTT, 1% (v/v) Triton X-100, 
O.lSpM leupeptin and 0.5% (v/v) RBS followed by homogenisation in a 
Potter-Elvenhjem teflon-glass homogeniser. The solution was warmed to 
approx. 20°C and stirred gently for Ih prior to sonication at lOOW for 
3 X 30 sec. Following clarification of the sample by centrifugation at 
40000g for 60 min the supernatant fraction was warmed to approx. 20°C 
and stirred gently for a further Ih. The pH of the solution was 
lowered to 6.4 by addition of 10% (v/v) acetic acid and 0.04 vol. 35% 
(w/v) PEG was added. This level of PEG was found to precipitate 
maximal amounts of OGDC while leaving the majority of PDC in the 
supernatant fraction. After 30 min stirring, the precipitate 
containing OGDC was collected by centrifugation at 25000g for 10 min.
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precipitated OGDC was resuspended in 20ml of 50mM sodium phosphate 
buffer, pH 7.0, containing 2.7mM EDTA and 1% (v/v) Triton X-100. This 
was centrifuged at 25000g for ID min to remove any insoluble material 
before applying to a 110cm x 3cm Sepharose CL-2B column equilibrated 
in 50mM sodium phosphate buffer, pH 7.0, containing 2.7mM EDTA and 1% 
(v/v) Triton X-100. The column was run at 24ml/h in the same buffer 
with the collection of 12ml fractions. OGDC was recovered from peak 
fractions (35-42) by centrifugation at 176000g for 5h in a Beckman 
Ti60 rotor. The complex was dissolved in 50mM MOPS, pH 7.0, containing 
2.7mM EDTA and 0.01% (w/v) NaN^ and was stored at -20°C in small 
portions after mixing with 0.33 vol. glycerol.
3.2.2 CHROMATOGRAPHY OF 2-OXOGLUTARATE DEHYDROGENASE USING VARIOUS 
COLUMN MATERIALS 
OGDC, of known protein concentration and enzymic activity, in 
0.5ml of 50mM sodium phosphate buffer, pH 7.0, containing 2.7mM EDTA 
and 1% (v/v) Triton X-100 was mixed with an equal volume of column 
material equilibrated in the same buffer. This mixture was incubated 
on ice for 15 min, with occasional shaking, before centrifugation at 
lOOOg for 5 min. The supernatant fraction was assayed for enzymic 
activity, the column matrix washed with 1.0ml starting buffer and the 
resulting supernatant fraction assayed again for enzymic activity. 
These washes were then repeated with the starting buffer containing 
0.25M, 0.5M and l.OM NaCl and the supernatant fractions assayed after 
each wash. A further wash in 6M urea containing 0.5M NaOH was carried 
out and the supernatant fraction analysed by SDS-PAGE.
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FIGURE 3.1 SDS-polyacrylamide gel analysis of the purification
of the 2-oxoglutarate dehydrogenase complex from bovine 
heart.
Fractions from various stages of the purification of OGDC 
from bovine heart were resolved on a 10% (w/v) SDS-polyacrylamide 
slab gel and the proteins were visualised by staining with 
Coomassie blue.
Lanes 1 & 13, standards; lane 2, initial homogenate (50pg); 
lane 3, 1st extract (50jig); lane 4, 2nd extract (50 pg); lane 5,
1st PEG precipitate, clarified (50pg); lane 6, 2nd PEG precipitate, 
clarified (50 pg); lane 7, material loaded onto Sepharose CL-2B 
column (40 pg); lanes 8-12, fractions 35-39 respectively from the 
Sepharose CL-2B column (15pg).
\ (x lO“^)
1 2 3 4 5 6 7 8 9 10 11 12 13
3.3 RESULTS
3.3.1 PROBLEMS ASSOCIATED WITH THE PURIFICATION OF 2-OXOGLUTARATE 
DEHYDROGENASE FROM BOVINE HEART
A summary of the purification resulting in a product with the 
highest specific activity and yield obtained is shown in Table 3.1 and 
SDS-polyacrylamide gel profiles of fractions from various stages of a 
purification are illustrated in Fig. 3.1.
Purified OGDC is composed of three protein bands with values, 
determined from SDS-PAGE as, 103500 + 1000, 54500 + 1000 and 48500 + 
1000 respectively. These values agree well with those already observed 
for OGDC isolated from bovine heart and have already been ascribed to 
the activities of El, E3 and E2 respectively (Linn, 1971; Stanley & 
Perham, 1980).
The percentage purity of OGDC fractions from different 
preparations varied between 75-95% as determined by densitometric 
scanning of Coomassie blue stained SDS-polyacrylamide gels (OGDC 
fractions seen in Fig. 3.1 are approx. 75-85% pure; OGDC fractions in 
Fig. 3.3 are >90% pure).
Inclusion of RBS and leupeptin in the buffers during the later 
stages of the preparation further protected the complex against 
endogenous proteases, leading to considerable improvement in overall 
yield. However this improved yield, 4-16 pkat/kg, was still much lower 
than that reported, 73 jukat/kg, by the original authors of this method 
(Stanley & Perham, 1980).
The main steps, during which enzymic activity was lost in the 
preparation, were in clarification of the PEG precipitates. Losses 
of up to 30-40% were observed at this stage. On occasions, the pellets
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FIGURE 3.2 Gel filtration of partially purified 2-oxoglutarate 
dehydrogenase complex on Sepharose CL-2B.
Partially purified OGDC (80mg:8.Sml) of specific activity,
25.6 nkat/mg OGDC and 0.8 nkat/mg PDC, was loaded onto a 
Sepharose CL-2B column (110cm x 3cm) at 24ml/h in 50mM sodium 
phosphate buffer, pH 7.0, containing 2.7mM EDTA and 1% (v/v) 
Triton X-100. The column was eluted at 24ml/hr in the same 
buffer. Fractions of 12.0ml were collected, assayed for overall 
OGDC (o) and PDC («) activities as described in section 2.2.1.
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FIGURE 3.3 SDS-polyacrylamide gel analysis of fractions from 
the Sepharose CL-2B column.
Peak fractions from the Sepharose CL-2B column (Fig. 3.2) were 
subjected to SDS-polyacrylamide gel electrophoresis in 10 7. (w/v) 
slab gels and the proteins were detected by staining with 
Coomassie blue.
Lanes 1,7 & 8, standards; lane 2, fraction 18 (50pg); 
lane 3, fraction 19 (50pg); lane 4, fraction 36 (IS^g); lane 5, 
fraction 37 (ISjig); lane 6, fraction 38 (15pg); lane 9, fraction 
42 (lOpg); lane 10, fraction 43 (lOpg).
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from these centrifugation steps were re-extracted in 50raM MOPS, pH 
6.8, containing 2.7mM EDTA, O.lmM DTT, 1% (v/v) Triton X-100, 0.15/iM 
leupeptin and 0.5% (v/v) RBS. Although this resulted in a 10-20% 
higher recovery at this stage, losses of 10-20% of total enzyme 
activity were still common. Increasing the Triton X-100 content of the 
re-extraction buffer to 3% (v/v), equivalent to that in the initial 
extraction buffer, had no effect.
Losses of total enzymic activity were also observed on the 
Sepharose CL-2B column. Recovery of enzymic activity from this column 
was approx. 50% on average. Analysis of the activity profile of OGDC 
eluting from the Sepharose CL-2B column revealed two peaks of 
enzymatic activity (Pig. 3.2). Fractions from the first peak of 
enzymic activity were opalescent and SDS-PAGE analysis showed that 
these fractions contained many proteins exhibiting a broad range of 
subunit values (Fig.3.3). A similar peak, eluting at the void 
volume, is found with preparations of PDC from bovine heart (0. L. De 
Marcucci, personal communication), and Bacillus subtills (Hodgson,
1983). This fraction from bovine heart, was seen to have a vesicular 
structure when examined under the electron microscope (Hodgson, 1983). 
One possibility is that this is a proteolipid structure formed from 
the cell membranes during sonication.
Fractions from the second major peak of enzymic activity 
contained pure OGDC (Fig. 3.3) which was concentrated as described 
previously. On occasions, pooled fractions of OGDC were passed down 
the Sepharose CL-2B column a second time to further increase the 
purity of the complex.
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FIGURE 3.4 2-oxoglutarate dehydrogenase fractions from the
Sepharose CL-2B column are contaminated with a 50000 
protein.
Peak fractions from the Sepharose CL-2B column were 
subjected to SDS-polyacrylamide gel electrophoresis on a 10% 
(w/v) slab gel. Protein bands were detected by staining with 
Coomassie blue.
Lanes 1 & 8, standards; lanes 2-7, fractions 35-40 
respectively from the Sepharose CL-2B column (15jjg) (see Fig. 
3.2).
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FIGURE 3.5 Reactivity of anti-X serum with the 50000
contaminant of purified 2-oxoglutarate dehydrogenase 
complex.
Peak fractions from the Sepharose CL-2B column were 
separated into component polypeptides on a 10% (w/v) SDS- 
polyacrylamide slab gel. One half of the duplicate gel was 
stained with Coomassie blue (see Fig. 3.4). Polypeptides on the 
other half were electrophoretically transferred to nitrocellulose 
paper and the replica was processed for detection of antigenic 
polypeptides using a 1:50 dilution of anti-X serum.
Lanes 1 & 8, standards; lanes 2-7» fractions 35-40 
respectively from the Sepharose CL-2B column (15jjg)(see Fig.
3.4).
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3.3.2 CONTAMINATION OF 2-OXOGLUTARATE DEHYDROGENASE WITH A 50000 
PROTEIN
Fractions from the Sepharose CL-2B column. Immediately following 
the main peak of enzymic activity, were observed to be brown in 
colour. When analysed by SDS-PAGE they were found to contain a major 
component of subunit 50000 (Fig. 3.3). In some preparations, this 
peak was found to overlap with the peak of enzymic activity. Thus, OGDC 
fractions from these preparations were contaminated with the 50000 
protein (Fig. 3.4).
PDC, which is purified in parallel with OGDC using this 
procedure, has been found to contain an associated polypeptide of 
unknown function, known as component X (De Marcucci & Lindsay, 1985), 
which is similar in to this 50000 contaminant band of OGDC. In 
order to test whether these proteins were identical or related, 
antiserum raised against component X (a gift from 0. L. De Marcucci) 
was employed in immune blotting analysis to probe the peak fractions 
from the Sepharose CL-2B column (Pig. 3.5). By comparing Fig. 3.4 with 
Fig. 3.5 it can be seen that whereas the amount of the contaminant 
present in OGDC increases in peak fractions 35-40, the amount of X is 
highest in fraction 35 and lowest in fraction 40. This infers that 
these protein species are not related since their distribution would 
be expected to be parallel were this true. The presence of X in early 
fractions of the peak from the Sepharose CL-2B column probably 
reflects contamination of these fractions with PDC. PDC elutes 
slightly before OGDC from this column and the material loaded onto the 
column generally contained low levels of PDC which co-precipitated with 
OGDC during separation of the complexes.
Various column materials were employed in attempts to eliminate
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FIGURE 3.6 Elution profile of 2-oxoglutarate dehydrogenase
complex from DEAE-Sephacel.
Peak fractions (5.5mg) from the Sepharose CL-2B column were 
concentrated by ultacentrifugation for 5h at 176000g, resuspended 
in 4.0ml of 50mM sodium phosphate buffer, pH 7.0, containing 
2.7tnM EDTA and 1% (v/v) Triton X-100 and loaded onto a 6cm x 
1.5cm DEAE-Sephacel column. The column was washed with 35ml of 
the above buffer, eluted using a 0-0.5M NaCl gradient and washed 
with a further 10ml of the above buffer, containing 0.5M NaCl. 
Fractions of 2.5ml were collected, assayed for OGDC activity 
and monitored for protein content.
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FIGURE 3.7 SDS-polyacrlyamide gel analysis of fractions from 
the DEAE-Sephacel column.
Material loaded onto the DEAE-Sephacel column and fractions 
collected from the column were compared by polyacrylamide gel 
electrophoresis on 10% (w/v) slab gels. Resolved proteins were 
located by staining with Coomassie blue.
Lanes 1 & 8, M^ standards; lane 2, material loaded onto DEAE- 
Sephacel (15yg); lanes 3-7, fractions 12-16 respectively from 
DEAE-Sephacel (15yg) (see Fig. 3.6).
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this 50000 contaminant protein including phenyl-Sepharose, DEAE- 
Sephacel, Procion Red A and Cibacron Blue A dye matrix columns.
Initial screening was carried out using the batch method described in 
section 3.2.2. It was found that OGDC did not bind to phenyl-Sepharose 
to any significant extent, whereas the binding to Red A and Blue A dye 
matrix column materials was strong and was not reversed by l.OM NaCl 
(Table 3.2) or by 6M urea containing 0.5M NaOK (not shown). These 
initial experiments indicated that DEAE-Sephacel bound OGDC and that 
the binding could be reversed by increasing the salt concentration 
(Table 3.2). Further experiments in which constant amounts of DEAE- 
Sephacel were incubated with increasing amounts of OGDC were carried 
out to determine the binding capacity of the gel matrix for OGDC. This 
was found to be approx. 2mg OGDC per ml gel.
OGDC fractions, containing the 50000 contaminant, were pooled 
and applied to a 8.0cm x 1.3cm column of DEAE-Sephacel equilibrated 
in 50mM sodium phosphate buffer, pH 7.0, containing 2.7mM EDTA and 
l%(v/v) Triton X-100. The column was washed in the loading buffer and 
eluted with a linear salt gradient, 0-0.5M NaCl (Fig. 3.6). OGDC 
eluted in the region 0.30-0.45M NaCl and a 75-90% recovery of protein 
from this column was observed. Recovery was not increased by washing 
the column in starting buffer supplemented with l.OM NaCl. SDS-PAGE of 
the fractions eluted from DEAE-Sephacel showed that the 50000 
contaminant band had been removed (Fig.3.7).
OGDC fractions from Sepharose CL-2B were observed to contain 
small amounts of PDC. Attempts to resolve the two complexes on DEAE- 
Sephacel failed as the two enzyme complexes gave a similar elution 
profile on this column.
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FIGURE 3.8 Cross reaction of subunit specific antisera with 
contaminant bands in purified 2-oxoglutarate 
dehydrogenase.
Various amounts of purified OGDC were subjected to 
polyacrylamide gel electrophoresis on a 10% (w/v) SDS- 
polyacrylamide slab gel. One third of the triplicate gel was 
stained with Coomassie blue (lanes 1 & 7, M standards; 
lanes 2-6, 20, 15, 10, 5 and 2jig respectively of purified OGDC). 
Protein bands on the remainder of the gel were
electrophoretically transferred to nitrocellulose paper. One half 
of the nitrocellulose was processed for detection of antigen 
using anti-El serum (lanes 8-13, as lanes 1-6), and the remainder 
with subunit specific antiserum directed against E2 (lanes 14-19, 
as lanes 1-6).
(x10"3)
92—
57—
S3
4 5 -
3 0 -
8 9 10 11 12 13
3.3.3 MINOR CONTAMINANTS OF 2-OXOGLUTARATE DEHYDROGENASE ARE NOT
IMMUNOLOGICALLY RELATED TO THE COMPONENT ENZYMES OF THE COMPLEX 
Protein bands ranging in from 100000 to 20000 were generally 
observed as minor contaminants of purified OGDC. Subunit specific 
antisera, raised to the El and E2 components of OGDC, as described In 
section 4.2, were used to probe purified fractions of the complex in 
order to determine whether these minor bands were the products of 
proteolysis of El or E2 respectively. Fig. 3.8 shows the result of 
this immune blotting analysis where it can be seen that El and E2 
subunit specific antisera each react with one band only, corresponding 
in M to the parent antigen. The antisera did not cross react with any 
of the minor bands which would be expected if these minor components 
were proteolytic fragments of the original subunits (De Marcucci et al., 
1985a; De Marcucci & Lindsay,1985). It was felt that these minor bands 
were unlikely to be degradation products of E3 since it had been 
demonstrated that E3 was resistant to degradation by several proteases 
including trypsin, elastase and papain (not shown). Indeed later 
characterisation of E3 antiserum by immune blotting versus purified 
OGDC revealed only one major band.
Further attempts to remove these contaminant bands involved 
washing the multienzyme complex in various detergent and salt 
solutions but no significant increase in purity was observed.
One possible source of contamination of OGDC are ribosomes. As 
they are similar in size they may elute in the same region as OGDC 
from the Sepharose CL-2B column, in this case they would also spin 
down during the concentration of OGDC. It may be possible to eliminate 
this potential source of contamination by treatment of fractions with 
ribonuclease, causing disassembly of the ribosome, before collecting
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FIGURE 3.9 Effect of ATP on the enzymic activities of the
2-oxoglutarate dehydrogenase complex and the pyruvate 
dehydrogenase complex.
o.
OGDC (80pg) or PDC (40pg) were incubated at 30 C in 20mM 
potassium phosphate buffer, pH7.2, containing 3mM MgCl^» 0.2mM 
DTT, plus or minus 0.2mM ATP, in a final volume of 200pl. At 
various time intervals, 2 0 |j1 aliquots were withdrawn from the 
incubation mix and assayed for enzymic activity.
(A) OGDC activity measured in the presence (o) or absence (o) of 
ATP.
<B) PDC activity measured in the presence (o) or absence (o) of 
ATP.
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3.3.4 EFFECT OF ATP ON THE ACTIVITY OF 2-OXOGLUTARATE DEHYDROGENASE 
COMPLEX
The effect of ATP on the enzymic activity of OGDC was tested. It
is known that the activities of PDC and BCDC are regulated by
alteration of the phosphorylation state of these complexes (Reed &
Yeaman, 1985). The EloC subunits of these complexes are phosphorylated
in the presence of ATP by specific kinases with concomitant loss of
activity. No role involving covalent modification has been ascribed to
ATP in the regulation of OGDC. Incubation of OGDC in the presence of
ATP showed no significant increase or decrease in overall complex
activity compared with OGDC incubated minus ATP. In contrast,
incubation of PDC in the presence of ATP resulted in a large, rapid
inhibition of overall activity (Fig.3.9). It seems unlikely that OGDC
activity is regulated by covalent modification involving ATP. The
structure of OGDC differs significantly from that of the other 2-oxo
acid dehydrogenase complexes. PDC and BCDC both have an type of
El subunit whereas the El component of OGDC has an subunit
arrangement. In addition, when isolated mitochondria were incubated 
32
with P , only two radioactive bands were seen after the
proteins were separated by SDS-PAGE and analysed by autoradiography. 
The M^ values of these bands corresponded with those of the El®4 
subunits of PDC and BCDC respectively (Cook et al., 1983).
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3.4 DISCUSSION
The modified method, described in this chapter, allowed 
purification of OGDCvwhich closely resembles that reported by Stanley 
& Perham (1980) in subunit and specific activity.
Fresh bovine hearts were always employed as starting material as 
it was found that the total enzymic activity extracted from tissue 
stored at either -20°C or -70°C was up to 50% less than that obtained 
from the fresh tissue.
Supplementing buffers with RBS and leupeptin greatly improved the 
yield of OGDC. Difficulties in the isolation of OGDC and PDC, 
especially from the gluconeogenic organs, kidney and liver, have 
already been observed (Linn, 1971; Welland, 1975; Roche & Cate, 1977).
In a study on the instability of OGDC in bovine kidney extracts, Linn 
(1971) found that the loss of activity was not caused by inactivation 
of any of the component enzymes of OGDC but was due to limited 
proteolysis of the E2 subunit which resulted in dissociation of the 
complex. This disassembly of the complex was responsible for the 
decrease in overall activity of OGDC. The protein which caused this 
cleavage, purified approx. 100-fold from bovine kidney, requires a thiol 
group for activity and shows no susceptibility to PMSF or diisopropyl- 
phosphofluoridate. It behaves like a protein of 25000-30000 on gel 
filtration. A similar protease, responsible for inactivation of OGDC 
and PDC in rat liver extracts, was partially purified by Lynen et al. 
(1978). This enzyme which exhibited an of 21000 was also shown to 
be a thiol protease which was not affected by PMSF. Activity of this 
'inactivase' was inhibited by leupeptin, iodoacetamide and rat serum. 
This effect of rat serum, attributed to the presence of
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macroglobulin, a potent protease inhibitor, had been reported 
previously by Weiland (1975). In the purification of OGDC and PDC from 
porcine liver, Roche & Cate (1977) included rabbit serum in their 
buffers. Omission of this protective agent resulted in a PDC product 
which had a lower specific activity, and a lower sedimentation 
coefficient (55S as opposed to 62S). In addition extra lower M bands 
were observed on SDS-PAGE together with a decrease in the relative 
intensity of the E2 component. These authors also reported that OGDC 
was more sensitive than PDC to proteolysis. In preparations carried 
out even in the presence of RBS, extra low M bands were observed, 
which were thought to be proteolytic products of the original 
subunits. In view of the result obtained in Fig. 3.8, where the 
additional lower bands of bovine heart OGDC were shown not to be 
related to either the El or E2 subunits, this conclusion, drawn by 
Roche & Cate (1977), may not be correct. However, as mentioned 
earlier, even with leupeptin and RBS present, the yield of enzyme 
obtained is much less than reported by Stanley & Perham (1980) and the 
reason for this is unclear.
The variation in percentage purity of OGDC between preparations 
also remains to be explained. It may be due to variation in the bovine 
hearts or in the chemicals used to prepare the solutions. In 
particular it was found that the source of the PEG was Important.
The most effective PEG, for purposes of purification of OGDC, was 
produced by Serva, Heidelberg, West Germany.
Investigation of storage conditions revealed that storage at 
-20°C with 0.33 vol glycerol was superior. Fractions were stored in 
small aliquots, as repeated freezing and thawing led to the appearance 
of a prominent 43000 protein, which was shown to be related to E2
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by immune blotting analysis using anti-E2 serum, and several other 
minor bands, which were also immunologically related to the component 
enzymes of OGDC. Under these conditions enzymic activity was preserved 
for up to 6 months at least.
Overall, this procedure allowed the isolation of OGDC in a 
sufficiently pure form to allow it to be used for the production of 
antiserum to whole native OGDC and the El and E2 component enzymes of 
OGDC, as will be described in the following chapter.
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CHAPTER FOUR
PREPARATION AND CHARACTERISATION 
OF ANTISERA
4.1 INTRODUCTION
The experimental approaches which have been employed to 
investigate the biosynthesis of mitochondrial precursors and their 
import into the organelle have used highly specific antisera raised 
against the mature protein with the assumption that cross reaction 
with the precursor will occur. In the majority of cases this 
assumption has proved valid. However, it is not unknown for antiserum 
raised against the mature protein to cross react only weakly or not at 
all with the precursor molecule. Antiserum raised against 
apocytochrome c will not cross react with the holocytochrome and vice 
versa (Hennig & Neupert, 1981). Also antiserum raised to subunit IX of 
the Fj-ATPase complex reacts only very weakly with the precursor form 
of this protein (Schmidt et al., 1983b).
Therefore, in order to monitor the molecular events in the 
biosynthesis, import and maturation of OGDC, it was necessary to obtain 
high titre, monospecific antisera to native, intact OGDC and subunit 
specific antisera to the component enzymes of this multiprotein 
assembly. This chapter deals with the production and characterisation 
of these antisera.
4.2 METHODS
4.2.1 PREPARATION OF ANTISERUM TO NATIVE INTACT 2-OXOGLUTARATE 
DEHYDROGENASE COMPLEX
OGDC, purified from bovine heart by the procedure described in 
section 3.2, was resolved by SDS-PAGE on 10% (w/v) slab gels. 
Densitometric scanning of Coomassie blue-stained gels allowed the 
selection of fractions of approx. 95% purity for immunisation of
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FIGURE 4.1 Determination of purity of 2-oxoglutarate
dehydrogenase complex fractions employed to raise 
antiserum to the intact, native complex.
OGDC (15ug) was resolved into its native component enzymes 
by SDS-PAGE on 10% (w/v) slab gels. Following staining of the gel 
in Coomassie blue, purity was determined by densitometric 
scanning of the protein bands.
(A) Densitometric trace of protein bands.
(B) Table showing % total area occupied by each peak.
(A)
Dye front
<B)
Protein Band 
El 
E2 
E3
% Total Area 
41 
34 
19
OGDC 94
FIGURE 4.2 Preparative SDS-polyacrlyamide gel electrophoresis of 
the 2-oxoglutarate dehydrogenase complex from bovine 
heart.
Purified OGDC (l.Smg) was resolved into its constituent 
polypeptides on a 10% (w/v) preparative slab gel. Protein bands 
were visualised by staining in Coomassie blue, excised from the 
gel and utilised to raise subunit specific antisera as described 
in section 4.3.
©
rabbits with native, intact OGDC (Fig. 4.1).
OGDC (Img) dissolved in 0.5ml of 50mM MOPS, pH 7.0, containing 
2.7mM EDTA was mixed with an equal volume of Freund's complete 
adjuvant and injected subcutaneously at multiple sites in the neck and 
back of a New Zealand White rabbit. Similar amounts of purified enzyme 
complex were administered at 2-3 week Intervals thereafter. Ten days 
after the 3rd injection, blood was obtained from a marginal ear vein. 
Additional booster injections were administered at approximately 1 
month intervals with 0.5mg of protein mixed with incomplete Freund's 
adjuvant. The serum was collected, divided into l.Oml aliquots and 
stored at -20°C until use.
4.2.2 PREPARATION OF ANTISERA TO THE El AND E2 COMPONENT ENZYMES OF 
2-OXOGLUTARATE DEHYDROGENASE COMPLEX 
Preparative SDS-PAGE was employed in order to obtain highly 
purified samples of the individual components of the complex which 
were necessary for the production of subunit specific antisera. In 
this way, it was possible to raise highly specific antisera to the El 
and E2 components of OGDC without the necessity for isolating large 
quantities of enzyme and resorting to the time consuming, conventional 
procedures for purification of the individual enzymatic activities 
(Koike & Koike, 1976).
Samples of OGDC of 80-95% purity (approx. I.Smg) were 
precipitated in 80% (v/v) acetone at -20°C, air dried and dissolved in 
l.Oml Laeramli sample buffer (section 2.2.4 c). The sample was 
resolved into the constituent polypeptides of the complex on 10% (w/v) 
SDS-polyacrylamlde preparative slab gels before staining with 
Coomassie blue (Fig. 4.2). After destaining, the gel was washed for 30
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FIGURE 4.3 Reactivity of antiserum to bovine heart
2-oxoglutarate dehydrogenase complex with the 
individual subunits of the complex.
Various amounts of purified OGDC were subjected to SDS-PAGE. 
One half of the 10% (w/v) gel was stained with Coomassie blue 
(lanes 1-6); polypeptides on the other half of the gel were 
transferred to nitrocellulose paper and processed for 
immunodetection of antigenic polypeptides using (1:100 dil.) 
anti-OGDC serum (lanes 7-11).
Lane 1, standards; lanes 2 6 7, 10|ig purified OGDC; lanes 3 & 
8, 5jjg; lanes 4 & 9, Ipg; lanes 5 & 10, 0.5pg; lanes 6 & 11,
0.Ipg.
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min in distilled water and protein bands, corresponding to the El and 
E2 polypeptides, were excised from the gel with a scalpel, diced, 
frozen in liquid nitrogen and ground finely using a mortar and pestle. 
The frozen powder was stored at -20°C until use.
For injection of the rabbit, Ig of powdered material, containing 
100-300jig of protein, was homogenised with 0.5ml of distilled water in 
a glass tube using a tight-fitting teflon pestle. This suspension was 
mixed thoroughly with l.Oml Freund’s complete adjuvant and injected 
subcutaneously at multiple sites on the back and neck of a New Zealand 
White rabbit. Similar amounts were administered at 2-3 week Intervals 
until, 10 days after the 4th set of injections, blood was drawn from a 
marginal ear vein. Additional booster injections were administered in 
Freund's incomplete adjuvant approx. two weeks before each bleeding. 
Serum was collected and stored in l.Oml aliquots at -20^C.
4.3 RESULTS
4.3.1 IMMUNOBLOTTING PATTERN OF PURIFIED 2-OXOGLUTARATE DEHYDROGENASE 
COMPLEX VERSUS ANTISERUM RAISED TO INTACT, NATIVE 
2-OXOGLUTARATE DEHYDROGENASE COMPLEX
The reactivity of antiserum raised against intact, native OGDC 
(section 4.2.1) with the individual subunits of the complex was tested 
using Immunoblotting analysis. Fig. 4.3 (lanes 2-5) shows the subunit 
composition when decreasing amounts of purified bovine heart OGDC were 
detected by Coomassie blue staining after polyacrylamide gel 
electrophoresis. Three major components were observed with M^ values 
1035000 + 1000 (El), 54500 + 1000 (E3) and 48500 + 1000 (E2). However,
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FIGURE 4.4 Reactivity of subunit specific antiserum with the
individual subunits of the 2-oxoglutarate dehydrogenase 
complex.
Different amounts of OGDC were resolved into component 
enzymes by SDS-PAGE. One part of the 10% (w/v) slab gel was 
stained with Coomassie blue (lanes 1-6); polypeptides on the 
remainder of the gel were transferred to nitrocellulose and 
treated with (1:100 dil.) of anti-El serum (lanes 7-11) or anti- 
E2 serum (lanes 12-17).
Lanes 1,7 & 12, standards; lanes 2-6, 10, 5, 1, 0.5 and 0.1|ig 
respectively of purified OGDC. Lanes 8-11 and lanes 13-17, as 
lanes 3-6. Lane 17, O.OSyg.
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when protein bands on a duplicate gel were electrophoretically 
transferred to nitrocellulose paper and probed with anti-OGDC serum to 
allow detection of antigenic polypeptides (see section 2.2.9 a) only 
two major bands were seen, corresponding in to the El and E2 
components of the complex. This technique is very sensitive and the 
antiserum was capable of detecting the El and E2 components of OGDC 
when as little as 0.5pg of purified OGDC was applied to the gel.
However, no reaction with the E3 subunit was observed even with larger 
amounts (up to lOjug) of protein. The lower bands observed at high 
levels of protein were probably proteolytic products resulting from 
degradation of OGDC subunits by endogenous proteases.
The poor antibody response elicited against E3 was also observed 
in antisera raised against intact, native bovine heart PDC 
(De Marcucci et al., 1985b) which has this subunit In common with OGDC. In 
both cases, OGDC and PDC, the titre of antibodies raised against E3 
was <2% of that raised against the other subunits.
6.3.2 IMMUNOBLOTTING ANALYSIS OF ANTI-El AND ANTI-E2 SERA VERSUS 
PURIFIED 2-OXOGLUTARATE DEHYDROGENASE COMPLEX
Immunoblotting analysis was again employed to check the 
specificity of the reaction of the subunit specific antisera, raised 
as described in section 4.2.2, with the individual components of OGDC.
Fig. 4.6 shows the precise reactivities of anti-EI and ant£-E2 versus 
varying amounts of OGDC resolved on SDS-polyacrylamide gels. In each 
case, the subunit specific antiserum reacted only with the antigen to 
which it was raised indicating the absence of cross-contamination in 
the antigen. Some idea of the titre of the antisera was also gained.
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FIGURE 4.5 Artefacts observed while using 2-mercaptoethanol 
in immune blotting analyses.
Protein fractions from different stages of the purification
of OGDC from bovine heart were separated on a 10% (w/v)
polyacrylamide gel. Following electrophoretic transfer of protein
bands to nitrocellulose the replica was probed with anti-El serum
(Is50 dil.). Immune complexes were located by incubation with 
125I-labelled protein A followed by autoradiography.
Lanes 1 & 9, standards; lanes 2-6, prepared in Laemmli sample 
buffer supplemented with 5% (v/v) 2-mercaptoethanol; lane 2, 
initial homogenate (20fjg); lane 3, 1st extract (20^g); lane 4,
2nd extract (20pg>; lane 5, 1st PEG precipitate, clarified (15pg); 
lane 6, 2nd PEG precipitate, clarified (15pg). Lanes 7 & 8, 
prepared in Laemmli sample buffer plus lOmM DTT; lane 7, material 
loaded onto Sepharose CL-2B (lOpg); lane 8, purified OGDC (Ipg).
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It Is seen that anti-El and anti~E2 sera were capable of detecting 
their parent antigens in O.lpg and O.OSpg of purified OGDC 
respectively when employed under standard conditions at a dilution of 
Is 100 and on exposure of the X-ray film for 48h at -70°C. The 
additional lower bands seen at high levels of protein loading are 
likely to be proteolytic fragments of the respective subunits.
At this time, it was decided not to attempt to raise antisera to 
E3. This decision was prompted by the comparatively poor antibody 
response elicited against E3 in comparison to the other subunits of 
OGDC. In addition, the method described in section 4.2.2 for the 
production of subunit specific antisera, involved multiple 
injections of relatively small amounts of protein and it was felt that 
this would not be a suitable regime for production of anti-E3 serum.
It must also be stressed at this stage that the antisera to El and E2 
were raised against the denatured polypeptide chains.
4.3.3 ARTEFACTS IN IMMUNOBLOTTING ANALYSES
In an attempt to demonstrate the absolute specificity of the 
antisera with respect to total cellular protein, anti-El serum was used 
to probe protein fractions from various stages in the purification of 
OGDC from bovine heart. The protein profile of these fractions has 
already been seen in Fig. 3.1. The corresponding immune replica in 
Fig. 4.5 reveals that anti-El serum is capable of detecting the El 
component of OGDC in these extracts with high specificity and 
sensitivity.
As can be seen from Fig. 4.5 (lanes 2-6), the immune replica of 
these samples, probed with anti-El serum, shows an additional band of
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approx. 65000 and a random distribution of dots over the 
autoradiograph. These artefacts were observed when the samples 
employed for SDS-PAGE had been prepared in Laemmli sample buffer 
supplemented with 5% (v/v) 2-mercaptoethanol. Both of these features 
are absent from lanes 7 & 8 which had been prepared in Laemmli sample 
buffer supplemented with lOraM DTT. It was demonstrated in two ways 
that the artefacts were caused by the presence of 2-mercaptoethanol and 
not the protein content of the samples (not shown). Firstly, an SDs- 
polyacrylamide gel was run with tracks containing Laemmli sample 
buffer in the absence of protein, Laemmli sample buffer plus 5% (v/v) 
2-mercaptoethanol and Laemmli sample buffer supplemented with lOmM 
DTT. This gel was then treated as normal for immunoblotting analysis 
(section 2.2.9 a) and probed with anti-El serum. Only the tracks 
containing 2-mercaptoethanol contained the artefacts. Secondly, the 
samples run in lanes 2-6 of Fig. 4.5 were precipitated in 80% (v/v) 
acetone, air dried, then solubilised in Laemmli sample buffer plus 
lOmM DTT and subjected to immunoblotting analysis as before. The 
artefacts observed in Pig. 4.5 were not present in this analysis.
Therefore, in future experiments, all samples for immunoblotting 
analysis were prepared in Laemmli sample buffer supplemented with 
lOmM DTT.
•4.3.4 EFFECT OF VARIOUS ANTISERA ON THE ACTIVITY OF 2-OXOGLUTARATE 
DEHYDROGENASE COMPLEX
Once the specificity of the antisera with regard to the 
individual components of the complex had been established, their 
effects on overall OGDC activity were tested. It was found that
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FIGURE 4.6 Effect of antiserum raised to intact, native 
2-oxoglutarate dehydrogenase complex, subunit 
specific antisera and preimmune serum on the overall 
activity of the 2-oxoglutarate dehydrogenase complex.
Purified OGDC (approx. 20pg) was incubated with various 
amounts of antisera in a final volume of 200ul of 50mM sodium 
phosphate buffer, pH 7.0, containing 2.7mM EDTA, 1% (v/v) Triton 
X—100 and O.lSpM leupeptin for 90min at room temperature. Overall 
complex activity was measured before and after this incubation as 
described in section 2.2.1 a.
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FIGURE 4.7 Immune precipitation of H-labelled
2-oxoglutarate dehydrogenase complex from Triton 
buffer with anti-El, anti-E2 sera and antiserum 
raised against the native complex.
OGDC, labelled with N-[^H)ethylmaleimide, was incubated with 
antiserum raised against native OGDC or subunit specific antisera 
in Triton buffer (section 2.2.5 b). Immune complexes were 
adsorbed onto formalinised ÊHEÊHE cells before SDS-PAGE on 10% 
(w/v) gels followed by fluorography.
(A) Lanes 1,7 & 10, ^H-labelled OGDC; lane 2, anti-El serum; lane
3, anti-El serum, antigen heated to 100°C for 2min before
addition of antiserum; lane 4, preimmune serum; lanes 5 & 6 and
lanes 8 & 9, as lanes 2 & 3 but with anti-E2 and anti-OGDC sera
respectively.
3
(B) Lane 1, H-labelled OGDC; lane 2, boiled antigen, no 
antiserum.
(A)
■El
E3
•E2
(B)
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incubation of OGDC with antiserum raised against native, intact OGDC 
or with anti-El or antl-E2 subunit specific sera, resulted in 
inhibition of enzymic activity (Fig. 4.6). At the highest levels of 
antisera tested, OGDC activity was inhibited by approx. 75%. It is 
possible that complete inhibition of enzymic activity may occur at 
higher levels of antisera but whether this would be a true effect or 
due to an inhibitory factor in normal serum could not be determined. 
However, it is not unknown for antisera to only partially inhibit the 
enzymic activity of the antigen as the major antigenic determinants of 
the protein may be located such that the antibody only partially 
blocks access to the active site of the enzyme.
4.3.5 IMMUNE PRECIPITATION OP 2-OXOGLUTARATE DEHYDROGENASE COMPLEX
To facilitate analysis of the components immunoprecipitated by 
the antisera raised against OGDC, the free thiol groups were labelled
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with N-[ Hjethylmaleimide (section 2.2.5 b). The pattern of 
radiolabelled polypeptides (Fig. 4.7, lane 1) reveals that the three 
components of OGDC were labelled to approximately the same extent.
Different buffer systems and conditions of immune precipitation 
were tried in order to obtain optimal conditions for efficient, clean 
immune reactions and promote maximal dissociation of the complex. Two 
methods of precipitating the immune complexes were tried, namely 
Staphylococcus aureus cells or the double antibody technique. The 
former technique is based on the ability of protein A, a cell wall 
component of formalinised aureus cells, to bind the F^ portion of 
certain immunoglobulins in Immune complexes, including rabbit IgG. The 
double antibody technique requires a second immune precipitation
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employing an antiserum raised to the IgG of the initial species, in 
this case rabbit. This latter technique is more time consuming as it 
involves a second overnight precipitation. Moreover, it requires the 
addition of an optimal volume of second antibody which must be 
determined by titration. Addition of large volumes of second antibody 
also leads to problems in SDS-PAGE analyses of the products of immune 
precipitation. Heavy protein bands, corresponding to the individual 
chains of the IgG molecule, are seen on SDS-polyacrylamide gels causing 
distortion in these regions. The heavy chain of IgG causes distortion 
in the M^ region of 50000, which is one of the areas of interest in 
the study of OGDC whose E2 and E3 components have M values of 48500 
and 54500 respectively. All immune precipitations were performed, 
therefore, using the aureus indirect immune precipitation 
technique. A commercial, standardised 10% (w/v) preparation of 
formalinised aureus cells, known as Pansorbin was employed in 
these studies.
Immune precipitations were carried out initially in lOmM Tris- 
HCl, pH 7.4, containing 300mM NaCl, 5mM EDTA and 1% (v/v) Triton X-100 
(section 2.2.5 b). Since the complexes were dissociated by SDS during 
the labelling procedure, immune precipitation in this system should 
reflect the relative titres of antisera against the individual 
subunits of the complex. In the case of anti-OGDC serum, only the El 
and E2 subunits of the complex were precipitated by the antiserum (De 
Marcucci et al., 1985b) reflecting the relative titres already observed 
by immune blotting analysis (Fig. 4.2). It was also found that anti- 
PDC serum was capable of immune precipitating all components of ^H- 
labelled PDC except E3 (De Marcucci et al., 1985b).
Fig. 4.7 (lane 8) illustrates that, although the titre of
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antibody to E3 is low initially, in later bleeds of the same rabbit 
the titre has risen sufficiently to enable some immune precipitation 
of E3. In the case of the subunit specific antisera, anti-El serum 
immunoprecipitated the El component of the complex exclusively (Fig. 
4.7, lane 2), indicating that the complex was completely dissociated. 
However, the precipitation carried out with anti-E2 serum contains 
some El in addition to E2. This was only occasionally observed and was 
probably due to incomplete dissociation and not cross reaction of 
anti-E2 serum with El which was ruled out by the earlier 
immunoblotting analysis (Fig. 4.4).
The eventual aim in these studies was to immune precipitate the 
component enzymes of OGDC from cellular extracts. Degradation of the 
polypeptides of interest by endogenous cellular proteases is one of 
the major problems of this procedure. One way of preventing . 
proteolysis in such extracts is to boil the extract in the presence of 
detergent. Thus, the effect of boiling the antigen in Triton buffer 
before addition of antiserum was tested. It was also thought that 
heating the sample in this way might improve the degree of 
dissociation of the complex. Subsequent immune precipitation and 
analysis of the products revealed that, irrespective of the antisera 
used, all three component enzymes of OGDC were precipitated (Fig. 4.7, 
lanes 3,6 & 9). Further experiments in this system showed that even in 
the absence of antisera the final product of precipitation contained 
the three subunits of OGDC (Fig. 4.7B). Either the complex had formed 
aggregates large enough to spin down independently during 
centrifugation of formalinised aureus cells or heating had 
denatured the complex components such that they adsorbed, non-
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FIGURE 4.8 Immune precipitation of H-labelled 2-oxoglutarate
dehydrogenase complex from 3D-TKM buffer with antisera 
raised against intact 2-oxogluarate dehydrogenase complex, 
El and E2.
OGDC, labelled with N-(^H)ethylmaleimide, was dissociated in 
3D-TKM buffer (section 2.2.8 b) and immune precipitated with
antisera raised to native OGDC and subunit specific antisera.
3 3
Lanes 1,7 & 13, H-labelled OGDC. Immune precipitates of H-
labelled OGDC with native OGDC antiserum, bleed 1 (lane 2), bleed
6, (lane 3); El subunit specific antlserum (lane 4); anti-E2
serum (lane 5) and preimmune serum (lane 6). Lanes 8-12, as lanes
2-6 but with antigen boiled before addition of antlserum.
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specifically, to the ^  aureus cells and were only dislodged by 
further boiling in Laemmli sample buffer prior to SDS-polyacrylamide 
gel analysis.
Immune precipitation in the 3D-TKM (section 2.2.8 b) buffer 
system is seen in Fig. 4.8. This buffer provides a much more stringent 
set of conditions for immune precipitation as 0.5% (w/v) SDS and 1% 
(w/v) DOC are present in the buffer in addition to 1% (v/v) Triton X- 
100. Accordingly, complete dissociation is observed and each of the 
subunit specific antisera immunoprecipitate only their parent antigen. 
Again the E3 component is absent from the products of immune 
precipitation carried out with anti-OGDC serum from the initial bleeds 
of the rabbit. However, it is present in immune precipitations 
employing serum from later bleeds of the same rabbit, indicating a 
rise in antibody titre to E3. In contrast to the immune precipitations 
carried out in Triton buffer, boiling the antigen in 3D-TKM before 
addition of antisera, had little or no effect on the products of 
immune precipitation (Fig. 4.8, lanes 8-12). One possible explanation 
for this, based on the previous theory of denatured polypeptides 
binding non-specifically to Pansorbin, is that although the denatured 
subunits adsorb to the aureus cells, as may be the case in Triton 
buffer, the washing conditions in this case, which include the 
detergents, SDS and DOC, were stringent enough to remove these 
contaminant bands while at the same time being mild enough to allow 
the association of antigen and antibody to proceed. It is also 
possible that, if boiling in Triton buffer resulted in the formation 
of large aggregates of OGDC, the presence of the extra detergents in 
3D-TKM would prevent this aggregation occurring when the antigen was 
heated to 100 C.
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FIGURE 4.9 Reactivity of anti-E3 serum and antiserum raised
to 2-oxoglutarate dehydrogenase complex with purified 
E3 and the three mitochondrial 2-oxo acid 
dehydrogenase complexes.
Purified E3 from porcine heart, OGDC and PDC from bovine 
heart and BCDC from bovine kidney were resolved on a 10% (w/v) 
SDS-polyacrylamide gel slab. One set of tracks was stained with 
Coomassle blue,(lanes 1-5); lane 1, standards; lane 2, E3 
(5|jg); lane 3, OGDC (lOpg); lane 4, BCDC (lOpg); lane 5, PDC 
(15pg). The protein in the duplicate sets of tracks was 
transferred to nitrocellulose and processed for immunological 
detection of E3 with 1:50 dil. of anti-E3 serum (lanes 6-9 as 
lanes 2-5, 2ug per track). The nitrocellulose was then overlayed 
with anti-OGDC serum (1:50 dil.) and the dried paper re-exposed 
to X-ray film (lanes 10-13 as lanes 6-9).
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4.3.6 PREPARATION AND CHARACTERISATION OF ANTI-E3 SERUM
Antiserum was raised against purified E3 by Miss Anne Phelps in 
our laboratory. Samples of a commercially purified porcine heart 
lipoamlde dehydrogenase (Img) were employed to immunise a rabbit 
following a regime similar to that used to raise antiserum to intact, 
native OGDC (section 4.2.1). The rabbit received four injections of E3 
(Img) in Freund's complete adjuvant before the initial bleeding. 
Subsequent booster injections of E3 (Img) were carried out in Freund's 
incomplete adjuvant. Serum collected was again stored at -20°C in 
aliquots of 1.0ml.
Immunoblotting analysis was employed to determine the cross 
reaction of this antlserum with purified E3 and the E3 component of 
the three 2-oxo acid dehydrogenase complexes. Samples of purified 
porcine heart E3, bovine heart OGDC, bovine kidney BCDC (a gift from 
G.H.D. Clarkson) and bovine heart PDC (a gift from O.L. De Marcucci) 
were resolved on a 10% (w/v) polyacrylamide gel and visualised by 
staining in Coomassie blue (Pig. 4.9, lanes 2-5 respectively). Bovine 
heart PDC is composed of 5 protein bands of 70000 (E2), 55000 (E3), 
50000 (component X), 42000 (Eld) and 37000 (Elp) (Linn et al., 1972; 
Stanley & Perham, 1980; De Marcucci & Lindsay, 1985) whereas bovine 
kidney BCDC is resolved into 3 polypeptides of 52000 (E2), 46000 
(Eld) and 35000 (Elp). The E3 component is missing from BCDC purified 
by this procedure (Lawson et al., 1983). The absence of E3 from the 
sample of BCDC is confirmed by examination of the Immune replica of 
these samples probed with anti-E3 serum (Fig. 4.9, lane 8). This 
antiserum is seen to react specifically with the purified porcine
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FIGURE 4.10 Immune precipitation of H-labelled 2-oxoglutarate
dehydrogenase complex with anti-E3 serum and antisera 
raised against native 2-oxogluarate dehydrogenase 
and pyruvate dehydrogenase complexes.
3
Pure H-labelled OGDC was immune precipitated from 3D-TKM 
buffer using anti-E3, anti-PDC or anti-OGDC sera. Products of 
Immune precipitation were separated by SDS-PAGE on 10% (w/v) gels 
and visualised using fluorography.
Lane 1, ^H-labelled OGDC; lane 2, anti-E3 serum; lanes 3 & 4, 
anti-OGDC serum; lane 5, anti PDC serum. Tracks 1-3 were exposed 
to X-ray film for 5 days and tracks 4 & 5 for 10 days.
1 2 3
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FIGURE 4.11 Titration of H-labelled 2-oxoglutarate
dehydrogenase complex with varying amounts of 
antisera raised to 2-oxoglutarate dehydrogenase 
complex and its component enzymes.
3
Pure H-labelled OGDC (0.2pg: approx 30000c.p.m.) was immune 
precipitated from 100^1 of either Triton buffer(/l) er3D-TKM^fij vOiHt, 
varying amounts of anti-OGDC serum or subunit specific antisera. 
Immune complexes were adsorbed onto formalinised aureus cells, 
collected by centrifugation and washed as described in section 
2.2.9 b). Final pellets were dissolved in 50yl of Laemmli sample 
buffer and lOyl of this was subjected to scintillation counting.
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heart E3 and the E3 components of both OGDC and PDC from bovine heart. 
After exposure of the X-ray film to yield the image in lanes 6-9 of 
Fig. 4.9, the nitrocellulose paper was then overlayed with anti-OGDC 
serum. The only additional reaction seen was with the El and E2 
components of the OGDC complex (Fig. 4.9, lanes 10-13). Antiserum 
raised against OGDC did not show cross reaction with the El or E2 
components of either PDC or BCDC indicating that unlike the E3 
components there is no immunological similarity between the El and E2 
subunits of the different 2-oxo acid dehydrogenase complexes. The 
ability of E3 subunit specific antisera to immunoprecipitate the E3 
component of ^H-labelled OGDC is revealed in Fig. 4.10. It was also 
seen that antlserum raised against bovine heart PDC had the capacity 
to immunoprecipitate small amounts of the E3 component of ^H-labelled 
OGDC. This would be expected to occur if lipoamide dehydrogenase (E3) 
was indeed common to the two multi-enzyme assemblies. The low yield of 
E3 in the immune precipitates with PDC antiserum is probably related 
to the low titre of antibodies to E3 in this serum.
4.3.7 TITRATION OF ^H-LABELLED 2-OXOGLUTARATE DEHYDROGENASE
COMPLEX WITH ANTISERUM TO NATIVE, INTACT 2-OXOGLUTARATE 
DEHYDROGENASE COMPLEX AND SUBUNIT SPECIFIC ANTISERA
A constant amount of ^H-labelled OGDC was incubated with various 
volumes of anti-OGDC serum or subunit specific antisera, and the 
extent of immune precipitation (c.p.m.) was determined in each case. 
Fig. 4.11A shows that, in the presence of Triton buffer, approximately 
66% of total c.p.m. can by precipitated with anti-OGDC serum whereas 
the subunit specific antisera allows precipitation of 20-35% of the
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FIGURE 4.12 Cross reactivity of antisera with mitochondria from
various sources.
Mitochondria purified from various sources were separated by 
SDS-PAGE on 10% (w/v) polyacrylamide slab gels. One gel was 
stained with Coomassie blue to visualise the protein bands (A). 
Protein bands on the duplicate gels were electrophoretically 
transferred to nitrocellulose and processed for detection of 
antigenic polypeptides using native OGDC antiserum, bleed 6 (B); 
anti-El serum (C); E2 subunit specific antlserum (D) and anti-E3 
serum (E).
Lane 1, M^ standards; lanes 2 S 8, pure OGDC (lO^g in A; 2pg in 
B-E); lane 3, bovine heart mitochondria (50/ig); lanes 4-6, 
mitochondria from PK-15, NBL-1 and BRL cell lines respectively 
(SOjjg); lane 7, rat liver mitochondria (SOyig).
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total OGDC. The supernatant fluid was not analysed following immune 
precipitation and the remaining radioactivity could represent soluble 
counts. The difference in radioactivity precipitated using antiserum 
to OGDC as opposed to subunit specific antisera probably reflects the 
number of radiolabelled protein bands in the immune complexes. In the 
case of OGDC antlserum, three radiolabelled protein bands are 
precipitated whereas with subunit specific antisera only one 
radioactive band is present in the immune complex.
In comparison the percentage of total c.p.m. precipitated in the 
presence of 3D-TKM buffer (Fig. A.llB) is approximately 50% of that 
achieved in the presence of Triton buffer. This probably reflects the 
increased stringency of the washing conditions where only high 
affinity binding is preserved.
4.3.8 CHOICE OF CELL LINE IN WHICH TO CARRY OUT FURTHER STUDIES
Three continuous cell lines were available in which to carry out 
biosynthetic studies: NBL-1, a bovine kidney cell line; PK-15, porcine 
kidney cells; and BRL, buffalo rat liver cells. Immune blotting 
analysis of these cell lines was carried out to determine the most 
suitable culture in which to pursue the biosynthetic studies.
Total mitochondrial protein from various cell types, purified 
bovine heart OGDC and standards were separated electrophoretically 
on 10% (w/v) SDS-polyacrylamide slab gels. The pattern of staining with 
Coomassie blue is illustrated in Fig. 4.12A while Fig. 4.12B-E shows 
the corresponding immunoblots with anti-OGDC, anti-El, anti-E2 and 
anti-E3 sera respectively. From these data, it is apparent that the 
antisera is highly specific for the constituent polypeptides of the
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OGDC complex, reacting exclusively with the El, E2 and E3 subunits in 
crude mitochondrial extracts. The extra band seen in Fig. 6.12B & D in 
the lanes corresponding to purified OGDC represents the major proteolytic 
fragment of E2, seen when the purified OGDC is subjected to repeated 
freezing and thawing. In the majority of cases (except anti-E3 serum), 
the antisera show strong cross reaction with bovine heart 
mitochondria (lane 3) and mitochondria prepared from porcine kidney 
(lane 4) and bovine kidney cells (lane 5). In comparison, a weaker 
cross reaction is exhibited against mitochondrial extracts from BRL 
cells or rat liver. With anti-Eji serum, a strong cross reaction is seen 
with all extracts.
4.4 DISCUSSION
. A major observation of this work is that the lipoamide 
dehydrogenase (E3) component of OGDC elicits a poor antibody response 
relative to the other component enzymes of the complex. This low 
immunogenicity of the common E3 subunit is also apparent in antisera 
raised to PDC (De Marcucci et al., 1985b).
Evidence supporting this conclusion was obtained by (a) employing 
immunoblotting to examine the precise reactivity of anti-OGDC serum 
versus the purified enzyme and (b) indirect immune precipitation of 
dissociated ^H-labelled OGDC. In both cases, a lack of reaction of 
antiserum with lipoamide dehydrogenase is observed. In the latter 
case, E3 is found in the supernatant fraction after Immune 
precipitation (not shown) ruling out the possibility of selective 
degradation of this component on incubation with ahtisera or with the 
formalinised S. aureus cells.
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This apparent low immunogenicity cannot be attributed to a low 
content of E3 in these purified multienzyme complexes as the 
polypeptide chain ratios of El, E2 and E3 are 1:2:1 and 5:5:1 in OGDC 
and PDC respectively (De Marcucci et al., 1985b). Also since the E3 
component is thought to be present on the surface of both multienzyme 
assemblies (Oliver & Reed, 1982), inaccessibility of the antigen cannot 
be the cause of the lack of antibody response.
One plausible explanation for these data is that the low 
immunogenicity of E3 reflects a high degree of conservation of amino 
acid sequence in this polypeptide chain. This seems feasible in view 
of the fact that E3 is a common component of three multienzyme 
assemblies and therefore severe constraints must be imposed on amino 
acid substitution by the multiple and differing subunit specific 
interactions involved in the three structurally and functionally 
analogous 2-oxo acid dehydrogenase complexes. Indeed, the complete 
sequence of ^  coli E3 has been deduced from examination of the cloned 
gene (Stephens et al., 1983) and considerable homologies are detected 
between the sequence of the ^  coli enzyme and tryptic peptides of the 
porcine heart E3 (Stephens et al., 1983; Arscott et al., 1986).
The ability to raise subunit specific antiserum directed against 
purified E3 is probably related to the large amounts of protein 
employed in the immunisation protocol. Immunoblotting analysis using 
this antiserum, revealed an absence of the E3 component from purified 
bovine kidney BCDC.
Although it is generally accepted that E3 is common to all three 
2-0X0 acid dehydrogenase complexes, this has been shown to be false in 
the case of Pseudomonas putida (Sokatch et al., 1981a). A lipoamide 
dehydrogenase component of 56000 was purified from putida cells
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grown in the presence of glucose, which contain OGDC and PDC 
activities. However, E3 from cells grown plus valine, which contain all 
three 2-oxo acid dehydrogenase complex activities, has an of 69000 
and differs from the E3 purified from glucose grown cells in pH 
optimum also. It was concluded that the latter E3, of 69000, was 
specific for BCDC and the former for the other two 2-oxo acid 
dehydrogenase complexes.
Multiple forms of mammalian E3 have been observed, although it is 
thought that these are all different conformations of the same protein 
(Sakurai et al., 1970). The assumption that there is only one 
mammalian E3, common to all three 2-oxo acid dehydrogenase complexes, 
can only be proved by the demonstration of only one gene for this 
particular protein. This has been demonstrated in E^ coli where E3 is 
common to OGDC and PDC (Guest & Creaghan, 1973; Guest, 1976).
The high selectivity and sensitivity of the antisera were 
monitored by Immunoblotting against whole cell and mitochondrial 
extracts. Transfer of proteins to nitrocellulose paper has several 
advantages; filters are easier to manage, proteins are more accessible 
and therefore processing times and amounts of reagent required are 
reduced, the same replica can be used for successive analyses. One of 
the most commonly encountered artefacts of this technique is that 
elution is dependent on M^. However, addition of 0.02% (w/v) SDS to the 
original transfer buffer of Towbin et al. (1979) facilitates the 
elution of higher proteins. After transfer of the protein to 
nitrocellulose, unbound sites on the paper must be quenched prior to 
treatment with antiserum. Initially this was achieved with 3% (w/v)
BSA in the washing buffer as described by Towbin et al. (1979).
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However, darkened backgrounds were observed so the non-ionic detergent 
Tween 20 was employed as a blocking agent (Batteiger et al., 1982). 
Improved backgrounds and specificity of interaction were achieved by 
this procedure. There was the additional advantage that the replicas 
could be stained for protein after use to check the efficiency and 
fidelity of transfer.
The observation that artefactual bands appear on 5DS- 
polyacrylamide gels when 2-raercaptoethanol is present in the sample 
buffer has been noted previously (Tasheva & Dessev, 1983). These 
authors claimed that 2-mercaptoethanol was responsible for the 
appearance of two non protein bands (M^ 54000 and 65000) in Coomassie 
blue or silver-stained gels. It was reported that this effect was 
observed on electrophoresis of pure mercaptoethanol but, in contrast 
to observations in this work, it was also suggested that this effect 
became even more pronounced when 2-mercaptoethanol was replaced by DTT.
The highly sensitive Immunoblotting technique, using samples 
prepared in Laemmli sample buffer plus lOmM DTT, revealed the 
specificity of the antisera which react exclusively with the 
respective antigens to which they were raised. It also revealed the 
fact that antisera raised to bovine heart OGDC can cross react with 
the corresponding polypeptides of OGDC in porcine kidney, bovine 
kidney and rat liver cells. Similarly antiserum raised to porcine 
heart E3 cross reacts with lipoamide dehydrogenase from the afore­
mentioned cell lines and also with bovine heart E3. It was not 
established whether the weaker cross reaction observed against cells 
derived from rat liver tissues reflected a genuine immunological 
difference or merely a lower abundance of the multienzyme complex in 
these tissues.
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However, on the basis of these results, biosynthetic analyses 
were initiated in both porcine kidney (PK-15) and bovine kidney 
(NBL-1) cells.
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CHAPTER FIVE
IMMUNE PRECIPITATION OF THE COMPONENT ENZYMES 
OF 2-OXOGLUTARATE DEHYDROGENASE 
FROM MAMMALIAN CELLS
5.1 INTRODUCTION
In the previous chapter the preparation of antisera to native,
whole OGDC, native E3 and the denatured El and E2 subunits was
described. The high specificity and sensitivity of these antisera was
determined by immune blotting analysis versus purified bovine heart
OGDC, porcine heart E3 and crude cellular or mitochondrial extracts.
In addition, the ability of these antisera to Immune precipitate the
component enzymes of OGDC was demonstrated using OGDC labelled with N- 
3
[ HJethylmaleimide. The next stage in the project involved immune
precipitation of the subunits of OGDC from crude extracts of
[^^S]methionine-labelled cell cultures.
Immunoblotting analysis revealed that porcine kidney (PK-15) or
bovine kidney (NBL-1) were the best cell lines in which to carry out
biosynthetic studies. These cell lines were chosen initially because
they produced very little lactic acid, suggesting a high degree of
aerobic metabolism and hopefully a high content of mitochondria. It
was also thought that, since they were closely related to bovine
heart, cross reaction with the antisera would occur. As the
immunoblotting studies showed this assumption proved valid and the
antisera cross reacted strongly with the component enzymes of OGDC in
both PK-15 and NBL-1 cell lines. This chapter deals with determining
35
optimal conditions for labelling the cells with [ S]methionine and 
reproducible immunoprécipitation of the subunits of OGDC from 
detergent extracts of these t^^S]methionine-labelled cells. It also 
concerns the detection of precursor forms of the component enzymes of
35
OGDC in cells labelled with [ 5]methlonine in the presence of 
uncouplers of oxidative phosphorylation.
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5.2 OPTIMISATION OF CONDITIONS FOR LABELLING CELLS
Considerable effort was expended in determining optimal
35conditions for incorporation of [ S}methionine into cellular protein.
The effect of various media (NGM, LMM, MMM; section 2.2.7) and the
presence or absence of serum were tested for their effect on
incorporation of Jmethionine into protein. Cells were introduced
into 5cm diam. petri-dishes in 3ml NGM at a concentration of 250000
cells/ml. Petri-dishes were incubated at 37°C in a humidified
incubator for 24-48h until semi-confluent monolayers were observed.
NGM was replaced by 2ml of one of the above media, made up with or
without serum (in those media made up without serum the volume was
kept constant by addition of sterile distilled water), after an
initial rinse in the same medium. lOpCi of [^^S]methionine was added
to the dishes which were incubated at 37°C for 30 min. After this time
radioactive medium was removed and the cell monolayers washed three
times in ice-cold PBS before the cells were harvested in 0.5ml of
Triton buffer (section 2.2.5 b). 50pl aliquots were spotted onto
Whatman filter discs, which were processed as described in section
352.2.6 b, to determine { SJmethionine incorporation into protein. In
the presence of NGM, incorporation of radioactivity into protein was
20-25% of that incorporated in either LMM or MMM. The presence or
absence of serum had very little effect on incorporation. Highest 
35levels of ( Sjmethionine in protein were observed in cells incubated 
in MMM. Incorporation in LMM was approx. 70% of that in MMM. However, 
comparison of methionine levels in the various media revealed that the 
concentration in LMM is 5pM whereas that in MMM is 0.7pM. Therefore, it
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was expected that incorporation in MMM would be much greater than that
in LMM. As this was not the case,it suggests that either there was an
intracellular pool of methionine large enough to make this difference
negligible or that the lack of methionine had an adverse effect on
protein synthesis and cell growth. In order to avoid this possible
adverse effect on protein synthesis, all further labelling was carried
out in LMM. Serum was also Included in the labelling medium since
removal of serum did not significantly increase the degree of
incorporation. In the presence of serum normal growth and cell
division is more likely to take place.
The effect of preincubation in LMM, prior to addition of
radioactive methionine, was tested also. Preincubation in LMM was seen
35
to increase incorporation of ( 5]methionine into protein with an 
optimal incubation time of Ih in LMM, prior to addition of the 
radioactive amino acid. This may indicate the presence of an 
intracellular pool of methionine which is depleted after an incubation 
period of Ih.
35
The time course of incorporation of t S]methionine into protein
over 24h was investigated. Cells were introduced into 2.5cm diam.
petri-dishes at a concentration of 300000 cells/ml in 1ml of NGM.
Petri-dishes were incubated at 37°C until semi-confluent monolayers
were observed. Monolayers were rinsed in LMM and incubated in 1ml of
LMM for Ih at 37*C prior to the addition of 5pCi )methionine/dish.
The incorporation of radioactivity into protein after various times
was determined as described earlier. It was found that incorporation 
35of [ S]methionine was linear for 8h after which the majority of the 
radioactivity had been incorporated.
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The concentration of cells Introduced initially into petri-dishes
was determined by trial and error. As already mentioned the levels
used were 250000-350000 cells/ml and the final volume depended on the
35
size of the petri-dish. The amount of [ Sjmethionine added was a 
compromise between c.p.m. incorporated over the period of interest and 
cost limitations.
In general, cells were labelled for 4h or overnight with 
100-200^Ci [^^Sjmethionine in LMM after a ih preincubation in the same 
medium.
5.3 IMMUNE PRECIPITATION OF 2-OXOGLUTARATE DEHYDROGENASE COMPLEX
FROM PORCINE KIDNEY CELLS
Initial attempts to immunoprecipitate the component enzymes of 
OGDC from crude extracts of cultured cells involved preparing cell 
extracts by homogenisation in Triton buffer. The products of immune 
precipitation from these extracts contained the subunits of OGDC but 
were also heavily contaminated with other cellular proteins. In the 
preparation of cellular extracts by this method, the nuclei were lysed 
with concomitant release of DNA. The presence of this 'sticky' genetic 
material was probably one of the major causes of this contamination. 
Preincubation of the extracts with Pansorbin for Ih at room 
temperature, followed by removal of the Pansorbin by centrifugation at 
14000g for 2 min and subsequent immune precipitation of the 
supernatant fluid, was tried in an attempt to eliminate the 
contamination. No improvement was observed.
The double antibody indirect immune precipitation technique was 
also employed. Results were similar to those obtained using Pansorbin
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and again there were problems of distortion in the gels (section 4.3.5) 
Pre-adsorption of the extracts with pre-immune serum and removal of 
the Immune complexes using goat anti-rabbit IgG prior to immune 
precipitation was attempted with no resultant decrease in the degree 
of contamination.
Attempts to improve the quality of the immune complex-Pansorbin 
assembly were also made by passage through a sucrose gradient.
Products of immune precipitation, after three washes in buffer plus 
detergent (section 2.2.9 c) were resuspended in 50^1 of buffer plus 
detergent. Sucrose gradients of 300pl each of 0.5M and IM sucrose in 
detergent containing buffer were prepared. The immune products were 
layered on top of these gradients and centrifuged at 3000g for 30 min 
at room temperature. Sucrose was removed with a Pasteur pipette and 
the pellets taken up in Laemmli sample buffer and analysed by SDS- 
PAGE (section 2.2.4). Again no improvement in the degree of 
contamination was observed.
A procedure for preparing extracts such that the nuclei remained 
intact had been developed previously for studies on the biosynthesis 
of immunoglobulins (Mosmann et al., 1979). Cells were harvested in 
buffer containing 1% (v/v) Triton X-100, lysing the cells but not 
the nuclei which were then removed by centrifugation. The detergent 
content of the buffer was adjusted to equal that of 3D-TKM (section
2.2.6 b) and the mixture clarified by centrifugation before addition 
of the antisera. This buffer gave minimal non-specific adsorption of 
contaminating material in control Immune precipitates while also 
promoting maximal dissociation of the multienzyme complex. Pre­
adsorption with Pansorbin was found to be unnecessary as was sucrose 
gradient centrifugation of the immune complexes.
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FIGURE 5.1 Immune precipitation of 2-oxoglutarate dehydrogenase
complex from porcine kidney cells.
(^ ^Sjmethionine-labelled cell extract from PK-15 cells, 
prepared as described in section 2.2.8 a, was incubated with 
various antisera. Immune complexes were precipitated using 
formalinised aureus cells and then analysed by SDS-PAGE on 
10% (w/v) slab gels followed by fluorography.
Lane 1, M standards; lane 2, ^H-labelled OGDC. Immune
precipitates of PK-15 cell extracts using preimmune serum (lane
3); native OGDC antiserum, bleed 1 (lane 4) and bleed 6 (lane 5);
anti-El serum (lane 6) and anti-E2 serum (lane 7).
Mp (xicr^)
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Immune precipitation profiles, observed after the various antisera
were employed to select specifically OGDC or individual subunits from 
35( Sjmethionine-labelled detergent extracts of porcine kidney cells
grown in culture, are seen in Fig. 5.1. Even under these stringent
conditions, on occasions, incomplete dissociation could be detected.
For example, anti-El immune precipitate (lane 5) contains a small
amount of associated E2.
Under these conditions, the pattern of immune precipitation again
reflects the titre of antibodies raised against the individual
subunits. It is clear that antiserum to the native complex is
initially capable of inducing specific precipitation of the El and E2
subunits only. The exclusion of E3 from the final immune complex
indicates that the titre of antibody to this component is low in
comparison to the other major enzymes. However, as already observed
(section 4.3.5), in later bleeds of the same rabbit it is apparent that
the antibody titre has increased substantially to the extent that some
precipitation of this component can be achieved also.
These results establish (a) the monospecific nature of the immune 
35
reaction in ( SJmethionine-labelled crude cell extracts and (b) that
antisera to the bovine heart enzymes can induce strong and efficient
immune precipitation of the equivalent complex from porcine kidney
cells. Similar highly specific and efficient immune precipitation of
35
the component enzymes of OGDC was observed from [ SJmethionlne- 
labelled detergent extracts of bovine kidney cells (not shown).
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FIGURE 5.2 Detection of 2-oxoglutarate dehydrogenase complex 
subunits in porcine kidney cells labelled with 
[^^Sjmethionine in the presence of uncouplers of 
oxidative phosphorylation.
Extracts were prepared from cells labelled with
35
[ Sjmethionine for 4h in the presence of lOjiM FCCP (A) or 
2mM 2,4-DNP (B). Immune precipitation was carried out using 
anti-OGDC serum or subunit specific antisera directed against El 
or E2. The products of immune precipitation were analysed on 10%
(w/v) SDS-polyacrlamide gels.
(A) Lane 1, anti-OGDC serum; lane 2, anti-El serum; lane 3, 
anti-E2 serum; lane 4, pure ^H-labelled OGDC.
(B) Lane 1, ^H-labelled OGDC; lanes 2-5, immune precipitation of 
PK-15 cell extracts with pre-immune serum (lane 2); anti-OGDC 
serum (lane 3); El subunit specific antiserum (lane4) and anti-E2 
serum (lane 5).
(A) (B)
—  El
— E 3  
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5.4 DETECTION OF SUBUNITS OF 2-OXOGLUTARATE DEHYDROGENASE
COMPLEX IN PORCINE KIDNEY CELLS LABELLED IN THE PRESENCE OF 
UNCOUPLERS OF OXIDATIVE PHOSPHORYLATION
As import of cytoplasmically-syntheslsed mitochondrial 
polypeptides is dependent on the electrochemical potential gradient 
across the inner membrane of the organelle, dissipation of Apy+ in 
the presence of uncouplers of oxidative phosphorylation can lead to 
the accumulation of precursor forms of the constituent enzymes of 
OGDC,
provided these are relatively stable in the cytosolic compartment of 
the cell.
Determination of conditions which prevented import of proteins
into mitochondria was a question of trial and error. Two readily
available uncouplers were 2,4-dinitrophenol (2,4-DNP) and
carbonyl cyanide p-trifluoromethoxyphenylhydrazone (FCCP). The latter
is reported to block import of proteins into mitochondria when used in
the pM range and the former in the mM range (Reid & Schatz, 1982;
Fenton et al., 1984). Immune precipitation from cells, labelled with 
35[ S]methionine in the presence of 5pM FCCP revealed, in addition to the 
subunits of OGDC, extra bands of higher value. If the concentration 
of FCCP was raised to lOpM the bands corresponding to the mature 
subunits disappeared and only the bands seen in Fig. 5.2B remained. A 
similar pattern was displayed in the presence of 2,4-DNP at ImM and 
2mM respectively. At the lower concentration, the mature forms were 
visible, in addition to the extra bands, but at the higher 
concentration, these had disappeared (Fig. 5.2A). Raising the 2,4-DNP 
concentration to 4raM resulted in decreased incorporation of
115
FIGURE 5.3 difference of El isolated from porcine kidney
35
cells labelled with [ Sjmethionine in the presence or 
absence of 2,4-DNP.
35
Extracts prepared from cells labelled with [ Sjmethionine 
in the presence or absence of 2mM 2,4-DNP were subjected to 
immune precipitation using El subunit specific antiserum. Immune 
products were separated on a 6% (w/v) polyacrylamide gel and 
visualised by fluorography.
Lane 1, standards; lanes 3 & 13, ^H-labelled OGDC. Immune 
prcipitates from cells grown minus uncoupler (lanes 5,7,9 & 11) 
and plus uncoupler (lanes 6,8 & 10).
El
1 2 3 4 5 6 7 8 9 10 11 12 13
35 35[ s]methionine. Incubation of cells with [ S}methionine for 2h or Ah
in the presence of uncouplers gave the same result. Since greater
incorporation of radioactivity into protein occurred in Ah, this
period of time was used for all subsequent incubations. The total 
35amount of [ Sjmethionine incorporated into protein in the presence of 
these uncouplers was approx. 50% of that in cells labelled in the 
absence of uncoupler.
Several interesting conclusions can be drawn from the data in Fig. 5.2 
(a) anti-E2 serum precipitates a precursor form of E2 with value 
6000-8000 larger than the mature subunit, (b) on 10% (w/v) SDS- 
polyacrylamide gels, there is no obvious difference in the value of 
mature El and the product precipitated from cells grown in the 
presence of uncouplers by anti-El serum, (c> anti-OGDC serum fails to 
detect accumulation of pre-E2, recognising only the same component as 
El-specific serum, (d) no polypeptide corresponding to E3 is observed 
in the final immune precipitates, again reflecting the low 
immunogenicity of this species and (e) precursor forms of identical 
value are detected, regardless of the chemical nature of the uncoupler.
Fig. 5.3 demonstrates the appearance of a larger precursor of 
the El subunit (pre-El) in PK-15 cells, treated with 2,A-DNP, after 
separation from mature El on 6% (w/v) SDS-polyacrylamide gels. As 
2-oxoglutarate dehydrogenase, El, has a high intrinsic value, 103500, 
it is difficult to observe the decreased mobility of pre-El on 
standard 10% (w/v) polyacrylamide gel systems. A combination of a 
lower percentage gel and Increased distance of migration was employed 
in this experiment to achieve the necessary resolution.
A similar protocol was employed to detect the precursor forms of 
the component enzymes of OGDC in NBL-1 cells. The difference in
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FIGURE 5.4 Immunological relationship of pre-El and pre-EZ to 
the mature subunits of mammalian 2-oxoglutarate 
dehydrogenase complex.
[^ ^S]methionine-labelled cell extracts were prepared from 
PK-15 cells grown for 4h in the presence or absence of 2mM 
2,4-DNP. Immune precipitation was performed on these extracts 
before or after addition of competing levels of purified OGDC 
(lOpg) or E3 (5pg). Radiolabelled products were analysed on 6% 
(w/v) SDS-polyacrylamide gels.
Lanes 1 & 15, ^H-labelled OGDC; lanes 2-14, Immune precipitates 
of OGDC subunits and their respective precursors with the 
following antisera: mature El, anti-El serum (lane 2); as lane 2 
plus lOpg OGDC (lane 3); pre-El, anti-El serum (lane 5); as lane 
5 plus 10|ig OGDC (lane ^); lanes 6-9, as lanes 2-5 but with anti- 
OGDC serum; lanes 10-13, as lanes 2-5 with anti-E2 serum. Lane 
14, cells labelled in the presence of 2mM 2,4-DNP 
immunopreclpitated with antl-E2 serum in the presence of 5pg E3.
E l -
E 3-]
El-
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between precursor and mature forms of the OGDC subunits in this cell 
line can be seen in Table 5.1. Again the difference in between pre- 
EZ and the mature subunit is much larger than that between pre-El or 
pre-E3 and their respective mature proteins. The same pattern was 
observed in the case of PDC (Table 5.1).
5.5 PRECURSOR FORMS ARE IMMÜNOLOGICAI.I.Y RELATED TO THE MATURE 
SUBUNITS OF 2-OXOGLUTARATE DEHYDROGENASE COMPLEX
Confirmation of the identity of the immunopreclpitated mature
polypeptides and their precursor states was achieved in competition
studies, where the immunological similarity of the two forms was
revealed Fig. 5.4. Immunoprécipitations were performed from 
35( S]methionine-labelled extracts of PK-15 cells with anti-OGDC, anti-
El and anti-E2 sera to yield the expected pattern of immune
precipitation (Fig. 5.1). If non-radioactive purified OGDC (lOpg) was
added to the extracts, prior to analysis, the radiolabelled bands
corresponding to mature El and E2 were excluded from the final immune
precipitate. A similar immunological relationship was illustrated, when 
35[ S]methionine-labelled pre-El and pre-E2 also disappeared from the 
final immune complex, if immune precipitation was conducted in the 
presence of pure OGDC. This suggests strongly that the precursor forms 
of El and E2 are immunologically related to the native polypeptides.
In the case of pre-E2 which has an apparent M^ value of 54500- 
56000, almost co-migrating with E3, 54500 on SDS-polyacrylamide
gels, it was also possible to confirm that this species was not the E3 
subunit which may have been immune-precipitated by virtue of its 
association with the E2 'core* enzyme. On specific immune
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FIGURE 5.5 Purified lipoamide dehydrogenase competes with pre-E3 
in immune precipitation studies.
Anti—E3 serum was employed in immune precipitation of
35[ S]methionine-labelled extracts of PK-15 cells, grown in the 
presence or absence of 2mM 2,4-DNP (A). In addition, immune 
precipitation was performed from these extracts with anti-E3 
serum in the presence of competing amounts of purified porcine 
heart E3, OGDC or PDC purified from bovine heart or pure BCDC 
from bovine kidney (B).
3
(A) Lane 1, H-labelled OGDC; lane 2, E3 from cells grown minus 
uncoupler; lane 3, E3 from cells grown in the presence of 
uncoupler; lane 4, as lane 3 with preimmune serum.
(B) Lanes 1-5, immune precipitation of E3 from cells grown minus 
uncoupler in the presence of no competition (lane 1); 5pg 
purified E3 (lane 2); lOpg pure OGDC (lane 3); lOpg PDC (lane 4) 
and lOpg pure BCDC (lane 5); lane 6, cells grown minus uncoupler 
immune precipitated with anti-OGDC serum. Lanes 7-11, as lanes
1-5 but from cells grown in the presence of 2,4-DNP.
(A)
1 2  3 4
pr e  E5 
E5
(B)
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precipitation of pre-E2 with anti-E2, no competing effects were 
observed after addition of pure lipoamide dehydrogenase (B3) to the 
cell extracts, confirming that E3 and the higher precursor of E2 
were separate molecules of similar size which are immunologically 
distinct.
Fig. 5.5A reveals that anti-E3 serum precipitates a precursor
form of E3 with value 1000-2000 larger than the mature subunit from 
35( S]methionine-labelled detergent extracts of PK-15 cells, grown in 
the presence of 2,4-DNP. The immunological relationship of this 
precursor to the mature E3 subunit of OGDC was confirmed by 
immunocompetition studies where, addition of purified porcine heart E3 
<S^g) to the extracts, prior to immune precipitation, resulted in both 
mature (lane 2) and precursor (lane 8) forms of E3 being excluded from 
the final immune complex (Fig. 5.5B).
An interesting finding in these immunocompetition studies arose 
when competing levels of purified bovine heart OGDC and PDC (lO^g) or 
bovine kidney BCDC (lOpg) were added to the extracts before the 
addition of the anti-E3 serum. Previous immune blotting analysis had 
revealed that the antiserum did cross react with the E3 components of 
OGDC and PDC, while E3 was absent from purified BCDC (Fig. 4.9). 
Therefore it was expected that OGDC and PDC but not BCDC would compete 
with E3 in crude extracts for the antiserum and that E3 would 
therefore be absent from the final immune precipitates. As can be seen 
from Fig. 5.5B, none of the three 2-oxo acid dehydrogenase complexes 
were effective in competing out the E3 polypeptide.
This could be explained by assuming that, although bovine heart E3 
has determinants in common with porcine heart E3 (the original
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FIGURE 5.6 Precursor forms of the component enzymes of
2-oxoglutarate dehydrogenase complex can be chased to 
the mature forms on removal of uncoupler.
Cells were labelled with [^^S]methionine for 4h either in 
the presence or absence of uncoupler. After this time the cells 
were either lysed as described in section 2.2.8 a, or the 
radioactive medium was replaced with normal growth medium and the 
cells incubated for another 40 min at 37^C before extracts were 
prepared. Extracts were then incubated with antisera against 
native OGDC (A), El (B), E2 (C) or E3 (D). Immune precipitated 
material was separated on (A & C) 10% (w/v) or (B & D) 6% (w/v) 
SDS-polyacrylamide slab gels and detected by fluorography.
Lane 0, ^H-labelled OGDC. Lane S, standards. Lane 1, 4h label, 
no uncoupler; lane 2, 4h label in presence of 2mM 2,4-DNP; lane 
3, as lane 2 with 40 min chase in NGM; lane 4, 4h label in 
presence of lO^M FCCP; lane 5, as lane 4 with 40 min chase.
0 1 2 3 4 5
El
E2
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antigen), there are some determinants shared between porcine heart and 
porcine kidney E3 which are absent from the equivalent bovine heart 
enzyme. At least two pieces of evidence have been presented to 
substantiate this theory. There must be common determinants between 
the original antigen and bovine heart E3 in order to explain the cross 
reaction seen in immunoblotting analysis (Fig. 6.9). In addition, there 
must be common determinants between porcine kidney E3 and the antigen 
to account for the ability of the antisera to immunoprecipltate E3 
from PK-15 cells. If both porcine kidney and bovine heart E3 are 
present, with the latter in excess, then bovine heart E3 will compete 
for antibody raised against the determinants common to itself and the 
antigen. However, if there are additional determinants on the antigen, 
not present on bovine heart E3 but present on porcine kidney E3, then 
antibodies to these determinants would not be competed out by bovine 
heart E3 and would still be free to react with E3 of OGDC in PK-15 
cells. In this case only if OGDC, PDC and BCDC, purified from porcine 
heart, were used in the competition experiments, assuming that the same 
E3 is common to all three complexes, would efficient competition 
result.
5.6 CONVERSION OF PRECURSORS TO THE MATURE FORMS OF THE SUBUNITS OF
2-OXOGLUTARATE DEHYDROGENASE COMPLEX
Precursor forms of the component enzymes of OGDC, accumulated for 
4h in the presence of 2,4-DNP or FCCP, are rapidly processed to the 
mature form on removal of either uncoupler, indicating a reversible 
mode of action of these agents (Fig. 5.6). The conversion to 
mitochondrially located mature subunits in this 'pulse-chase'
119
FIGURE 5.7 Time-course of processing of precursors to the
component enzymes of the 2-oxoglutarate dehydrogenase 
complex.
PK—15 cells were labelled with [ ^Sjmethionine for 4h in the 
presence of 2mM 2,4-DNP. Radioactive medium was replaced with 
normal growth medium and the cells incubated for further 2-40 min 
before being lysed with detergent. Extracts were immune 
precipitated with El (A), E2 (B) or E3 (C) subunit specific 
antisera and products were analysed on (B) 10% (w/v) or (A & C)
6% (w/v) SDS-polyacrylamide slab gels.
3
Lanes 1 & 10, H-labelled OGDC; lane 2» 4h label no 2,4-WP; lanes 
3-9, 4h label chase for 0.L5, 10, 15, 25 and 40 min respectively.
(A)
-El
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procedure is monitored efficiently with the subunit specific antisera 
which are capable of immune precipitation of both precursors and 
mature enzymes. In contrast, as already seen in Fig. 5.2, the 
polyclonal serum to the native multienzyme complex fails to recognise 
E2 precursor molecules. However, after a 40min chase in the presence of 
non-radioactive methionine, it can detect the appearance of a 
component of 48500, corresponding to the processed (mature) E2 
polypeptide.
Subunit specific antisera were employed to follow the time course 
of processing on removal of 2,4-DNP (Fig. 5.7). Owing to the slight 
difference in M between the precursor and mature forms of both El and 
E3, it was difficult to find conditions which would allow separation of 
both forms when run in the same track on SDS-PAGE. Longer gels of 
lower percentage, 6% (w/v), acrylamide were run and separation of pre- 
E3 and the mature protein was achieved (Fig. 5.7C, lane 5). From this 
it can be seen that processing had begun 5 min after removal of 
uncoupler and although it is difficult to determine the exact time at 
which it was completed, all precursor had been converted to mature by 
40 min after replacement of,radioactive medium with NGM. Even under 
these conditions of longer 6% (w/v) polyacrylamide gels, pre-El and the 
mature subunit could not be easily resolved. Gels containing 6% (w/v) 
acrylamide with various degrees of crosslinking were tried with no 
further success (not shown). The band on the autoradiograph 
corresponding to El seems to migrate faster or slower depending on the 
expected relative amounts of pre-El and El present. In the initial 
stages, its mobility is similar to that of the precursor, while later 
comparison of the mobility of the band in adjacent tracks reveals that 
it describes a curve, culminating in the 40 min time point which runs
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FIGURE 5.8 Stability of precursors to component enzymes of
2-oxoglutarate dehydrogenase in porcine kidney cells 
maintained in the presence of 2mM 2,4-DNP.
PK-15 cells were labelled with (^ ^S]methionine for 4h in the
presence of 2mM 2,4-DNP. Radioactive medium was replaced by NGM
supplemented with 2raM 2,4-DNP and the cells incubated for a
further 0.5-4.5h. Cell extracts were incubated with anti-El (A),
anti-E2 (B) or anti-E3 (C) sera. Immune products were resolved on
(B) 10% (w/v) or (A & C) 6% (w/v) SDS-polyacrylamide gels which
were then processed for fluorography.
3
Lanes 1 & 8, H-labelled OGDC; lane 2, 4h label no2,/^ *iNi>; lanes
3-7, 4h label chase for 30 min, Ih, 2h, 3h and 4.5h respectively 
in the presence of 2,4-DNP.
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with the same mobility as mature El. All that can be concluded from 
these studies is that processing is complete within 60 min after 
removal of uncoupler.
In comparison the conversion of pre-E2 to its mature form is 
followed with relative ease on 10% (w/v) SDS-polyacrylamide gels. As 
time after removal of uncoupler progresses, the amount of precursor 
decreases with a parallel increase in the amount of mature protein 
(Fig. 5.7B). Determination of the initiation of processing is 
complicated by the co-precipitation of two protein bands, the higher 
of which overlaps that of the mature subunit. However, it is certainly 
well underway by 10 min and completed by 40 min after removal of 2,4- 
DNP.
5.7 STABILITY OF PRECURSOR FORMS OF THE COMPONENT ENZYMES OF
2-OXOGLUTARATE DEHYDROGENASE COMPLEX IN PORCINE KIDNEY CELLS 
MAINTAINED IN THE PRESENCE OF 2,4-DNP
In order to determine the stability of the precursor forms of the 
component enzymes of OGDC an alternative protocol to the 'pulse- 
chase' procedure was followed. [^^S)methionine-labelled precursors 
were accumulated for 4h in the presence of 2,4-DNP. Radioactive medium 
was then replaced by NGM supplemented with 2mM 2,4-DNP and the cells 
incubated for various times at 37°C (section 2.2.5 e).
In this case, since uncoupler is present throughout, no 
processing of precursor to mature forms can take place. Pre-El is seen 
to be the most stable of the three precursors (Fig. 5.8A), being 
present 4.5h after the removal of radioactive methionine. In the cases 
of pre-E2 (Pig. 5.8B) and pre-E3 (Fig. 5.8C), the precursor forms
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start to disappear 2h after addition of the non-radioactive medium and 
very little, if any, is still present after 6.5h.
5.8 LOCATION OF PRE-E2 IN THE CELL
As stated earlier (section 1.3.2), the determination of the 
intracellular site of synthesis of mitochondrial precursors is central 
to the question of how mitochondria import proteins. The majority of 
mitochondrial precursors studied to date are located in the cytosol of 
the cell.
Cells were treated with digitonin in order to prepare soluble and 
particulate fractions. Digitonin disrupts cellular membranes by 
interaction with cholesterol in these membranes. The high cholesterol 
content of the plasma membrane in comparison to the mitochondrial 
inner membrane allows conditions to be determined whereby the cells 
are lysed but mitochondria remain intact.
In order to determine the correct levels to use, cells were 
treated with various levels of digitonin (see section 2.2.8 b) and 
activities of fumarase and citrate synthase in the soluble fractions 
were assayed (see section 2.2.1). Citrate synthase is a mitochondrial 
matrix enzyme and the presence of its activity in the soluble fraction 
was an indication of mitochondrial disruption. Fumarase has a dual 
location in the cell, being present both in the cytosol and the 
mitochondrial matrix. Activity of fumarase would be expected to rise 
initially as cells are broken, then plateau as all cells are lysed but 
no mitochondria are broken i.e. cytosolic fumarase is released. A 
further increase in fumarase activity which should parallel the rise
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FIGURE 5.9 Activity of mitochondrial matrix enzymes in the
cytosol of porcine kidney cells treated with digitonin.
Soluble fractions from cells treated with 0, 0.25, 0.5, 1.0, 
2.0, 5.0 or lO.Omg/ml digitonin as described in section 2.2.8 
were assayed for fumarase (section 2.2.1 c ) citrate synthase 
(section 2.2.1 b ) and protein (section 2.2.2) Enzyme activity 
was then plotted against mg digitonin/mg protein.
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FIGURE 5.10 Reactivity of citrate synthase antiserum with
cytosolic fractions from porcine kidney cells treated 
with various levels of digitonin.
Soluble fractions were obtained from PK-15 cells treated 
with various levels of digitonin as described in section 2.2.8 
Samples of these fractions were resolved on 10% (w/v) SDS- 
polyacrylamide slab gels. One gel was stained with Coomassie blue 
to detect protein bands (A) and the polypeptides on the other gel 
were transferred to nitrocellulose and then probed with citrate 
synthase antiserum (1:100 dil.) to detect antigenic proteins (B). 
Lane 1, standards; lanes 2 & 11, 5pg pure citrate synthase; 
lane 3, PK-15 mitochondria (40pg in A; 75pg in B); lanes 6-10, 
cytosolic fractions from cells treated with 10.0, 5.0, 2.0, 1.0, 
0.5, 0.25 and Omg/ml digitonin respectively (60pg in A; 75pg in 
B).
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FIGURE 5.11 Pre-E2 is located in the cytosol of porcine kidney 
cells.
PK-15 cells labelled for 4h with [^^S]methionine in the 
presence or absence of 2mM 2,4-DNP were extracted with detergent 
as normal, or treated with O.Snig/ml digitonin to prepare 
soluble and particulate fractions. Immune precipitation was 
performed with anti-E2 serum and the products analysed on a 10% 
(w/v) SDS-polyacrylamide gel.
Lane 1, standards; lanes 2, 6 & 10, ^H-labelled OGDC. Lanes 3- 
5, PK-15 cells grown in the absence of uncoupler; lane 3, 
cell extract; lane 4, soluble fraction; lane 5, particulate 
fraction. Lanes 7-9, PK-15 cells labelled in the presence of
2,4-DNP and extracted with detergent (lane 7) or separated into 
soluble (lane 8) and mitochondrial (lane 9) fractions.
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in citrate synthase activity would indicate mitochondria were being 
disrupted.
Fig. 5.9 reveals that even at Otng digitonin/mg protein, fumarase 
activity can still be detected. This is probably due to mechanical 
breakage of the cells during the harvesting from petri-dishes and 
subsequent vortexing. Citrate synthase activity was not detected until 
digitonin levels of 0.4mg/mg protein were employed.
Soluble fractions from these digitonin-treated cells were
resolved by SDS-PAGE and probed with anti-citrate synthase antiserum
(a gift from 0. L. De Marcucci). The immunoblotting technique is
probably a more sensitive indication of the appearance of citrate
synthase i.e. disruption of mitochondria and was used to confirm
the result of Fig. 5.9 involving enzymic activity measurements. A low
level of citrate synthase activity was observed in all fractions while a
significant increase in the amount of citrate synthase present is seen
when 0.8-1.0mg digitonin/mg protein is employed (Fig. 5.10, lanes 6 &
5 respectively). It was concluded that digitonin levels of < 0.3mg/mg
protein could break open cells and keep mitochondrial disruption to a
35minimum. Digitonin levels used to treat [ Sjmethionine-labelled cells 
were 0.5mg/ml or 0.25mg/dish i.e. in the region 0.1-0.3mg 
digitonin/mg protein.
When immune precipitations were performed from whole cells,
35
soluble and particulate fractions prepared from [ S]methionine- 
labelled cells by digitonin treatment, mature E2 was found to be located 
almost exclusively in the particulate fraction (Fig. 5.11). The small 
percentage of E2 in the soluble fraction can be attributed to breakage 
or leakiness of some mitochondria. In contrast, immune precipitations 
from soluble and particulate fractions, prepared from cells labelled
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with [ S]methionlne in the presence of 2,4-DNP, revealed that pre-E2 
was located almost solely in the cytosolic fraction. A small amount of 
precursor was seen in the particulate fraction and may represent 
binding of pre—E2 to receptors on the surface of mitochondria.
On trypsin treatment of these extracts prior to immune 
precipitation, precursor present in both soluble and particulate 
fractions was digested while mature E2 in the particulate fraction was 
protected from degradation (not shown). In addition, after a chase 
period of 40 min, pre-E2 had been converted to the mature protein which 
was found in the particulate fraction (not shown).
The conclusion drawn from this result is that pre-E2 is 
synthesised in the cytoplasm. It is likely that the other precursors 
are also located in this compartment although this was not tested.
5.9 DISCUSSION
Considerable effort was expended in determining optimal 
conditions for labelling cells with (^^S]methionine and in obtaining 
reproducible immunoprecipitates of the component enzymes of OGDC with 
minimal background from contaminating polypeptides. Most of the 
protocols reported in the literature rely on detergent mixtures 
containing various combinations of SDS and Triton X-100 in which cells 
are often treated initially with hot SDS to eliminate possible 
proteolysis of precursor polypeptides (Ohashi et al., 1982; Casser, 
1983). Unfortunately, these protocols involve nuclear lysis, releasing 
DNA into the supernatant fractions, with the attendant problems of 
contamination of immune precipitates described earlier (section 5.2).
Our strategy involves initial solubilisation of cells and rapid
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removal of nuclei. Proteolysis is kept to a minimum by carrying out
o
all procedures at 4 C and by including ImM 1,10-phenanthroline, an 
inhibitor of the matrix protease responsible for maturation of 
precursors, and ImM benzamidine-HCl, a general protease inhibitor, in 
the buffers. In addition all buffers were sterilised by passage 
through Nalgene filters, pore size 0.20^m, prior to use. This reduced 
the risk of contamination of the extracts with bacterial protein or 
degradation by bacterial proteases.
The buffer system employed for these immune precipitations 
contained 1% (v/v) Triton X-100, 0.5% (w/v) SDS and 1% (w/v) DOC, and 
although the yield of precipitated antigen was lower than in other 
buffers (Fig. 4.11), the stringent washing conditions resulted in 
excellent backgrounds in control samples.
Immune precipitation of mature El and E3 revealed that in porcine 
kidney cells the apparent value of these subunits was higher than 
the corresponding bovine heart enzymes (Figs. 5.5; 5.6; 5.7 & 5.8).
Data presented here clearly demonstrated that all three enzyme 
components of OGDC were synthesised as larger precursor molecules in 
these cell lines. This contrasts with the results of Matuda &
Saheki (1982) who reported that the primary translation product of rat 
liver lipoamide dehydrogenase had the same M value as the mature E3. 
However, the authors conceded that a larger precursor could have been 
present but was not detected due to rapid degradation by endogenous 
proteases or because the size difference was so small that it could 
not be detected on 10% (w/v) polyacrylamide gels. In agreement with 
the latter point, it was difficult to differentiate between pre-E3 and 
mature E3 on 10% (w/v) gels using fluorographic analysis which is
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probably more sensitive to small differences in than the gel 
slicing technique employed by Matuda & Saheki (1982). Indeed, in a 
later paper, the same authors (Matuda ^  al^, 1983) claim that E3 of 
rat liver is initially synthesised as a precursor form which is 
approximately 3000 larger in than the mature E3. This second study 
is concerned with immune precipitation of E3 from the translation 
products of a cell-free system primed with rat liver mRNA. However 
direct comparison of mature and precursor forms of E3 on SDS- 
polyacrylamide gels was not carried out.
It is difficult to make an accurate determination of the absolute 
of pre-El and pre-E2. In the case of El this is because of the 
difficulty in determining in the region 100000-200000 by SDS-PAGE. 
Pre-E2, however, exhibits a differential mobility on 10% (w/v) and 6% 
(w/v) polyacrylamide gels. As seen in Fig. 5.2, pre-E2 appears to have 
a marginally lower mobility than mature bovine heart E3 whereas on 
6% (w/v) polyacrylamide gels, this polypeptide appears to migrate faster 
than E3.
The available evidence also suggests that the E2 precursor, at 
least, is located in the cytosol of the cell on completion of 
translation. Matuda et al. (1983) reported that E3 was synthesised on 
free ribosomes suggesting that pre-E3 would also be located in the 
cytosol.
It is fortunate that the precursor polypeptides are relatively 
stable, remaining in the cytosol for several hours if the cells are 
maintained In the presence of uncoupler. In some cases, it has been 
reported that precursor forms are degraded rapidly if normal import is 
prevented in this manner (Raymond 6 Shore, 1981).
Complete reversal of uncoupler action was achieved by incubation
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of the cells in fresh medium. Each Individual activity, synthesised
separately as an individual precursor protein, was converted to the
mature form on removal of the uncoupler. The lag phase observed before
initiation of maturation could be the time required for re-
energisation of mitochondria. A similar lag between reversal of
uncoupler action and import of protein was observed in rho yeast
35cells labelled with [ S]methionine in the presence of the uncoupler, 
carbonyl cyanide m-chlorophenylhydrazone (CCCP) (Reid & Schatz, 1982).
Two points of interest emerged in relation to the structure of 
these mitochondrial precursor molecules. It was apparent that pre-E2 
was not recognised to any significant extent by antibody to native 
OGDC. On occasions, a faint band was observed, in immune precipitations 
of cells labelled in the presence of 2,4-DNP, with approximately 
equal to E3 but it was impossible to tell whether this was small 
amounts of pre-E2 or small amounts of pre-E3 due to the relatively low 
titre of antibody to E3. The presence of pre-E2 was monitored easily 
with subunit specific antiserum, prepared against the denatured 
polypeptide. As it is a major assumption in these experiments that 
antisera raised to the mature protein will cross react with the 
precursor, it is fortunate that antiserum to denatured E2 was also 
produced.
Similar effects have been noted previously e.g. antibody to 
apocytochrome c fails to recognise the holocytochrome and vice versa 
(Hennig & Neupert, 1981). In addition, antibody to ATPase subunit IX 
exhibits only a very weak cross reaction with the precursor form of 
this protein (Schmidt et al., 1983b)
A plausible interpretation of these data is that the conformation
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of pre-E2 is so different from that of the mature form that it is 
recognised only weakly or not at all by antibody raised to the native 
E2 component of OGDC.
Recent studies on the nature of antigenic determinants in 
proteins have suggested that considerable proportions of these 
antigenic determinants are discontinuous in nature (Todd et al., 1982; 
Westhof et al., 1984). Thus, they consist of specific regions of the 
protein which exist in a defined three-dimensional conformation often 
composed of non-continuous segments of amino acid sequence in close 
proximity. In contrast, for the denatured protein, it is short regions 
of primary sequence (5—8 amino acids) which are thought to provoke the 
dominant antibody response. Such an Interpretation would account for 
our present observations, confirming that pre-E2 and mature E2 have 
many sequences in common, while existing in dissimilar conformational 
states.
Another point of interest relates to the size of the signal
sequence of pre-E2, which has an M value of 6000-8000, in comparison
T
to those of pre-El and pre-E3 which are only 1000-3000. In relation to 
this point, the signal sequence of the precursor to the lipoate 
acetyltransferase (E2) core of mammalian PDC is much larger than that 
for the other subunits (Table 5.1).
The signal sequence on E2 may not be required solely for 
targetting this polypeptide to mitochondria but, in addition, may also 
contain elements necessary to maintain the precursor in a conformation 
distinct from the mature protein, thereby preventing premature 
aggregation into the core assembly before import into the organelle.
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CHAPTER SIX
DISCUSSION
6.1 DISCUSSION
It is now clear that the limited coding potential of the 
mitochondrial genome necessitates that the vast majority of 
mitochondrial polypeptides are nuclear-coded, and must be synthesised 
on cytoplasmic ribosomes, usually as larger precursor forms 
containing an NH^-terminal extension (Hay et al., 1984). Subsequent 
uptake into the organelle is a posttranslaClonal event, which is 
dependent on the presence of an electrochemical gradient (^p^+) across 
the mitochondrial inner membrane (Gasser et al., 1982a; Schleyer 
et al., 1982). Proteolytic cleavage of these higher precursors is 
carried out by a neutral, chelator-sensitive, matrix protease (Mori 
et al., 1980; McAda & Douglas, 1982; Bohnl et al., 1983; Schmidt & 
Neupert, 1984). The final stage in the import process, following 
translocation and processing, is assembly of newly-synthesised 
polypeptides into functional units inside the mitochondrion. In 
comparison to other steps in the pathway, there have been relatively 
few reports on assembly of mitochondrial proteins into functional 
complexes. Another area of mitochondrial biogenesis where information 
is lacking is that of attachment of cofactors or prosthetic groups to 
mitochondrial proteins.
Unlike the problems of determination of sequences responsible for 
targetting proteins to mitochondria and identification of receptor 
molecules responsible for specific binding of mitochondrial 
precursors, which are probably best tackled in systems such as yeast 
using genetic manipulation and recombinant DNA technology, the 
question of cofactor attachment and assembly of multiprotein complexes 
can be addressed in mammalian cells.
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A good candidate for studies relating to these problems is the 
2-oxoglutarate dehydrogenase complex which is a mitochondrial matrix 
assembly composed of three different enzyme subunits. Five coenzymes 
and prosthetic groups are involved in the sequence of reactions 
catalysed by this multiprotein aggregate: thiamine pyrophosphate, 
lipoic acid, CoA, FAD and NAD*. A survey of the literature has 
revealed that, although the structural, functional and regulatory 
properties of this key multienzyme complex have been thoroughly 
investigated over the years (Koike & Koike, 1976; Roche & Lawlis,
1982), no detailed studies on the biogenesis, translocation and 
assembly have been performed to date. Examination of the biosynthesis 
of OGDC also has the advantage of the possibility of comparison with 
the other 2-oxo acid dehydrogenase complexes (PDC & BCDC) which 
are structurally and functionally analogous to OGDC.
Bovine heart was chosen as the source for purification of OGDC as 
a rapid procedure giving a good yield of pure enzyme had been well 
described by Stanley & Perham (1980). High titre, monospecific, 
polyclonal antisera were raised to intact, native OGDC and its component 
enzymes, 2-oxoglutarate dehydrogenase (El), lipoyl succinyltransferase 
(E2) and lipoamide dehydrogenase (E3). Specific immune precipitation, 
employing these antisera, revealed that all three subunits of OGDC were 
initially synthesised as larger precursors in PK-15 and NBL-1 
cells. These higher forms were identified in cells labelled with 
t^^SJmethionine in the presence of uncouplers of oxidative 
phosphorylation. This protocol was employed in preference to 
attempting to detect the precursor molecules in cells labelled for a 
very short time with [^^Sjmethionine. In the latter situation, there 
are problems of incorporating sufficient radioactivity into protein
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and also of short half-lives of precursor molecules in the extra- 
mitochondrial pool. In the presence of uncouplers of oxidative 
phosphorylation, the electrochemical gradient across the mitochondrial 
inner membrane is dissipated, import of proteins into the organelle is 
inhibited and therefore precursors accumulate in the cytoplasm. It is 
fortunate that the precursor forms of the component enzymes of OGDC 
are stable for several hours in cells maintained in the presence of
2,4-DNP, allowing their detection with highly specific antisera.
The presence of these precursor forms in the cytosol, several 
hours after the removal of radioactive methionine, is in agreement with 
results obtained by Fenton et al. (1984) who observed 
pre-methylmalonyl-CoA mutase in BRL cells after a 5h chase in the 
presence of 2,4-DNP. This is, however, in complete contrast to the 
results obtained for pre-carbamylphosphate synthase (Raymond & Shore, 
1981) and pre-aspartate aminotransferase (Jaussi et al., 1982). In both 
cases, when processing or translocation was blocked, the respective 
precursors disappeared within 10 min. This unequal stability of 
precursor molecules was also observed in rho mutants of cerevisiae 
(Reid & Schatz, 1982) maintained in the presence of uncoupler.
Precursor forms of both the oCand ^ subunits of F^-ATPase were found 
to be considerably more stable than the precursor of cytochrome c^. 
Therefore, there does not seem to be a proteolytic system in the 
cytosol specifically responsible for the rapid removal of excess 
amounts of accumulated precursor. The different stabilities of 
mitochondrial precursors may simply reflect differing susceptibilities 
of these molecules to endogenous cellular proteases.
The size differences between precursor and mature forms of the
131
component enzymes of OGDC fall within the range observed for 
mitochondrial precursor extension sequences of 500-10000 (Hay 
et al.» 1984). In general, the variability in size of mitochondrial 
presequences is greater than that of signal sequences of secreted 
proteins which consist of 15-30 amino acids. It could be argued that 
the larger size and greater variability of extension sequences in 
mitochondrial precursors is a result of the greater amount of 
information encoded in these sections of polypeptide chain. An example 
of this would be cytochrome b^, an intermembrane space protein in 
yeast (Daum et al., 1982), the precursor of which is 10000 larger in 
than the mature protein. The presequence of this protein must 
contain information necessary for targetting to mitochondria, and 
specifically to the intermembrane space, a stop transfer signal which 
prevents the whole protein being imported into the matrix and two 
specific proteolytic cleavage sites as this precursor is processed by 
a two-step mechanism (section 1.6.2). As previously mentioned (section 
5.9), for proteins which normally exist as highly ordered 
multimolecular aggregates, the presequence may contain information 
which prevents premature aggregation of subunits in the cytosol.
In the case of multiprotein assemblies, there is also the problem 
of co-ordinating the expression of the individual protein subunits of 
the multienzyme complex. Cell lines derived from patients with Maple 
Syrup Urine Disease were probed with antiserum raised against BCDC 
using the immunoblotting technique. The results revealed that, 
although the E2 component of BCDC was missing from the mitochondria of 
one cell line, the other enzyme subunits of this complex were present 
(Danner et al., 1985). Therefore, lack of E2 had not interfered with 
synthesis of the other enzyme -components of this complex and, as
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mature, not precursor forms were observed it would appear that 
processing also was not affected. Although the El and E3 subunits were 
present in these mitochondria, presumably they are not assembled since 
the presence of the E2 'core* would be required before this could 
occur. A similar situation was observed in immunoblotting analysis, 
employing PDC antiserum, of fibroblasts from patients with lactic 
acidosis (J. A. Hodgson, personal communication). It was obvious that 
in some of these patients the E2 component of PDC was missing, while 
in others it was either El or component X, the associated polypeptide 
of unknown function (De Marcucci & Lindsay, 1985) which was absent. In 
all cases studied, although one enzyme component of PDC was missing 
the cell extracts contained the mature forms of the other subunits. 
Whether the PDC in these cells is assembled or not remains to be 
determined. In those cell lines which lack only El or E3 it is 
possible that E2-E3 or E2-E1 subcomplexes exist.
Examination of tissue samples from a child suffering from 
persistant metabolic acidosis and having elevated blood levels of 
pyruvate, 2-oxoglutarate and branched-chain 2-oxo acids revealed 
that all tissues were defective in both PDC and OGDC activity. 
Measurement of subunit specific activities revealed a deficiency in 
E3, explaining why both PDC and OGDC activities were absent, E3 being 
common to both complexes. Activity of the El component of PDC was 
normal and the subunit activities of OGDC were not tested (Robinson 
et al., 1977).
When BCDC is induced by differentiation of 3T3-L1 fibroblasts 
into adipocytes, the proteins increase disproportionately. El is 
increased almost twenty fold, E2 six fold and E3 four fold, based on
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activity measurements (Chuang et al., 1983). Therefore, there is no 
suggestion of co-ordinate expression of the components of either PDC 
or BCDC.
The question of regulation of expression of E3 is interesting 
since this protein is involved in the structure and function of all 
three 2-oxo acid dehydrogenase complexes. One possible method for 
looking at this problem involves isolation of the genes coding for the 
component enzymes of these complexes. Analysis of sequences upstream 
from the coding regions may reveal information about control of 
expression. Also, addition of these cloned genes to cell lines 
containing mutations in one specific protein may allow the events 
involved in assembly of these multienzyme complexes to be studied. 
Indeed a cDNA clone for the transacylase component of BCDC has been 
identified (Litwer & Danner 1985).
6.2 PRELIMINARY STUDIES OH THE ASSEMBLY OF THE 2-OXOGLUTARATE
DEHYDROGENASE COMPLEX
With the development of conditions for accumulation of 
precursors in the cytosol and subsequent import and processing of 
these proteins on removal of uncouplers, the problem of assembly was 
ready to be addressed. The E2 'core' of OGDC is a highly-ordered 
aggregate of 24 E2 subunits with a total M^ of approximately 1 x 10^. 
It is, therefore, unlikely that such a structure would be assembled 
prior to import into mitochondria. The form of pre-E2 accumulated in 
the cytosol of cells labelled with )methionine in the presence of
uncouplers was investigated by passing either total homogenates of 
cells or a post-mitochondrial fraction down various gel filtration
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columns prior to immune precipitation with anti-E2 serum. Samples for
gel filtration were prepared in the absence of detergents, in case the
detergents altered the mobility of precursors on these columns.
However, before immune precipitation, the detergent concentration in
the buffer was adjusted to equal that of 3D-TKM. The main problem in
these experiments was dilution of the sample. Two petri-dishes of 
35( S]methionine-labelled cell extract was loaded onto the columns.
On elution, the peak fractions contained 2-5 x 10^ c.p.m.. In Immune 
precipitation from detergent extracts of whole cells antisera was 
added to aliquots of extract containing 10-20 x 10^ c.p.m.. This 
generally gave sufficient [ ]methionine-labelled protein in the 
immune complex to allow detection after SDS-PAGE and fluorographic 
analysis. From 2-5 x 10^ c.p.m., there was too little radiolabelled 
precursor in the products of immune precipitation to permit 
visualisation and, of course, pre-E2 may not be located in the peak 
fractions. Immune precipitates from these column fractions were also 
more susceptible to contamination than normal. Attempting to load more 
c.p.m. onto the columns initially would not only be expensive, but may 
create problems, such as poor resolution, associated with loading 
increased volumes and too much protein onto gel filtration columns.
In the literature protocols involving gel filtration prior to 
immune precipitation employ in vitro translation products as starting 
material (Zimmermann & Neupert, 1980a; Miura et al., 1981; Ono et al., 
1985). In this way proteins are labelled to a higher specific activity 
initially.
Attempts to immunoprecipitate pre-E2 from primary translation 
products of rat liver mRNA (a gift from G.H.D. Clarkson) failed to 
reveal the expected product, which probably reflects the poor cross
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reactivity of antisera raised to bovine heart proteins with the
corresponding enzymes from rat liver. In vitro translation of bovine
heart mRNA (a gift from G.H.D. Clarkson) did not give as high
35
incorporation of [ S]methionine as rat liver mRNA. Immune
precipitation was attempted from these ^  vitro translation products
(0.5 X 10^) using anti-E2 serum. After exposing the dried gel to film
for one month a faint band of equivalent to pre-E2 was observed. A
further purification of mRNA from bovine heart was tried using the
guanidinium thiocyanate procedure of Chirguin et al. (1979) to
35
determine whether incorporation of I S]methionine into protein was 
improved by using freshly-made mRNA. This proved not to be so and 
subsequent immune precipitation from this translation was heavily 
contaminated with many protein bands of high and low values. The 
same protein bands were present in immune precipitations from 
translation products from bovine heart mRNA and from the control, 
globin mRNA, suggesting a problem in the methodology. In the first 
immune precipitation from an in vitro translation mix, ribosomes were 
removed by centrifugation prior to the addition of antisera. This step 
was omitted in immune precipitation from the products of in vitro 
translation directed by the second batch of bovine heart mRNA and it 
now appears to be necessary to reduce the level of background in 
immune precipitations.
6.3 FUTURE WORK
In order to be able to carry out studies on assembly it will be 
necessary to purify mRNA from a suitable source and define optimal 
conditions for translation followed by immune precipitation. It will
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also be necessary to determine maximal conditions for immune 
precipitation of native OGDC in order to have conditions where subunit 
interactions are preserved and under which the order of assembly can 
be examined. The 3D-TKM buffer system will be unsuitable for studies 
on assembly since it causes dissociation of OGDC. Possibly, in immune 
precipitation from in vitro translation products, less stringent 
conditions may be required, under which immune precipitates are free 
from contaminating polypeptides, but subunit interactions are 
preserved. Certainly the problem of nuclear lysis will not apply.
The question of cofactor addition to the component enzymes of 
OGDC was not addressed at all. It may be possible to study this by 
immune precipitation from cells labelled, in the presence of 
uncouplers, with a radioactive derivative of the coenzyme or 
prosthetic group e.g. [^^S]lipoic acid. If coenzyme attachment occurs 
inside the mitochondrion, it may be possible to examine whether it is 
inserted before or after processing, by immune precipitation from 
cells labelled with radiolabelled coenzyme, in the presence of 1,10- 
phenanthroline, which would allow import of the precursor into the 
mitochondrion but prevent processing by inhibiting the matrix 
protease. Metabolism of the cofactor would have to be taken into 
account before these types of experiments were carried out.
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